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ABSTRACT
Age-related Macular Degeneration (AMD) is a degenerative disorder that accounts for 
about 50% o f blindness in England and Wales. At present there is no effective treatment. It 
occurs in genetically susceptible individuals exposed to environmental factors such as 
smoking but so far specific factors remain to be identified.
For this descriptive study, 879 patients with Age-Related Maculopathy (ARM) and AMD 
and 44 spouses with normal maculae, to act as a comparison group, were recruited from a 
tertiary referral centre. The clinical phenotypes were analysed from fundus photographs, 
fluorescein angiography and autofluorescence (AF) images. Fundus features were 
characterised as they are thought to reflect the genes conferring risk in an individual and 
may allow greater understanding o f disease mechanisms.
These data demonstrated (1) A revised grading system shown to be reproducible for use 
with digital images (2) A moderate concordance rate for phenotype between eyes with end- 
stage AMD (kappa statistic=0.48; 95% Cl = 0.38-0.57, p<0.001). (3) Distinct 
characteristics, including a larger area and higher counts o f soft drusen with focal areas o f 
increased AF, in fellow eyes o f those with unilateral visual loss due to geographic atrophy 
(GA). (4) An increased susceptibility o f the inferotemporal macula to GA. (5) Preserved 
integrity o f the retinal pigment epithelium (RPE) in the initial stages o f CNV development 
as identified from AF images. (6) Loss o f scotopic rather than photopic function over areas 
o f increased AF, as determined by fine matrix mapping, indicating the preferential 
vulnerability o f rods. (7) No difference in smoking history between those with neovascular 
compared to non-neovascular AMD.
Although AMD has been extensively investigated, this study extends our knowledge o f 
retinal AF, the relative susceptibility o f rods compared to cones at the macula and suggests 
both eyes o f an individual are more discordant for late stages o f AMD compared to drusen.
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1 Introduction & Background
1.1 What is age-related macular degeneration?
Age-related macular degeneration (AMD) has been divided into early disease termed age- 
related maculopathy (ARM) that has little effect on vision, and late disease termed age- 
related macular disease (AMD) which is a degenerative disorder causing significant visual 
impairment, which is more frequent after the age o f 65 years.
ARM is defined clinically by areas o f drusen deposit that can either be hard and small, soft 
and intermediate or large (see figures la-c [page 11]) and / or areas o f hyperpigmentation 
(in the outer retina or choroid) or hypopigmentation o f the retinal pigment epithelium 
(RPE),). The presence of soft drusen alone is sufficient for the diagnosis o f ARM whereas 
small hard drusen do not themselves characterize the disorder (Bird, A. C. et al; 1995).
In the later stages, AMD affects several layers o f the central retina including the RPE, the 
photoreceptor cell layer and the choriocapillaris (Green, W. R.; 1999),(Bird, A. C. et al; 
1995) causing visual impairment. The lesions causing visual loss, namely choroidal 
neovascularisation (CNV) (see figure Id), pigment epithelial detachment (PED) (see figure 
1 e) and geographic atrophy (GA) (see figure 1 f) appear to occur as a reaction to ARM. 
AMD causes loss of central vision in patients but peripheral visual field is predominantly 
left intact.
More recently, additional phenotypes of macular disease in the elderly have been 
characterised, including retinal angiomatous proliferation (RAP) and idiopathic polypoidal 
choroidal vasculopathy (IPCV). RAP occurs on a background of ARM and involves 
invasion o f the outer retina by retinal blood vessels and may precede or occur 
simultaneously with CNV (Yannuzzi, L. A. et al; 2001). Idiopathic PCV was a term coined 
in 1990 by Yannuzzi, but the condition was originally described as lesions occurring in the 
peripapillary region in African women (Stem, R. M. et al; 1985).
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Figure 1
Fundus photographs dem onstrating (a) small hard drusen only (<63pm )- classified as the com parison 
group(b) interm ediate sized soft drusen (125-250pm ) (c) interm ediate and large soft drusen (125-500pm ) (d) 
a choroidal neovascular lesion with subretinal scar and exudates (e) a pigm ent epithelial detachm ent with 
dom e like elevation o f  the RPE (f) m ultiple areas o f  geographic atrophy
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Since then, a macular variant of IPCV has been described (Yannuzzi, L. A. et al\ 1990) 
involving polypoidal dilatations arising from the choroidal vascular network but its 
relevance to ARM is unknown.
The importance of AMD is underlined by the fact that it accounts for about 50% of blind or 
partially sighted registrations in England & Wales (Evans, J.; 1995) and with the population 
over the age of 60 set to increase by 45% in the next 20-25 years, this will represent a huge 
burden on the National Health and Social Services (RCO; 2000)(Royal College guidelines). 
In addition the prevalence of AMD appears to be increasing at a rate that is not fully 
explained by the ageing population (Evans, J. et al\ 1996) and occurring at an earlier age 
than before causing further increases to public health costs.
There is currently no treatment that will have an influence on blindness from AMD in the 
community, and the results of treatments (i.e. submacular surgery, argon laser, 
radiotherapy, photodynamic therapy) over the years have been disappointing. Although 
the prognosis will be affected in some cases, treatment serves only to reduce the magnitude 
o f visual loss; gain of visual acuity rarely occurs. This has stimulated research into the 
fundamental causes of the disorder in the hope that new therapeutic approaches will 
emerge. It is believed that AMD occurs in those with a genetic predisposition and becomes 
evident with appropriate environmental pressures. Environmental factors have been sought 
and attempts have been made to identify those genes involved. Alongside this, efforts have 
been made to determine the intermediate disease mechanisms.
Page 12
Detailed Clinical Phenotyping of Age-Related M acular Degeneration
Dr S Dandekar
1.2 Physiology of the tissues involved and mechanisms of 
disease
1.2.1 Normal macula
The macula is anatomically defined as the area within the arcades centred on the foveola in 
which the ganglion cell layer is more than one cell in thickness. It has an approximate 
diameter o f 5.5mm (Hogan, M. J. et al; 1971).
1.2.2 The ageing macula
Ageing is the single most important risk factor for retinal disease in the Western World 
(Ganley and Roberts 1983). The mechanisms underlying these retinopathies are not 
understood, but it is believed that changes in the retinal pigment epithelium (RPE) and 
Bruch’s membrane play a vital role in degenerative changes in the adjacent photoreceptors, 
neural retina and the supporting choroid (Hogan, M. J.; 1972).
1.2.2.1 Ageing o f the photoreceptors
The outer segments o f the photoreceptors are constantly being renewed with the distal disc 
membranes being shed each day. Thirty to fifty photoreceptors are apposed to each RPE 
cell, and it is within the RPE cell that phagocytosis, fusion of lysosomes to form 
phagolysosomes and digestion o f the outer segments occurs (Feeney L 1976 Exp Eye Res). 
Much o f the degraded material is then recycled to provide the substrate for formation of 
new outer segment membranes. There is good evidence to suggest that the RPE discharges 
cytoplasmic material into the inner portion o f Bruch’s membrane (Feeney-Bums, L. et al; 
1980). This material is believed to consist of degradation products from rod outer segment 
(ROS) renewal however, neither rhodopsin sequences nor phagosomal enzyme activity 
have been shown in Bruch’s membrane using monoclonal antibodies (Feeney-Bums, L. et 
al; 1988). An explanation for this was that superficial hydrophilic antigen binding sites on 
the molecules for which the antibodies were specific had been altered or destroyed by
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lysosomal enzyme digestion within the phagolysosomal system of the RPE, prior to the 
formation o f definitive lipofuscin granules. The authors concluded that these monoclonal 
antibodies are of limited value in studying degradation products from rod outer segment 
renewal (Feeney-Bums, L. et al; 1988).
With age, human rods and cones appear to undergo degeneration and distortion o f the outer 
segments (Curcio, C. A. et al; 1996; Grindle, C. F. et al; 1978). Histological studies have 
shown a selective vulnerability o f rods compared to cones. In maculae of older adults 
lacking visible drusen and pigmentary change (i.e., they do not have ARM), the number of 
cones appears to remain stable, but the number o f rods decreases by up to 30% and the 
greatest loss occurs in the parafoveal area (Curcio, C. A. et al; 1993).
There is also suggestive evidence that rod and cone photopigments regenerate by different 
mechanisms. In frog retinas separated from the RPE, cone opsin, but not rhodopsin, 
regenerates spontaneously (Goldstein, E. B. et al; 1973; Hood, D. C. et al; 1973). Mata and 
co-workers very recently found several catalytic steps of an alternate visual cycle that 
mediates pigment regeneration in cones. This alternate pigment regeneration is independent 
o f the RPE and may involve Muller cells (Mata, N. L. et al; 2002). This implies that visual- 
pigment regeneration in cones is not exclusively dependent on RPE function as it is in rods.
Throughout life, oxidative damage to the photoreceptor outer segments is thought to occur 
as a result o f light energy allowing the formation o f singlet oxygen free radicals. The outer 
segments are particularly vulnerable to oxidative damage as they are rich in 
polyunsaturated fatty acids (Kennedy et al 1995, Katz 1978) and dissolved oxygen is 
concentrated in the fatty acid layer. These oxidative changes may make the outer segments 
more resistant to degradation by the RPE cell.
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1.2.2.2 Ageing o f the retinal pigment epithelium (RPE)
The adult RPE is a non-dividing system that sustains a number of functions essential for the 
preservation of photoreceptor cells (Boulton 2001). It is composed of a single layer of 
hexano-cuboidal epithelial cells positioned between the neural retina and the choroid. Its 
predominant roles include:
• Regulation of the transport of nutrients and waste products to and from the retina
through the expression and activity o f specific proteins.
• Phagocytosis and degradation of photoreceptor outer segments (approx a million 
rod discs per RPE cell per year (Grindle, C. F. et al; 1978).
• Protection against free radical damage induced by high oxygen levels and light 
irradiation and absorption o f unused optical radiation that has passed through the 
neural retina.
• Storage o f Vitamin A and its conversion to a form that can be utilised by the 
photoreceptors for the synthesis o f rhodopsin (Hogan, M. J.; 1972).
• Production of growth factors that influence the function o f neighbouring tissues.
• Ionic homeostasis of the outer retinal extracellular space
Given the high metabolic load placed on the RPE, it is not surprising that this tissue
consistently undergoes ageing changes.
It is the phagocytosis and degradation o f photoreceptor outer segments that is responsible 
for the formation of the compound, lipofuscin. The accumulation of this autofluorescent 
compound is one o f the most pronounced changes to occur with ageing in the RPE (Wing, 
G. L. et al; 1978) and is at least partly responsible for the subsequent pleomorphic changes, 
loss o f intact melanin granules, significant metabolic changes and cell loss that occurs 
(Boulton, M. et al; 2001).
It is lipofuscin accumulation that is believed to contribute to the pathogenesis o f age-related 
macular degeneration as photoreceptor loss has been directly correlated with lipofuscin 
concentration in the opposing RPE (Dorey, C. K. et al; 1989).
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1.2.2.2.1 Lipofuscin
Lipofuscin is a heterogeneous material made up o f lipids, proteins and fluorescent 
compounds that accumulate within the human RPE as yellow-brown refractile granules 
(Feeney-Bums 1980, Kennedy C 1995, Eldred 1988 Exp Eye Res). It characteristically 
fluoresces maximally with short wavelength light excitation (Feeney, L.; 1978) increasing 
in intensity with age (Boulton, M. et al; 1990; Okubo, A. et al; 1999). When age is plotted 
against RPE residual body content or RPE autofluorescence, a quadratic relationship is 
obtained. The greatest accumulation o f RPE auto fluorescence occurs in the first few 
decades o f life and reaches a plateau by the eighth to ninth decade. This can be explained 
by the fact that lipofuscin has a finite half-life (Delori, F. C. et al; 1995a) and photoreceptor 
population decreases after the sixth decade (Curcio, C. A. et al; 1993).
1.2.2.2.2 Origin o f lipofuscin
Substantial evidence now supports the proposal that lipofuscin is derived from 
photoreceptor outer segment contents. After phagocytosis and digestion by lysosomal 
enzymes including Cathepsin D (Feeney-Bums 1984 IOVS), the resulting compounds are 
able to diffuse out of the phagolysosome into the cytoplasm (Feeney-Bums L 1983). The 
degradative process however is incomplete (see figure 2-[pagel7]), resulting in residual 
bodies seen on electron microscopy as electron dense inclusions containing lipofuscin 
granules within the RPE (Katz, M. L. et al; 1982).
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Figure 2: Diagram showing origin of lipofuscin in RPE cell. Modified from Kennedy et al 1995.
Further evidence comes from experimental rats with retinae lacking photoreceptors due to 
light damage or a genetic defect that show less residual body accumulation (Katz et al 
1986, 1989) (Boulton 1986). Additionally RPE cells cultured without exposure to 
photoreceptor outer segments accumulate very little lipofuscin (Boulton et al 1989), but if 
these cells are allowed to phagocytose exogenously added outer segments, they quickly 
accumulate large amounts of lipofuscin (Boulton et al 1989).
It was previously believed that the lipofuscin-containing residual bodies were 
undegradeable and therefore accumulated over time. Katz however, demonstrated that if 
albino rats were given intravitreal injections of the protease inhibitor leupeptin (which 
blocks the degradation o f outer segment proteins), there was a rapid accumulation o f 
lipofuscin-like inclusions within the RPE (Katz, M. L. et al\ 1999). Twelve weeks 
following the injection, the amounts o f inclusion material and fluorescence returned to 
normal levels. This suggested that the age-related increase in RPE lipofuscin results from 
an imbalance in the rates of lipofuscin formation and disposal rather than an absence o f a 
disposal mechanism (Katz, M. L. et al\ 1999).
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1.2.2.2.3 Composition o f lipofuscin
Lipofuscin is a mixture of several distinct fluorescent components and may contain up to 
ten different fluorophores (Eldred, G. E. et al\ 1988). Among the likely candidates for 
conversion into these fluorophores are vitamin A compounds, which are present in the 
retina and RPE in high concentrations. Dietary deficiency of retinoid precursors (vitamin A 
palmitate) have been shown to eliminate the orange emitting fluorophore of lipofuscin and 
reduce the number of lipofuscin granules in rats (Katz, M. L. et al; 1986).
An important component of lipofuscin is the fluorophore known as A2E, (N-retinylidene- 
N-retinylethanolamine) a pyridinium bisretinoid, which is formed in the photoreceptor 
outer segment membrane from sequential reactions o f ‘phosphatidylethanolamine’ and 
‘retinal’ to produce the phosphatidylethanolamine-bisretinoid A2-PE; subsequent 
hydrolysis releases the fluorophore A2E (Liu, J. et al; 2000).
1.2.2.2.4 Toxicity o f lipofuscin
The concept that excessive lipofuscin can be harmful is supported by observations in 
Stargardt macular dystrophy (Allikmets, R. et al; 1997) and other inherited dystrophies 
such as Best vitelliform macular dystrophy (Kramer, F. et al; 2000). Lipofuscin levels in 
these patients were found to be significantly higher than those in normal subjects o f the 
same age (Delori, F. C. et al; 1995b),(von Ruckmann, A. et al; 1997b). Histological studies 
have also shown that lipofuscin concentration directly correlates with photoreceptor cell 
loss in humans (Dorey, C. K. et al; 1989).
Excessive levels o f lipofuscin have been postulated to compromise essential RPE functions 
by various mechanisms (Feeney-Bums, L. et al; 1984; Schutt, F. et al; 2000). Firstly it acts 
as a photosensitiser in blue light, generating free radicals within the RPE cell 
(Boulton,M;1990). Secondly the fluorophore, A2E, has surfactant like properties causing 
disintegration of the lysosomal membrane resulting in a rise in the pH which would disable 
the lysosomal enzymes (Schutt, F. et al; 2002). Thirdly, A2E it is believed to be toxic to 
mitochondria by releasing cytochrome C and AIF (apoptosis-inducing factor), which 
initiates apoptosis (Sparrow, J. R. et al; 2000; Suter, M. et al; 2000). Fourthly, there may be
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a mechanical effect caused by the inclusion bodies engorging the cells with non-functional 
waste that may damage cellular architecture particularly the smooth endoplasmic reticulum 
(SER) and finally, there may be a reduction in the recycled material needed for synthesis of 
photoreceptor outer segments (Okubo, A. et al; 2000).
Okubo et al also showed widespread structural changes in the outer retina following 
repeated injections of the lysosomal protease inhibitor E-64 into the vitreous o f Sprague 
Dawley rats (Okubo, A. et al; 2000). Progressive accumulation o f A2-E occurred within the 
RPE followed by loss of SER, shortening and loss of photoreceptor outer segments, 
alteration of choroidal capillaries and invasion of Bruch’s membrane by fibroblasts and 
pericytes. She postulated that the high levels were witness to lack o f avaliable catabolites 
that are recycled to provide the substrate for photoreceptor outer segment renewal.
It is hoped that increased knowledge o f in vivo lipofuscin accumulation, which is now 
possible with the advent of autofluorescence imaging (Delori, F. C. et al; 1995a; von 
Ruckmann, A. et al; 1997a), may give important clues as to the pathogenesis and progress 
o f ageing in the human eye, especially at the macula.
1.2.2.3 Ageing o f Bruch’s membrane
Bruch’s membrane undergoes progressive thickening and hyalinisation with an increase in 
basophilia and periodic acid -Schiff (PAS) staining throughout life (Hogan, M. J. et al;
1967; Pauleikhoff, D. et al; 1990c; Sarks, S. H.; 1976). Electron microscopy has also 
shown changes in the collagen and elastic fibres o f the membrane with increased 
calcification (Grindle, C. F. et al; 1978; Hogan, M. J. et al; 1967).
Unlike RPE changes, the thickening o f Bruch’s membrane with age is linear and is thought 
to be due to accumulation of waste material (Okubo, A. et al; 1999). These changes are 
recognised clinically as drusen when the deposits are focal. The thickness would be 
influenced by the rate o f deposition and the rate o f clearance. This material is thought to be 
cytoplasmic in origin. It is thought that the RPE discharges material into the inner portion
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of Bruch’s membrane to achieve cytoplasmic renewal, an attribute of non-dividing cells 
that are metabolically active. It is thought ultimately to be cleared by the choroid although 
this process is poorly understood (Feeney-Bums, L. et al; 1980; Sheraidah, G. et al; 1993). 
Since the thickening of Bruch’s membrane cannot be fully explained by ageing alone, other 
factors must play a role (correlation between age and Bruch’s membrane thickness; R2 = 
0.57) (Okubo, A. et al; 1999).
Lipid content in Bruch’s membrane, especially the accumulation o f neutral lipids and 
phospholipids (Holz, F. G. et al; 1994a; Sheraidah, G. et al; 1993) has been shown to 
increase with age. Experiments using material extracted from Bruch’s membrane in donor 
eyes using lipid solvents and then analysed using thin-layer and gas chromatography have 
confirmed this (Sheraidah, G. et al; 1993). A second series of specimens, where the 
pigment epithelium was removed and then analysed, gave similar results confirming that 
the lipids were from Bruch’s membrane (Sheraidah, G. et al; 1993). Subsequent studies 
then confirmed a reduction in the hydraulic conductivity of the layer primarily due to this 
accumulation o f lipid (Fisher, R. F.; 1987; Moore, D. J. et al; 1995).
All the above changes are associated with progressive disruption o f Bruch’s membrane and 
believed to contribute to a decrease in the exchange efficiency between the choriocapillaris 
and pigment epithelium.
Okubo studied the relationship between ageing in Bruch’s membrane and that o f the retinal 
pigment epithelium. Changes in both layers increased with age and although there was a 
linear relationship between the two, giving strength to the belief that the deposits in Bruch’s 
membrane are derived from the RPE, there was considerable variation within each age 
group and between specimens. The R2 correlation was 0.18 to 0.37 using electron and light 
microscopy respectively implying that only a small proportion of thickness o f Bruch’s 
membrane can be explained by increase in RPE residual bodies or autofluorescence 
(Okubo, A. et al; 1999).
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1.2.2.4 Ageing o f  the choriocapillaris
Thickening o f the intercapillary pillars and dropout o f the choriocapillaris are seen 
histologically with age and in AMD (Lutty, G. et a l:; 1999; Sarks, S. H.; 1976). The 
subsequent reduced blood flow to the choriocapillaris has been associated with the 
appearance of filling defects on ICG angiography (Lutty, G. et al; 1999), and has been 
implicated as a pathogenetic factor in choroidal neovascularisation via angiogenic factor 
release induced by hypoxia (Mori, F.; 2003). The structure of the blood vessels has also 
been described to change from a sinusoidal system to become more tubular with age 
(Olver, J. M.; 1990).
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1.2.3 Pathological consequences o f the ageing process
1.2.3.1 Mechanism o f drusen formation
Drusen are thought to be the clinically recognisable discrete deposits seen histologically on 
the inner surface o f Bruch’s membrane. They can be focal and nodular or more diffuse in 
nature.
The origin o f drusen has been disputed. Two theories referred to by Coats in 1905 as the 
‘transformation’ and ‘deposition’ theory of drusen biogenesis may both play some role 
(Hageman, G. S. et al\ 2001). The former involved the transformation of degenerating RPE 
cells into drusen and the latter proposed that drusen result from the secretion o f abnormal 
material derived from RPE or photoreceptors into Bruch’s membrane (Hageman, G. S. et 
al; 2001). It is also thought that inflammatory components are important in the 
development of drusen (Hageman, G. S. et al; 2001). Complement components and 
fibrinogen, thrombin and acute phase proteins such as vitronectin have all been found to be 
contained within drusen but their role in the pathogenesis of AMD is unclear. Degenerating 
RPE cells and debris trapped between the RPE monolayer and Bruch’s membrane may act 
as a chronic inflammatory stimulus and target for complement attack (Hageman, G. S. et al; 
2001). Recent evidence suggests that a polymorphism in the CFH (complement factor H) 
gene may be an important factor in AMD susceptibility (Klein, R. J. et al; 2005)(see page 
51).
Various studies have confirmed the presence o f lipids and proteins in drusen. Pauleikhoff 
and colleagues showed a correlation between the lipid biochemical composition and 
fluorescein binding properties of drusen. Other studies have identified several proteins that 
are believed to undergo oxidative modifications (i.e. TIMP 3, clusterin and vitronectin) and 
may play a role in drusen formation (Crabb, J. W. et al; 2002).
While focal thickening o f Bruch’s membrane can be seen clinically, diffuse thickening is 
not visible on biomicroscopy. It has been postulated that “prolonged choroidal filling” on
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fluorescein angiography (Pauleikhoff, D. et al; 1990b) may be a consequence o f this diffuse 
thickening. Similar changes in Bruch’s membrane are known to occur in Sorsby fundus 
dystrophy due to mutations in TIMP-3 and are also associated with prolonged choroidal 
filling (Capon, M. R. et al; 1989; Polkinghome, P. J. et al; 1989). In AMD, it is eyes with 
patchy choroidal fluorescence in the transit phase of the angiogram that tend to have fewer, 
central drusen and are hypothesised to have diffuse changes in Bruch’s membrane 
(Pauleikhoff, D. et al; 1990c; Piguet, B. et al; 1992). This may hamper diffusion between 
the choriocapillaris and retinal pigment epithelium and cause secondary changes to occur in 
the choroidal capillaries. Further, scotopic threshold studies using the Humphrey automated 
perimeter and fine matrix mapping showed up to 3.4 log units of scotopic threshold 
elevation in areas o f choroidal perfusion abnormality. It has been postulated that diffuse 
deposits in Bruch’s membrane might account for both the perfusion abnormality and the 
functional loss seen (Chen, J. C. et al; 1992). Slow choroidal filling, caused by diffuse 
deposits therefore represent a risk factor for pigment epithelial detachment or choroidal 
neovascularisation in AMD.
1.2.3.2 Mechanism o f pigment epithelial detachments (PED)
The theory that the sub-retinal pigment epithelial fluid in a PED is derived from the active 
outward movement o f water from the RPE rather than from the choroid was introduced in 
1986 (Bird, A. C. et a l; 1986; Holz, F. G. et al; 2004). It was proposed that a reduction in 
the hydraulic conductivity of Bruch’s membrane would cause increased resistance to water 
flow towards the choroid, thus causing it to accumulate in the sub-retinal pigment epithelial 
space. As stated above, Bruch’s membrane increases in thickness with age (Green, W. R. 
et al; 1977) and subsequent studies have confirmed a reduction in the hydraulic 
conductivity o f the layer (Fisher, R. F.; 1987; Moore, D. J. et al; 1995) primarily due to the 
progressive accumulation o f neutral lipids (Holz, F. G. et al; 1994a; Sheraidah, G. et al; 
1993). This would subsequently increase the hydrophobicity of Bruch’s membrane causing 
the development of a pigment epithelial detachment (Bird, A. C. et al; 1986). Clinical 
observations by Pauleikhoff and colleagues are in accordance with this hypothesis as they 
have shown that drusen in the fellow eyes o f those with PED are more densely packed,
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larger and less fluorescent on fluorescein angiography implying that they are hydrophobic 
due to the presence o f neutral lipid (Pauleikhoff, D. et al; 1990a).
1.2.3.3 Mechanism o f choroidal neovascularisation and angiogenesis
In choroidal neovascularisation (CNV), blood vessels derived from the choroid extend 
through Bruch’s membrane and into the sub-RPE space (Green, W. R. et al; 1993) usually 
in association with diffuse or focal drusen. This process may also be associated with a 
cellular breakdown o f Bruch’s membrane with the presence of multinucleated giant cells 
(Penfold, P. L. et al; 1987) or the stimulation o f blood vessel growth by macrophages on 
the inner surface o f Bruch’s membrane (Sarks 1976). The current theory however is that 
CNV is likely to occur in response to the release of an angiogenic stimulus. Evidence that 
the RPE may produce this stimulus comes from work by Uyama and colleagues 
(Yamagishi, K. et al; 1988) where sodium iodate (NalCb) was used to damage RPE cells in 
primates while inducing CNV with photocoagulation. Viable RPE was required at least 
initially to allow induction of new vessel growth.
Vascular endothelial growth factor (VEGF) is believed to be the predominant stimulus to 
new vessel growth in retinal disorders including diabetes, retinopathy o f prematurity and 
central retinal vein occlusion. It has been proposed that it is produced in response to 
hypoxia or ischaemia. Although other growth factors such as basic fibroblast growth factor 
(bFGF)(Ogata, N. et al; 1996) and transforming growth factor -  beta (TGF-(3) (Ogata, N. et 
al; 1997) have been suggested to promote the development of CNV, increasing evidence 
suggests that VEGF is the most likely candidate (Schwesinger, C. et al; 2001; Wada, M. et 
al; 1999; Wells, J. A. et al; 1996) even though CNV is not obviously an ischaemic-driven 
process. Wells et al demonstrated that vitreous levels o f VEGF are significantly elevated in 
those eyes with subretinal neovascularisation (Wells, J. A. etal; 1996). Intrachoroidal 
neovascularisation has been shown to occur in transgenic mice over-expressing VEGF in 
the RPE (Schwesinger, C. et al; 2001). Similarly, CNV has been induced in rats when an 
adeno-associated viral vector encoding human VEGF 165 has been injected into the 
subretinal space (Wang, F. et al; 2003). Additionally, both VEGF and VEGF receptor
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mRNA expression has been localised to retinal pigment epithelial cells and endothelial cells 
by in situ hybridisation techniques within experimentally induced CNV (Wada, M. et al; 
1999).
Further studies have shown that there is likely to be an imbalance of growth factors 
operating in the development of CNV, namely VEGF stimulating growth and PEDF 
(pigment epithelium -derived factor) suppressing growth (Ohno-Matsui, K. et al; 2001). 
PEDF is a dual function protein which acts as a neurotrophic factor promoting the survival 
o f photoreceptors (Cayouette, M. et al; 1999), and is also a potent inhibitor o f angiogenesis 
(Dawson, D. W. et al; 1999). It is thought to act directly on endothelial cells, halting the 
formation o f new vessels by inducing the apoptotic death of endothelial cells that have been 
stimulated to form new vessels (Stellmach 2001} (Mori, K. et al; 2002). Work on vitreous 
samples o f patients with CNV due to AMD has shown deficient levels of PEDF 
(Holekamp, N. M. et al; 2002). Additionally in the presence o f oxidative stress in vitro, 
PEDF levels were shown to decrease and disrupt the balance, promoting angiogenesis 
(Ohno-Matsui, K. et al; 2001). Others have also shown that increased expression o f PEDF 
in the eye reduces the amount of ocular neovascularisation in mice and in a model o f laser 
induced CNV (Mori, K. et al; 2001).
In addition to VEGF and PEDF, recent results have implicated angiopoietins 1 and 2 (ang 
1 &2) to play a role in CNV formation. Ang 1 promotes vascular integrity and maturation 
and inhibits apoptosis and ang 2 is an antagonist o f ang 1 and promotes VEGF-induced 
angiogenesis. These factors may also be modulated by VEGF (Hangai, M. et al; 2001;
Holz, F. G. et al; 2004).
Observations that up-regulation and suppression o f growth factors are able to influence the 
behaviour of endothelial cells in vitro and inhibit new vessels in vivo support the belief that 
these may lead to alternative and more selective treatment strategies in the coming years.
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1.2.3.4 Mechanisms o f geographic atrophy
It was Blair in 1975 who described geographic atrophy (GA) of the RPE as a separate 
disease entity secondary to macular degeneration (Blair, C. J.; 1975). It is defined as a 
discrete area of retinal depigmentation >175 pm, characterised by a sharp border and the 
presence of visible choroidal vessels at the posterior pole (Bird, A. C. et al; 1995). 
Histologically, this represents RPE cell degeneration with accumulating lipofuscin granules 
which aggregate as clumps. The overlying photoreceptors also degenerate becoming 
grossly abnormal with shortened inner segments and fragmented outer segments. Bruch’s 
membrane becomes hyalinised and there is a variable degree o f choroidal atrophy and 
partial obliteration of capillaries by fibrous tissue (Sarks, J. P. et al; 1988; Sarks, S. H.; 
1976).
One o f the explanations for the focal nature o f the atrophic process, has been ascribed to the 
lobular microvascular anatomy o f the choriocapillaris. It was thought that closure or 
sclerosis o f the underlying choriocapillaris lobule could result in focal atrophic areas o f the 
RPE. Both the lobules and areas o f atrophy are o f similar size (Maguire, P. et al; 1986) but 
the fact that the choriocapillaris changes could occur secondary to changes in the RPE 
cannot be discounted.
With the knowledge o f lipofuscin accumulation during ageing and the advent of 
auto fluorescence (AF) imaging, attention has switched to the RPE cell being the initial site 
o f disease. Evidence suggests that lipofuscin reflects the inability o f the RPE to recycle 
phagosomal contents and as it accumulates, its toxicity (see section 1.2.2.2.4) causes a 
number of changes within the RPE, photoreceptors, Bruch’s membrane and choroidal 
capillaries resulting in areas of atrophy (Okubo, A. et al; 2000). Focal increases in 
autofluorescence, seen on scanning laser ophthalmoscopy, have been shown to represent 
increased levels of lipofuscin within the RPE (Delori, F. C. et al; 1995a) and are thought to 
predict the development of atrophy (Holz, F. G. et al; 2004). Additionally, areas with high 
levels o f autofluorescence seen at the perimeter o f established geographic atrophy have 
been shown to become atrophic within 1 year (Holz, F. G. et al; 2001). If the presence of 
increased levels of lipofuscin or A2-E is important in the pathogenesis of GA, this would
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argue against the use of vitamin A supplements. Instead a dietary restriction o f vitamin A or 
ways o f slowing down retinoid recycling would be advocated for possible treatment 
strategies (Holz, F. G. et al; 2004).
1.2.4 Why the macula?
Attempts have been made to explain why lesions associated with ageing are more 
frequently seen in the macular and perimacular areas compared to more peripheral areas of 
the eye.
One explanation from Gass is the organisation o f the rich vascular system at the macular 
region. Here the blood passes from large arterial trunks in the choroid to large sinusoidal 
spaces o f the choriocapillaris. The intracapillary pressure and choroidal blood flow are 
likely to be very high and it is thought that age changes may cause decompensation in an 
area o f greatest intracapillary stress (Gass, J. D.; 1967). No further evidence however 
suggests that macular degeneration is due to capillary disease (Hogan, M. J. et al; 1967).
Bruch’s membrane has also been shown to differ structurally at the macula, with a 
decreased thickness (3-6 times) of the elastic lamina at the macular region compared to 
extramacular regions (Chong, N. H. et al; 2005). In cases with active CNV and disciform 
scars the integrity of the layer was significantly reduced becoming more porous compared 
to controls (Chong, N. H. et al; 2005). This may help to explain why the macula is more 
susceptible to AMD allowing choroidal vessels to breach Bruch’s membrane and grow into 
the retina.
The distribution o f lipofuscin and cytoplasmic volume within the RPE increases from the 
periphery to the posterior pole (Feeney-Bums, L. et al; 1984; Weiter, J. J. et al; 1986). One 
explanation is that the higher ratio of photoreceptors to RPE cells in the macula area results 
in increased phagocytic and metabolic load on the RPE and increased accumulation of 
lipofuscin (Dorey, C. K. et al; 1989). Marshall et al showed a similar profile o f lipofuscin 
to the distribution of rod photoreceptor cells across the retina (Marshall, J.; 1987) and
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Dorey demonstrated that the temporal equator had much higher ratios of rod photoreceptors 
than the nasal equator.
Other factors implicated include the high metabolic rate in the macular region and the long 
term effects o f light (Gass, J. D.; 1967) although no further evidence has substantiated this.
1.3 Prevalence and incidence of ARM/AMD
1.3.1 Prevalence of ARM/AM D
The prevalence of AMD in Caucasian populations in the Western World is increasing. In 
Britain in 1950, only 14% of blind registrations were attributable to AMD and by 1990 this 
figure had increased to nearly 50% (Evans, J. et al; 1996). This figure is greater than would 
be expected when adjusted for age and so other factors must also be involved (Evans, J. et 
al; 1996). This increase may partly be explained by a change in the classification or coding 
o f AMD over the years and partly by improvements in the treatment of the other blinding 
conditions assessed such as glaucoma and cataract.
Population based studies have shown variable estimates for the prevalence o f ARM/AMD 
amongst different populations (see table 1 {page 29}), but collectively they all show that 
the frequency increases with age. Reasons for differences between studies include 
differences in definitions, methodology, socio-demographic factors and genetic differences 
among the groups being studied (Kahn, H. A. et al; 1977), (Bressler, N. M. et al; 1989; 
Klein, R. et al; 1992; Mitchell, P. et al; 1995; Vingerling, J. R. et al; 1995b).
Examples o f differences in definitions include the Framingham Eye Study (Leibowitz, H.
M. et al; 1980) and the National Health and Nutrition Eye Study (Goldberg, J. et al; 1988) 
which included visual acuity in the definition whereas other population-based studies 
(Beaver Dam, Rotterdam and Chesapeake Bay Study) did not. Drusen were also included in 
the definition o f ‘dry’ or non-neovascular AMD in the Framingham study increasing its 
prevalence in relation to the neovascular form. The Rotterdam Study (Vingerling, J. R. et 
al; 1995b), the Blue Mountains Eye Study (Mitchell, P. et al; 1995) and the Beaver Dam
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Eye study (Klein, R. et al; 1992) all used a grading system with standard protocols to grade 
fundus photographs objectively (based on the Wisconsin Age-related Maculopathy Grading 
System -WARMGS) (Klein, R. et al; 1991). Essentially a transparent grid, centred on the 
foveola was placed over colour 35mm slides to allow grading of the various features within 
3000pm of the centre o f the macula and the National Health and Nutrition Examination 
Survey (NHANES) (Klein, B. E. et al; 1982) was based on clinical examination only.
Table 1: Prevalence of ARM/AMD amongst different populations
Study Time period No of 
participants
Age range Prevalence o f 
ARM (%) 
(difficult to 
compare between 
studies)
Prevalence o f 
late AMD 
(%)
Framingham, U.S. 
(Kahn 1977)
1973-1975 2477 52-85 8.8 1.5 %
(exudative) 
(Leibowitz 
1980 surv)
Beaver Dam Eye 
Study, U.S. 
(Klein 199)
1988-1990 4771 43-86 20% (any soft 
drusen)
13% (pigment 
abnormality)
1.6% 
exudative 
1.2%, GA 
0.6%
Blue Mountains 
Eye Study, 
Australia 
(Mitchell 1995)
1992 3654 49+ 13.3% (any soft 
drusen)
12.6% (pigment 
abnormality)
1.9% total 
(exudative 
1.3% atrophic 
0.7%)
Rotterdam Study, 
Netherlands 
(Vingerling 1995)
1990-1993 6251 55-98 Higher rates o f soft 
drusen compared to 
Beaver Dam and 
Blue mountains but 
not comparable. 
7.2% (Pigment 
abnormalities)
1.7% total 
(exudative 
7.4% > 85 yrs; 
atrophic 3.7% 
> 85 yrs)
Reykjavik Eye
Study
Iceland
(Jonasson, F. et al\ 
2003)
1996-2001 1021 50+ Age 50-59;
4.8% intermediate 
soft drusen, 1.2% 
large soft, 0.6% 
large semisolid. 
Age > 8 0 ; 18.2%, 
10.9% and 25.5% 
respectively
exudative 
2.3% (> 70 
years)
atrophy 9.2% 
(> 70 years)
1.3.1. J Prevalence o f geographic atrophy
Geographic atrophy is a less common cause o f visual loss in AMD in most surveys, but 
increases sharply in prevalence with age (Klein, R. et al; 1997; Mitchell, P. et al; 1995). In
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the Beaver Dam Study the prevalence increased from 0% in those less than 54 years to 
2.0% in those over 75 years and in the Rotterdam Study the prevalence increased from 
0.1% (< 64 yrs) to 3.7% in those greater than 85 years. GA has different prevalences in 
different populations. In Rotterdam, North America and Australia the prevalence appears to 
be half that o f neovascular AMD (Klein, R. et al; 1997; Mitchell, P. et al; 1995; Vingerling, 
J. R. et al; 1995b). In Greenland and Iceland however, geographic atrophy occurs more 
frequently than neovascular AMD. In the latter, the prevalence is 9.2% in those >70 years 
compared to 2.3% with exudative macular degeneration in the same age group (Jonasson,
F. et al; 2003). Reasons for this are unclear but environmental factors such as diet, notably 
vitamin A intake, or genetic influences may play a role.
1.3.1.2 Prevalence o f neovascular AMD /  exudative AMD
Exudative AMD, which is responsible for much o f the blindness caused by AMD, was 
twice as prevalent as GA in the Beaver Dam (Klein, R. et al; 1992), Blue Mountain Study 
(Mitchell, P. et al; 1995) and the Rotterdam Study (Vingerling, J. R. et al; 1995b) (see table 
1 {page 29}). In the Framingham study however, drusen were included in the definition o f 
non-exudative AMD thus lowering the proportion o f exudative AMD (Leibowitz, H. M. et 
al; 1980). No differences existed between the sexes once the results were adjusted for age 
(Vingerling, J. R. et al; 1995b) (Mitchell, P. et al; 1995).
1.3.2 Incidence of AMD
According to the Rotterdam study, the incidence rate of AMD was 1.2 per 1000 persons per 
year for subjects aged 55 years and over, increasing to 8.8 per 1000 persons per year in 
those subjects aged 85 years and older (Klaver, C. C. et al; 2001). This rate is lower than 
that shown by the Beaver Dam Study where the incidence rate for those over the age o f 85 
was calculated as approximately 27 per 1000 persons per year (Klaver, C. C. et al; 2001) 
(Klein, R. et al; 1997). Although the follow up period in the Rotterdam study was shorter 
and only a small number of participants developed incident AMD, the difference appears 
considerable and is consistent over the age groups. This is also in accord with other reports 
suggesting that there are global differences in the occurrence of AMD (Klaver, C. C. et al; 
2001). The incidence of AMD in the contralateral eye of subjects already affected by
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unilateral AMD was markedly increased at 170.6 per 1000 persons per year suggesting that 
age-related macular degeneration in one eye considerably increases the risk to the second 
eye(Klaver, C. C. et al; 2001).
1.4 Risk factors for AMD
1.4.1 Demographic factors
1.4.1.1 Age profile
Age is known to be the strongest risk factor as all studies have shown a marked increase in 
prevalence with age. In the Framingham eye study, “senile macular degeneration” was 
infrequent below the age of 65 (1.2%) and increased rapidly with age to 6.4% for ages 65- 
74 and to 19.7% for ages 75 and older (Leibowitz, H. M. et al; 1980). The vast majority 
were classified as ‘dry’ AMD although drusen and pigment alterations were included in this 
definition making it difficult to compare with other studies. The Beaver Dam Study (1987- 
1990) reported on 4926 people between the ages o f 43 and 86. People 75 years o f age or 
older had significantly higher frequencies (p<0.01) o f large drusen (>125pm, 24% v 1.9%), 
soft indistinct drusen (23% v 2.1%), retinal pigment abnormalities (26.6% v 7.3%), 
exudative macular degeneration (5.2% v 0.1%) and geographic atrophy (2% v 0%) 
compared to those aged 43 to 54 years (Klein, R. et al; 1992).
1.4.1.2 Gender
Unlike the Rotterdam (Klaver, C. C. et al; 2001) or the Framingham Study, the Beaver 
Dam Study, after adjusting for age, found an increased incidence of early ARM (x2.2) and 
over seven times the incidence of late ARM in women over 75 years (Klein, R. et al;
1997). The Blue Mountain Study found higher frequencies for soft drusen in women but 
this did not reach statistical significance (Mitchell, P. et al; 1995). Arguments put forward, 
after age adjustment, as to the cause o f this difference include the differences in health 
seeking behaviour between the sexes (Evans, J. R.; 2001). It has also been suggested that 
there may be a loss o f a protective effect o f oestrogens in post menopausal women. The 
Eye Disease Case Control Study showed that women taking replacement oestrogen were at
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a reduced risk of neovascular AMD (Evans, J. R.; 2001). After further analysis o f pooled 
data however, from Beaver Dam, Rotterdam and the Blue Mountains, it was concluded that 
there were no significant gender differences in the prevalence of neovascular or atrophic 
AMD (Smith et al 2001).
1.4.1.3 Race
AMD is believed to be a disease predominantly affecting Caucasian western populations. 
The prevalence, especially of neovascular disease, has been shown to vary between racial 
groups being lower in afro-Caribbean populations (Friedman, D. S. et al; 1999; Schachat,
A. P. et al\ 1995). With regard to studies o f photoreceptor to RPE cell ratios in the macula, 
it was found that afro-Caribbeans had fewer photoreceptors to each RPE cell compared to 
whites older than 50, indicating less lipofuscin accumulation and subsequently less 
photoreceptor cell death (Dorey, C. K. et al; 1989).
Within the Western World, the age specific incidences o f AMD appear to be lower in the 
Netherlands compared to the US (Klein, R. et al; 1997)and are consistent over the age 
groups. This difference is not explained by risk factors such as smoking or cardiovascular 
factors (Klaver, C. C. et al; 2001). It remains to be seen if other environmental or genetic 
factors are accountable.
In Japan, AMD was virtually unknown 30 years ago but the prevalence has dramatically 
increased in urban communities recently, most likely due to environmental factors 
(Yuzawa, M. et al; 1997). The Inuit o f Greenland interestingly appear to have a particularly 
high incidence o f AMD (Rosenberg, T.; 1987), the cause of which is still unknown. 
Genetically they are clearly distinct from western Caucasian societies and their lifestyle is 
quite different.
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1.4.2 Genetic factors
1.4.2.1 Evidence fo r  genetic involvement
Over the last three decades there has been increasing evidence of the role o f genetic 
influences in the pathogenesis o f age-related macular disease. It was Don Gass in 1973 
who reported that 20% of 200 patients had ‘a positive family history of loss of central 
vision’. Since then several twin and sibling studies have suggested that a genetic 
predisposition exists (Klein ML et al, 1994; Meyers SM et al,1995; Piguet B et al 1993; 
Hammond et al 2002) and that various environmental factors may trigger the disorder in 
susceptible individuals. In a study by Seddon et al (Seddon 1997) the prevalence o f age- 
related maculopathy in the first-degree relatives o f subjects with the disease was found to 
be greater than those without the disease. This was particularly the case with exudative 
rather than non-exudative disease. This led to the conclusion that the relative contributions 
o f genetic and environmental factors may differ in the various phenotypes o f AMD.
The genes conferring risk are as yet unidentified but it is recognised that AMD is a complex 
disorder in which several genes are likely to be involved.
1.4.2.1.1 Twin studies
Klein et al (1994) reported eight o f nine monozygotic (MZ) twins concordant for AMD 
with a similar fundal appearance. In the ninth pair, one twin had advanced exudative 
ARMD with vision loss in one eye, while the other had large, confluent drusen and good 
visual function in both eyes. Meyers et al (1995) reported 100% concordance in MZ twins 
(n=25) compared to 42% concordance in dizygotic (DZ) twins (n=12). The twin pairs 
however were not necessarily concordant for individual phenotypes of AMD and showed 
variable clinical expression between twins and between eyes of the same twin. Concerns 
with this study included a recruitment bias towards women and monozygotic twins. There 
is also potential for discordant dizygotic twin pairs to become concordant with time. 
Hammond et al more recently {Hammond 2002) demonstrated that the concordance of 
ARM in MZ twins was 0.37 compared to 0.19 in DZ twins. The most heritable phenotypes 
were soft drusen > 125 pm and > 20 hard drusen. No case had evidence of geographic
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atrophy or neovascular AMD. These studies represent good evidence of a genetic role in 
AMD.
1.4.2.1.2 Familial aggregation studies
Piguet et al (1993) compared the density, size and confluence o f drusen between AMD 
patients and their spouses and siblings and found statistically significant concordance with 
the siblings, but not with the spouses, for number and density o f drusen in the central 
macula. Other studies have also shown greater concordance between siblings for features of 
AMD than between spouses (Gorin, M. B. et al; 1999; Heiba, I. M. et al; 1994; Seddon, J. 
M. et al; 1997; Silvestri, G. et al; 1994).
Klaver (Klaver, C. C. et al; 1998b) carried out a familial aggregation study based on 
probands from the population- based Rotterdam Study. The prevalence of early and late 
ARM assessed from colour photographs was significantly higher in first-degree relatives o f 
87 patients with late ARM compared to first-degree relatives o f 135 control subjects. A 
relative risk of 4.2 was obtained. It was also found that relatives o f patients developed 
ARM at a younger age, which suggests genetic factors may play a role in determining age 
o f onset.
Hyman (Hyman, L. G. et al; 1983) found that 20% of the siblings o f index cases were 
affected compared to 8% of the siblings of controls, demonstrating a 2.9 fold increased risk 
o f ARMD if one or more family members was affected. Silvestri (Silvestri, G. et al; 1994) 
observed a family history of ARMD in 58.3% o f affected patients compared to none in the 
controls. One important limitation o f the study was the inability to examine all patients and 
the reliance on reports from other ophthalmologists and optometrists. The late onset of 
disease and variable expressivity also makes identification o f the disease difficult in family 
members who may not have reached the age o f disease expression or had insufficient 
disease to experience symptoms.
The Beaver Dam Eye Study (Klein, B. E. et al; 2001) investigated the 5-year incidence of 
specific lesions o f age-related maculopathy in the younger sibling o f those with an affected
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older sibling with the same lesion. The odds ratios for the younger sibling developing each 
specific lesion was 1.82 (95% Cl 0.91- 3.66) for soft drusen, 3.59 (95% Cl 1.71-7.57) for 
increased retinal pigment and 10.32 (95% Cl 0.83-128.58) for exudative AMD. These 
results were consistent with genetic influences being important in specific phenotypes of 
AMD.
1.4.2.2 Approaches fo r identifying genetic risk factors
1.4.2.2.1 Linkage studies
Linkage analysis allows the mapping o f genes within a pedigree using genetic markers 
(usually microsatellite markers such as (CA)n repeats o f the DNA sequence) that are 
sufficiently polymorphic. This ensures a reasonable chance that family members will be 
heterozygous, having two different alleles, and therefore be informative for the marker. If 
the disease locus is on the same chromosomal segment as one of the markers they will tend 
to segregate together provided they are not separated by recombination during meiosis 
(Strachan, T. et al\ 1999a).
A simple form o f linkage analysis commonly used is sib-pair analysis. Here pairs of 
affected siblings, who share a proportion o f their parental alleles, are typed for markers. 
The chromosomal regions, where there is greater than expected sharing, are studied 
allowing candidate susceptibility regions to be defined. However, these are often large 
making the subsequent determination of the susceptibility genes a real challenge. The next 
step is to seek associations in the general population between the disease and alleles of 
candidate genes or markers within the susceptibility region. (Strachan, T. et al\ 1999b).
1.4.2.2.2 Association studies
An alternative strategy to linkage mapping is to look for statistical associations in the 
general population between the disease and some marker genotype. This approach can be 
used with case control studies to look for sequence variants or candidate genes enriched in 
one group compared to the other. With associations between an allele and a disease, the 
allele itself increases the susceptibility or risk o f an individual developing the disorder but
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does not necessarily cause the disease. This type o f study is dependant upon the founder 
effect whereby a population is genetically homogeneous and descended from a small 
number o f original founders. It relies on a base change which has occurred in a common 
ancestor where a significant proportion of those affected have inherited the mutation 
(Strachan, T. et al; 1999a). The choice of controls is also crucial to ensure that study 
patients and control groups are drawn from genetically similar populations (Strachan, T. et 
al\ 1999b).
1.4.2.3 Genetics o f complex disorders
Attempting to map genes in complex disorders is complicated by the fact that multiple 
genes are likely to either interact or act independently with environmental variables to 
cause susceptibility to disease. Even when using large numbers of families, initial detection 
o f loci by linkage analysis may be difficult, either because their predisposing effects are 
mild, are masked by interaction with other loci or are strong but relevant to only a small 
subset o f cases (Field, L. L. et al; 1994). Despite this, there is currently great optimism for 
the discovery o f genes in complex disorders.
Research in other complex diseases has benefited from the identification of biochemical 
pathways involved and likely candidate genes. Alzheimer disease, an adult onset 
neurodegenerative disease is an example o f this (Sisodia, S. S. et al; 2002). The past decade 
has seen the identification of 3 causative genes ((3-amyloid precursor protein, presenilin 1, 
presenilin 2) and one susceptibility gene (apolipoprotein E e4) for Alzheimer’s disease. 
Disappointingly these genes although involved in transmitting familial Alzheimer disease, 
have not been shown to be important in simplex cases.
Potential advantages of studying a disorder such as AMD include the existence o f several 
inherited monogenic retinal dystrophies with phenotypes similar to that of AMD. The genes 
responsible for these disorders have been previously characterised and will serve as 
invaluable candidate genes for subsequent association studies. The subdivision o f AMD 
into its various phenotypes will allow purer samples o f disease to be investigated with 
molecular genetic techniques in the future in the hope o f finding gene associations.
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Additionally as our knowledge increases of the underlying mechanisms involved in AMD, 
these pathways can be investigated for further candidate genes.
1.4.2.4 What is known to date?
1.4.2.4.1 Linkage studies
A large pedigree o f 10/21 members with AMD was identified in the US allowing linkage to 
be carried out. Those affected had predominantly large soft drusen (n=7, with 2 cases with 
early GA) or extensive geographic atrophy (n=3).The disorder was found to segregate as an 
autosomal dominant trait with the disease locus mapping to chromosome Iq25-q31, 
between markers D1S466 and D1S413. The multipoint lod score was found to be 3.00 
giving evidence for linkage (Klein, M. L. et a l; 1998). The LOD (logarithm o f the odds) 
score is a statistical estimate of whether 2 loci lie near each other and therefore are likely to 
be linked.
More recently, the 1 q31 locus was independently shown to map to other families with age- 
related macular degeneration using an expanded genome-wide scan (Weeks, D. E. et al; 
2001).
1.4.2.4.2 Association studies and candidate genes
Several hereditary retinal dystrophies have some phenotypic similarity to AMD. Stargardt 
disease (ABCA4 gene) (Allikmets, R. et al; 1997) commonly results in macular atrophy (see 
figure 3a [page 40]) and mutations in the peripherin /RDS 172 gene give rise to a 
phenotype very similar to geographic atrophy (see figure 3b) (Downes, S. M. et al; 1999). 
ELOVL 4 is associated with dominant Stargardt disease and has been evaluated in AMD 
(Ayyagari, R. et al; 2002). Drusen nasal to the disc is a characteristic feature in Doyne 
honeycomb retinal dystrophy (see figure 3c) or Malattia Leventinese (see figure 3d)
(EFEMP1 [EGF-containing fibulin-like extracellular matrix protein 1] gene) (Stone, E. M.
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et al; 1999). A gene similar to EFEMP1, namely a member of the fibulin gene family, has 
recently been implicated in AMD(Stone, E. M. et al; 2004).
Choroidal neovascularisation, which is a prominent feature in Sorsby fundus dystrophy (see 
figure 3e) (TIMP3 gene) (Weber, B. H. et al; 1994) is also a common finding in AMD.
VMD 2 is the gene known to cause Best disease which is also associated with 
neovascularisation in the later stages (Petrukhin, K. et al; 1998) and adult onset vitelliform 
macular dystrophy (see figure 4a [page 41]) can be mistaken for drusen or RPE 
pigmentation without the assistance o f autofluorescence imaging (see figure 4a&b). The 
genes responsible for these conditions are therefore attractive candidate susceptibility genes 
for AMD. Various association studies have been carried out to investigate the role o f these 
genes in AMD.
• ABCA4 gene
The ABCA4 gene, which encodes an ATP-binding cassette (ABC) transporter protein 
ABCR, corresponds to a previously identified rod outer segment protein called rim protein 
(RmP), is known to be defective in Stargardt disease (Allikmets 1997 Nat Genet). The 
protein, ABCR, is believed to be involved in the transport o f vitamin A across membranes 
between the rod and RPE cell. This is disrupted in Stargardt disease resulting in an 
abnormal accumulation of a rhodopsin by-product, N-RPE (N-retinylidene phosphatydal 
ethanolamine) which accumulates in the rod outer segment. This then results in lipofuscin 
accumulating within the RPE (Eagle, R. C., Jr. et al; 1980; Glazer, L. C. et al; 2002; Mata, 
N. L. et al; 2001; Weng, J. et al; 1999) leading to RPE cell and rod cell death. These 
changes are characterised by early adult onset of progressive atrophy o f the macular RPE 
and photoreceptors not dissimilar to the appearance of geographic atrophy in AMD. 
Stargardt disease patients also demonstrate peripheral yellow flecks at the posterior pole 
which fluoresce brightly on AF imaging (von Ruckmann, A. et al; 1997b) (see figure 
4c&d).
In an association study, 167 unrelated AMD patients were screened for alterations in all 51 
exons o f the ABCA4 (ABCR) gene (Allikmets, R. et al; 1997). The results showed 13
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different AMD-associated alterations, mostly missense mutations in conserved amino acid 
positions, in 26 AMD patients (16%). These alterations were concluded to be associated 
with AMD on the basis that they were significantly less frequent in controls (0.45%).
Critics have since expressed their concern that sequence variations which occurred in 
controls were ignored and DNA from controls was not completely screened. In a 
subsequent study, 215 individuals with Stargardt disease, 182 cases o f AMD and 96 
controls were equally screened for sequence variations (Stone, E. M. et al\ 1998). A large 
degree o f sequence variation was seen in all three groups with no significant difference 
between the proportion o f AMD and control subjects with non-conservative variants or 
single DNA changes.
Further investigation o f the two most frequent AMD associated variants in ABCA4, by the 
international ABCR screening consortium (Allikmets, R.; 2000) have shown that G 196IE 
was found in 1.56% patients with AMD compared to 0.32% control subjects (OR: 5.0, 
95%CI 1.6-20) and D2177N was present in 1.77% AMD cases compared to 0.64% controls 
(OR: 2.8, 95%CI 1.2-7.4). The patients in this study were segregated by phenotype into 
“dry” and ”wet” forms of AMD but the prevalence o f both the G 196 IE and D2177N 
variants were not significantly different between the 2 groups (OR: 1.77 95% Cl 0.9-3.4). 
Critics have argued that the phenotyping was not precise and this remains a major weakness 
o f the study. In addition the original series was included in the second study.
The role o f ABCR in AMD remains as yet unresolved. Although various studies have 
conflicting results, no study has been large enough to exclude the gene. Bernstein 
(Bernstein et al 2002) concluded that there is mounting evidence to suggest that 
heterozygous variants in ABCR may well contribute to AMD susceptibility.
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Figure 3
Fundus photographs demonstrating (a) Stargardt macular dystrophy (b) peripherin RDS 172 gene mutation 
phenotype (c) Doyne honeycomb retinal dystrophy (d) Malattia Leventinese (e) Sorsby fundus dystrophy with 
CNV like phenotype (f) variant o f Sorsby fundus dystrophy with appearance similar to GA
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Figure 4 (a to h)
Fundus photographs with corresponding AF images demonstrating (a&b) Adult vitelliform macular dystrophy 
(c&d) Stargardt macular dystrophy with lipofuscin deposits (e&f) Best macular dystrophy (g&h) pattern 
dystrophy (butterfly phenotype)
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Figure 4 (i to p)
Fundus photographs with corresponding AF images demonstrating (i&j) a ‘comparison group’ eye (k&l) 
maternally inherited diabetes and deafness (MIDD) with perimacular areas o f atrophy (m&n) geographic 
atrophy which is more readily seen with AF imaging, especially where extensive drusen is present (o&p)
Page 42
Detailed Clinical Phenotyping of Age-Related M acular Degeneration
Dr S Dandekar
• Peripherin / RDS gene
Mutations in this gene can present with a variety of phenotypes including a dystrophy 
looking very similar to geographic atrophy (RDS mutation 172) (see figure 3b [page 40]) 
(Downes et al 1999). Other dystrophies include pattern dystrophy (see figure 4g&h [page 
41]) which can be mistaken for bilateral drusen to the untrained eye (see figure lb  [page 
1 1 ]).
Mutation screening in 50 AMD patients however did not identify significant sequence 
changes (Silvestri et al 1997).
• EFEMP1 gene
A single non-conservative mutation (Arg345Trp) in the gene EFEMP1{EGF-containing 
fibrillin-like extracellular matrix protein 1) or also known as fibulin 3 has been found to be 
associated with both Doyne honeycomb retinal dystrophy and Malattia Leventinese (Stone 
et al 1999). This autosomal dominant disease is characterised by drusen deposits similar in 
appearance to that in AMD. The distinguishing feature described in Malattia is radial 
drusen (see figure 3d [page 40]) and in Doyne honeycomb dystrophy, is drusen nasal to the 
optic nerve head (see figure 3c). Although EFEMP1 is an attractive candidate gene for 
AMD and is expressed in tissues close to the site o f drusen formation (RPE and retina), the 
mutation was not found in a panel o f 494 patients with AMD (Stone, E. M. et al; 1999).
• Fibulin Genes
There has been a lot of interest in the fibulin gene family recently (closely related to 
EFEMP 1) which is thought to play an important role in AMD. It was a recent study from 
Iowa City, that showed amino acid-altering sequence variations in the fibulin 5 gene (now 
published as fibulin 6) in seven of 402 patients with AMD, whereas none were observed 
among the 429 control subjects (P<0.01). Several o f the altered residues have been
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conserved in evolution. All seven patients had small circular drusen as the clinical 
phenotype (Stone, E. M. et al; 2004).
• TIMP-3 gene
Sorsby fundus dystrophy, an autosomal dominant disorder caused by mutations in the tissue 
inhibitor o f metalloproteinases-3 gene on chr 22 (TIMP-3) (Weber, B. H. et al; 1994), has a 
phenotypic appearance not dissimilar to choroidal neovascularisation in AMD (Capon, M.
R. et al; 1988) (see figure 3e). A further mutation in the gene has also been associated with 
a phenotype more like geographic atrophy (see figure 3f). The gene is thought to be 
involved in extracellular matrix modelling (controlled by matrix metalloproteinases) and 
the normal turnover o f proteins. Histologically, mutations in this gene causes widespread 
marked thickening of Bruch’s membrane and subretinal deposits (Capon, M. R. et al; 1989) 
which is seen clinically by choroidal perfusion abnormalities (Pauleikhoff, D. et al; 1990b) 
(Polkinghome, P. J. et al; 1989). Linkage studies, association studies, sib pair analysis and 
mutation screening looking for a role in AMD have not yet yielded any positive results to 
date (De La Paz, M. A. et al; 1997; Felbor, U. et al; 1997).
Studies of protein content of drusen have interestingly shown the presence of TIMP-3 and 
oxidative modifications of TIMP-3 and are thought to be important in dmsen formation 
(Crabb, J. W. et al; 2002).
• Bestrophin gene
VMD2 has been identified as the gene causing Best disease, which is also an autosomal 
dominant macular dystrophy mapping to 11 q 13 (Petrukhin, K. et al; 1998). The disorder is 
associated with an accumulation of autofluorescent material in the RPE thought to represent 
lipofuscin (see figure 4e& f [page 41]) (von Ruckmann, A. et al; 1997b) but as yet, the gene 
has not been found to play a major role in AMD (Allikmets, R. et al; 1999).
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The following three candidate genes have no recognised specific phenotype but may still 
play a role in increasing susceptibility to AMD.
• APOE gene
Apolipoprotein E (ApoE) is a polymorphic protein that plays an important role in lipid 
metabolism in the central nervous system and in neurodegeneration. It exists in three forms, 
E2, E3 and E4 coded by three co-dominant alleles s2, s3 and s4 each associated with 
different biochemical properties (Mahley, R. W.; 1988). The s4 allele is associated with 
elevated cholesterol, increased risk o f coronary heart disease (Davignon, J. et al; 1988) and 
the earlier onset o f Alzheimer disease (van Duijn, C. M. et al; 1994). It was the lipid 
composition o f drusen that prompted analysis o f the Apo E gene.
Two studies have shown a protective effect o f the ApoE e4 allele in AMD. Souied et al 
(Souied, E. H. et al; 1998) demonstrated a lower frequency o f s4 allele in 116 unrelated 
patients with exudative AMD in one eye and soft drusen in the other compared to 168 age 
and sex matched controls (p<0.002). The risk for an individual with the s4 allele to be 
affected was 4.8 times lower than that for an s4 noncarrier. This finding was also found by 
Klaver et al (Klaver, C. C. et al; 1998a) who reported a reduced risk o f AMD in association 
with the s4 allele (OR 0.43; 95%CI 0.21-0.88). This group also confirmed an increased risk 
of AMD with the e2 allele (OR 1.5; 95%CI 0.8-2.82) and showed ApoE immunoreactivity 
in drusen and basal laminar deposit.
One hypothesis that explains the protective effect of ApoE4 protein in contrast to E2 and 
E3 is that it lacks cysteine residues at certain positions preventing the formation o f 
disulphide bridges and dimers. This would favour easier transport o f smaller lipid particles 
and in turn could prevent the formation of soft drusen by allowing better elimination of 
lipids through Bruch’s membrane (Souied, E. H. et al; 1998).
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Although none o f the candidate genes above have been implicated to have a major role in 
AMD as yet (Schultz, D. W. et al; 2003), it is felt that there is insufficient evidence at 
present to exclude them.
• Angiotensin Converting Enzyme (ACE) gene (Alu polymorphism)
The Alu insert, responsible for the polymorphism, occurs in intron 16 o f the ACE gene 
(Rigat, B. et al; 1992). It is thought to regulate circulating levels o f ACE in the bloodstream 
(Rigat, B. et al; 1990) and ACE itself has been localised to the retinal pigment epithelial 
cells (RPE), choroid and neural retina (Wagner, J. et al; 1996). Recent studies have shown 
that this Alu +/+ polymorphism has a protective effect for ARMD in that it occurred 4.5 
times more frequently in an age-matched controls compared to those with atrophic AMD 
(Hamdi, H. K. et al; 2002) but there was no statistically significant difference in the 
frequency o f the polymorphism between controls and those with neovascular AMD. 
Although ACE is an enzyme known to be involved in regulating blood pressure and 
electrolyte balance, one potential mechanism is that the renin-angiotensin system has been 
shown to regulate cell proliferation and cell death (Fernandez, L. A. et al; 1985). 
Interestingly, in likeness to the Apoe e2 allele, the Alu polymorphism has also been shown 
to be a risk factor for Alzheimer disease (Kehoe, P. G. et al; 2003).
• Complement Factor H Polymorphism (CFH)
One o f the most exciting new developments in AMD genetics has been the identification of 
polymorphisms within the complement factor H gene (on chromosome lq32) which are 
thought to be strongly associated with AMD(Haines, J. L. et al; 2005). These 
polymorphisms have been proposed to explain up to 40-60% of AMD susceptibility 
(Haines, J. L. et al; 2005; Klein, R. J. et al; 2005). The most common variant which 
represents a tyrosine -histidine change at amino acid 402 significantly increases the risk of 
AMD with odds ratios between 2.45 and 5.57 (Haines, J. L. et al; 2005).
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Several lines o f evidence make the CFH polymorphism an attractive candidate for AMD. 
Firstly, the gene is located on chr lq31 which has been repeatedly implicated in 
AMD(Weeks, D. E. et al; 2001). Secondly, CFH is a key regulator of the alternative 
complement system, protecting against infection and attacking diseased and dysplastic 
cells. Various components of the complement cascade have previously been identified 
within drusen(Hageman, G. S. et al, 2001). Thirdly, both age and smoking, two significant 
risk factors in AMD, influence plasma levels o f complement factor H(Klein, R. J. et al, 
2005). Additionally, drusen of a similar composition to that in AMD are found in the 
kidney disease, membranoproliferative glomerulonephritis type II, which is known to be 
caused by CFH deficiency(Mullins, R. F. et al; 2001).
1.4.3 Environmental risk factors
It is believed that environmental factors play an important role in AMD in that they may 
trigger the disease in genetically susceptible individuals. Studies of AMD in communities 
such as those from Japanese fishing villages who have migrated from rural to urban areas 
and adapted a more westernised lifestyle as well as others in Europe, Greenland and North 
America, would contribute greatly to our knowledge but these have yet to be carried out.
Various environmental factors identified as a result of the larger epidemiological studies are 
given below. The extent to which these factors are involved remains controversial.
1.4.3.1 Cardio-vascular factors
1.4.3.1.1 Smoking
There has been increasing interest in the link between smoking and AMD. Oxidative stress 
(Beatty, S. et al; 2000) and atherosclerosis (Vingerling, J. R. et al; 1995a) have been 
proposed as potential mechanisms to explain the causal association. It is known that 
tobacco smoke lowers plasma antioxidant levels (Sanders, T. A. etal; 1993),(Stryker, W. S. 
et al; 1988) and reduces macular pigment density (Beatty, S. et al; 2000) thus allowing 
more oxidative damage to occur at the retina.
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A recent article in the BMJ has highlighted that more than a quarter o f all cases o f AMD 
with blindness or visual impairment in the UK are attributable to current or past exposure to 
smoking (Kelly, S. P. et al; 2004). Other studies have shown a three to four-fold increased 
age adjusted risk of age-related macular degeneration in current smokers compared to never 
smokers from a pooled analysis of 3 cross sectional studies from Australia, North America 
and Europe(Smith, W. et al; 2001).
It has also been demonstrated that the association is stronger between smoking and late 
AMD (CNV or GA) compared to early ARM (Drusen and pigment abnormalities) (Smith, 
W. et al; 1996),(Delcourt, C. et al; 1998). Some studies have reported that smoking is 
associated with only neovascular AMD (Klein, R. et al; 1993),(Vingerling, J. R. et al; 
1995a), others with only atrophic AMD (Vinding, T. et al; 1992) and in a study o f women 
by Seddon and colleagues, there was an association with both types o f AMD (Seddon, J. M. 
et al; 1996). The Blue Mountain study however did not show an association between 
smoking and type of late AMD but this could be attributed to small numbers o f patients in 
the study with CNV(n=50) and GA (n=22).
1.4.3.1.2 Hypertension
Hypertension is believed to damage choroidal vasculature. Although the Macular 
Photocoagulation Study Group did find a relationship between hypertension and an 
increased risk of AMD (MPS; 1997) none of the major population-based studies (Beaver 
Dam, Rotterdam, Blue Mountains or the POLA [Pathologies Oculaires Liees a l'Age] 
study) confirmed this (Smith, W. et al; 2001) (Delcourt, C. et al; 2001). It has been 
suggested that if  a moderate increase in risk existed with hypertension, a large number o f 
cases o f disease would be required to detect this, and hence this may be the reason why 
certain studies have failed to find a statistically significant association (Evans, J. R.; 2001). 
It is unlikely however that hypertension has a strong direct effect on the development of 
AMD.
Page 48
Detailed Clinical Phenotyping of Age-Related M acular Degeneration
Dr S Dandekar
1.4.3.1.3 Atherosclerosis
The association o f atherosclerosis and AMD was investigated by the Rotterdam study 
(Vingerling, J. R. et al; 1995a). Using carotid ultrasonography, people with plaques in the 
carotid bifurcation were at increased risk o f ARMD (OR 4.5; 95%CI 1.9-10.7). A 
subsequent Finnish study looked at people with retinal arteriosclerosis (marked generalised 
narrowing of the arterioles) and found a higher prevalence of age-related macular 
degeneration but only 2 people in the age group studied did not have arteriosclerotic 
changes (Evans, J. R.; 2001).
1.4.3.2 Dietary factors
1.4.3.2.1 Dietary fa t /  cholesterol
The Beaver Dam study demonstrated that a high intake of saturated fat and cholesterol was 
associated with an increased risk o f early rather than late ARM (Mares-Perlman, J. A. et al; 
1995). Serum lipids and dietary fat have been hypothesised to increase the risk o f AMD by 
promoting arteriosclerosis in the choroidal vasculature (Bird, A. C. et al; 1986). 
Alternatively, increases in serum fatty acids and triglycerides have been proposed to 
increase deposition o f neutral fats in Bruch’s membrane that would adversely affect the 
supply o f nutrients and removal of waste products from the RPE (Mares-Perlman, J. A. et 
al; 1995). This deposition of fats is also thought to decrease hydraulic conductivity of 
Bruch’s membrane resulting in the development o f RPE detachments (Moore, D. J. et al; 
1995).
In contrast to the Beaver Dam study, dietary data from the eye disease case control study 
(EDCCS) did not show any association with dietary cholesterol or saturated fats but rather 
an increase in risk for AMD with a higher intake of monounsaturated and polyunsaturated 
fats and linoleic acid (an omega 6 fatty acid). Omega 3 fatty acids and a higher frequency 
o f fish intake with low levels of linoleic acid were however found to be protective (Seddon, 
J. M. et al; 2001).
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1.4.3.2.2 Dietary antioxidant micronutrients
Dietary antioxidants are increasingly thought to have a protective role in reducing oxidative 
damage to the retina caused by incoming blue light and formation of oxygen free radicals. 
The retina is perceived as being particularly susceptible due to its high consumption of 
oxygen, its high proportion o f polyunsaturated fatty acids and its exposure to visible light 
throughout life (Beatty, S. et al; 2000). It is thought that age related macular damage may 
occur in those patients with reduced amounts o f antioxidant micronutrients in the serum or 
retina. High levels o f macular pigments, primarily lutein and zeaxanthin, may also limit 
retinal damage (Beatty, S. et al; 2000).
Further evidence supporting this comes from observations by the EDCCS group. They 
found that those with higher serum levels of the carotenoids lutein, zeaxanthin and P- 
carotene, had a markedly reduced risk o f neovascular AMD (OR =0.4; 95% Cl 0.2- 
0.6)(EDCCS; 1993). Additionally, those with a higher dietary intake of carotenoids had a 
43% lower risk for neovascular AMD compared to those with the lowest intake (odds ratio, 
0.57; 95% confidence interval, 0.35 to 0.92; P for trend = .02) (Seddon, J. M. et al; 1994).
Since serum and retinal antioxidants are potentially modifiable risk factors, there has been 
much interest in the role of dietary supplements in reducing the risk o f AMD (Beatty, S. et 
al; 1999).
The most promising supplementation clinical trial to date is the age-related eye disease 
study (AREDS 2001, report no. 8). This studied the effect of antioxidants (beta-carotene, 
Vit C, E) and zinc supplements on the progression of AMD and visual loss from AMD in 
3640 participants aged between 55-80 years over 6.3 years. Patients were divided into 4 
categories according to the severity of AMD and all cases recruited had a best corrected 
visual acuity o f at least 20/32 in the study eye. Category 1 consisted o f all those essentially 
free o f AMD with no more than 5 small drusen in each eye (<63pm). Category 2 consisted 
of those with multiple small drusen or non-extensive intermediate drusen (63-124 pm) or 
pigment abnormalities. Category 3 participants required at least one large druse (125pm), 
extensive intermediate drusen or an area o f extrafoveal geographic atrophy. Finally
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Category 4 included those with advanced AMD (central geographic atrophy or choroidal 
neovascularisation) in one eye and no advanced AMD in the study eye. Interestingly 
eccentric GA was not included in the definition o f advanced AMD.
All categories were then randomised to 4 treatment groups (A) antioxidants only (500mg 
vitamin C, 400 IU vitamin E and 15mg beta-carotene) (B) zinc (80mg as zinc oxide with 
copper to prevent anaemia) (C) antioxidants plus zinc (D) placebo. The results showed that 
participants in category 3& 4 did benefit, albeit modestly, from supplementation with 
antioxidants and zinc in that the risk o f progressing to advanced AMD was reduced by 25% 
and the risk o f visual loss (15 letters) was reduced by 19%. In both groups the combination 
o f antioxidants plus zinc was more effective than each supplement alone. When analysed 
individually, the effect was however only statistically significant in category 4 and only in 
those with CNV in the affected eye. Why it did not protect in group 3 or in those with 
geographic atrophy in the first eye is not explained.
As a result o f other studies during the course o f the trial, beta- carotene was found to be 
associated with an increased risk o f lung cancer in smokers. Treatment regimens were 
therefore altered and beta- carotene is now not recommended for smokers (AREDS; 2001a)
Criticisms o f this study include the fact that since category 3 was the largest group, it was 
statistically more likely to show an effect if  one existed. Additionally, there was evidence 
from the trial to suggest that antioxidants and zinc may be harmful in those with moderate 
geographic atrophy. Other concerns have been raised as to the dose o f zinc which may have 
toxic side effects including a link with Alzheimer disease (Koh, J. Y.; 2001; Newsome, D. 
A. et al; 1988).
Further studies o f Vitamin E supplements have failed to show a protective effect in AMD 
(Taylor, H. R. et al; 2002) and the results o f various lutein supplement trials are awaited.
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1.4.3.3 Other factors
Body Mass Index greater than 30 (Delcourt, C. et al\ 2001), sunlight exposure 
(Cruickshanks, K. J. et al; 2001; Darzins, P. et al; 1997), blue iris colour (Mitchell, P. et al;
1998), early menopause (EDCCS; 1992);(Klein, M. L. et al; 1994; Vingerling, J. R. et al; 
1995c) and raised fibrinogen levels (Smith, W. et al; 1998) have all been linked to an 
increased prevalence of AMD. Conflicting evidence however exists for most o f these 
factors (EDCCS; 1992) making interpretation of their importance difficult. One of the 
difficulties, especially with measuring light exposure, is the accuracy o f data obtained and 
the considerable recall bias amongst patients.
1.5 Phenotyping of AMD / classification
1.5.1 W hy is phenotyping important?
There is evidence that certain attributes of the phenotype o f ARM reflect the influence of 
the genes conferring risk (Piguet, B. et al; 1993). Certain phenotypes such as large soft 
drusen and multiple hard drusen show stronger genetic influences than phenotypes with 
other features such as pigmentary changes (Hammond, C. J. et al; 2002). To date, little 
attempt has been made to separate out distinct phenotypes in ARM or AMD and no 
association has been found with any specific candidate gene. It may be that subdivision 
according to phenotype will allow generation o f purer samples o f disease, which may in 
turn help to identify the genes contributing to the pathogenesis of the disease. It may be that 
once various phenotypic characteristics are segregated, certain genetic variants may be 
significantly more prevalent in the specific phenotypic groups compared to controls.
At present, it is not clear which features o f ARM and AMD will show the strongest 
correlation to genetic risk. Any attempt to phenotype ARM and AMD will depend on a 
widely accepted classification system for grading of lesions. Such a grading system has 
been established by the International ARM Epidemiological Study Group (Bird, A. C. et al; 
1995). In this study a revised version o f the grading system is introduced and validated for 
use with digital images (see results section).
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Another benefit o f accurate phenotyping is that it allows the discarding those cases that do 
not have AMD. With careful assessment o f drusen distribution, autofluorescence patterns 
and distribution o f atrophy, conditions such as Doyne honeycomb dystrophy (see figure 3c 
[page 40]), pattern dystrophy (see figure 4g&h [page 41]), adult onset Stargardt disease and 
Maternally Inherited Diabetes and Deafness (MIDD) can be identified and excluded from 
the analyses. The latter is a relatively recently discovered mitochondrial disorder which is 
seen in 0.5% to 2.8% of patients with type II diabetes related to a point mutation at position 
3243 o f mitochondrial DNA (Guillausseau, P. J. et al; 2001). It is associated with younger 
onset o f diabetes, neurosensory hearing loss with a normal or low body mass index and 
46% of non insulin dependent patients progressed to insulin dependence after 
approximately 10 years. In the eyes, patients have been found to have patches o f atrophy at 
the posterior pole sparing the fovea (see figure 4k&l [page 42]).
Lastly, once patients have been categorised phenotypically and once genetic variants have 
been identified, this will allow further investigation of various environmental factors which 
are thought to play a role in AMD aetiology.
1.5.2 The international classification and grading system (colour 
images)
In 1995 the International ARM epidemiological Study Group proposed a classification 
system for ARM and AMD to try to standardise the definitions and the grading o f colour 
fundus photographs (Bird, A. C. et al; 1995). They defined the disorder as affecting the 
macular area (approx 5.5mm in diameter centred on the foveola) in those > 50 years o f age. 
The presence o f soft drusen (>63 pm) and RPE pigmentary hyperpigmentation and/or RPE 
hypopigmentation constituted early ARM whereas the presence of geographic atrophy of 
the RPE or neovascular AMD (including RPE detachment, subretinal or sub RPE 
neovascular membranes, subretinal haemorrhages, fibrous scarring or exudate in the 
absence o f other retinal vascular disorders) was defined as late ARM or AMD. Visual 
acuity was not required to make the diagnosis.
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In order to perform the grading, a standard grid on a transparent background made up of 
three concentric circles o f radii 500pm, 1500pm and 3000pm is used to define the central 
circle, the inner and outer macula. Four further radial lines subdivide the areas into 
subfields. The central circle is then centred on the fovea of the 30° or 35° stereoscopic 
colour fundus image. The number o f drusen, drusen morphology (hard, soft, distinct and 
indistinct), drusen size, area covered by drusen, presence or absence o f hypo and hyper 
pigmentation are then graded separately in each zone. Additionally, the presence, location 
and area covered by geographic atrophy (GA) (min 175pm) and the presence, location, and 
area covered by the typifying features o f neovascular AMD (see earlier) are also graded 
separately. Wherever, neovascular AMD develops in an eye with previous GA this is 
reclassified as neovascular AMD and where atrophy develops around or replaces previous 
neovascular disease, the classification remains as neovascular AMD. All studies utilising 
the Wisconsin grading system (including the International classification) focus 
predominantly on the posterior pole (up to 6000pm diameter), largely disregarding the 
retinal periphery. Others studies (Lewis, H. et al; 1985) have previously demonstrated a 
correlation between peripheral reticular degeneration and AMD that can occur before the 
onset o f macular changes. A further study however (Sunness, J. S. et al; 1985), did not 
show any difference in peripheral retinal function between eyes with AMD and the fellow 
eye with only drusen as assessed by electrophysiology. Static perimetry also showed 
sensitivity loss in the central 20 degrees, but normal thresholds peripheral to this. These 
results therefore suggest that retinal function abnormalities are confined to the central retina 
in AMD.
1.5.3 Digital Versus Film photography
Film-based fundus photography is currently acknowledged as the gold-standard in both 
clinical practice and research, but is often complicated with difficulties in archiving 
photographs and limited transfer o f images amongst clinicians. With the advent of 
advanced digital technology, electronic storage, software manipulation and improvements 
in image quality (Lee, S. C. et al; 2001) digital imaging is fast becoming a realistic 
alternative.
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A recent study investigated the feasibility o f using digitised colour fundus transparencies 
for grading diabetic retinopathy and showed good agreement between the digitised images 
and 35 mm colour transparencies viewed as slides (George, L. D. et al; 1999). Regarding 
AMD, one recent study has semi-quantitatively compared standard fundus photographs to 
digitised images but the study population, was not restricted to ARM and AMD patients, 
the grading only included four categories (drusen characteristics), and kappa statistics were 
not performed (Lee, M. S. et al; 2000).
Potential disadvantages o f digital photography include the loss of quality and resolution 
when images are compressed to allow for storage requirements and poorer stereopsis.
1.5.4 Autofluorescence (AF) imaging
As lipofuscin is now believed to play a central role in the pathogenesis o f age-related 
macular degeneration (AMD), the technique o f autofluorescence (AF) imaging using a 
confocal scanning laser ophthalmoscope (SLO) has become an invaluable tool.
Observations by Delori and co-workers (Delori, F. C. et al; 1995a) provided evidence that 
autofluorescence is largely derived from lipofuscin in the RPE. He demonstrated that the 
spectral characteristics of the dominant fundus fluorophore and the retinal location between 
choriocapillaris and the photoreceptors correlated with RPE lipofuscin. Further evidence 
supporting the origin o f autofluorescence arising posterior to the neurosensory retina comes 
from the increased autofluorescence seen in stage IV macular holes where there is a full 
thickness neurosensory retinal defect (von Ruckmann, A. et al; 1997a).
Von Ruckmann and colleagues were the first to publish images of the spatial distribution of 
fundal autofluorescence in normal subjects and those with age-related macular degeneration 
and macular dystrophies (von Ruckmann, A. et al; 1995; von Ruckmann, A. et al; 1997a; 
von Ruckmann, A. et al; 1997b).
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1.5.4.1 Normal subjects
The characteristics and the rate of accumulation o f lipofuscin at different sites in the 
posterior pole and the changes with age have been documented in a population o f normal 
subjects (Delori, F. C. et al\ 2001; von Ruckmann, A. et al; 1997b).
Fundus AF intensity is highest at the posterior pole (between 5°and 15° from the fovea) and 
dips at the fovea and toward the periphery. The optic disc and retinal blood vessels are 
shown as dark structures and these features remain consistent regardless of age. This 
indicates that the image is not caused by reflected light as the disc is the most reflectant 
feature o f the fundus (von Ruckmann, A. et al; 1997a). Delori and colleagues found the 
spatial distribution o f fluorescence to be 40% lower in the fovea than at 7 degrees 
eccentricity and asymmetrically distributed around the fovea. The fluorescence was 
maximal at 11 degrees temporally, 7 degrees nasally, 13 degrees superiorly and 9 degrees 
inferiorly. This distribution o f lipofuscin generally matches that of rods and reflects the 
pattern o f age- related loss o f rod photoreceptors (Delori, F. C. et al; 2001).
1.5.4.2 AF in age-related macular degeneration
The spatial distribution of AF of the various phenotypes in age-related macular 
degeneration described to date is given below.
1.5.4.2.1 Drusen
In patients with early age-related macular degeneration with non-crystalline drusen deposits 
at the level of Bruch’s membrane (inner collagenous layer), the intensity of 
autofluorescence has been shown to be no greater than background levels when compared 
to age-matched controls. This was true for both hard and soft drusen (von Ruckmann, A. et 
al; 1997a). Lois subsequently described patterns of AF in eyes with drusen, where large 
foveal drusen corresponded to areas o f increased AF, but drusen outside the foveal area did 
not show changes in AF (Lois, N. et al; 2002). A reticular pattern of AF can be seen outside 
the foveal area but does not always correspond to drusen. It is thought that these areas 
represent varying quantities o f lipofuscin within the RPE.
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Delori has looked at AF associated with drusen using a different imaging device (Delori, F.
C. et al; 2000). In contrast he describes a distinct pattern associated with individual hard 
(>60 pm) and soft drusen with a centre o f low autofluorescence surrounded by an annulus 
o f high autofluorescence. A possible explanation for this appearance is the peripheral 
displacement o f the RPE cells over the drusen causing central thinning o f RPE and a 
peripheral increase in autofluorescence. This pattern however has not been reported with 
SLO autofluorescence imaging and is likely to be due to the different methodology used.
1.5.4.2.2 Hyperpigmentation
In eyes with focal hyperpigmentation or pigment figures at the level o f the retinal pigment 
epithelium there was intense increased AF corresponding to these regions (von Ruckmann, 
A. et al; 1997a) (Solbach, U. et al; 1997). This could be explained by the presence of 
melanolipofuscin (von Ruckmann, A. et al; 1997a) or possibly an increased metabolic 
activity of the RPE in areas with hyperpigmentation (Solbach, U. et al; 1997).
1.5.4.2.3 Geographic atrophy
In geographic atrophy, there is consistently decreased autofluorescence corresponding to 
the area of atrophy and photoreceptor loss (von Ruckmann, A. et al; 1997a). Various 
patterns in the junctional zone o f geographic atrophy have been described (Holz, F. G. et al; 
1999a). These include a continuous band o f increased autofluorescence surrounding the 
atrophy, a diffusely increased autofluorescence at the entire posterior pole and finally small 
focal spots o f increased autofluorescence at the junctional zone. These differing patterns in 
geographic atrophy may represent varying reactive changes in the surrounding RPE cells 
and are thought to precede cell death (Holz, F. G. et al; 1999a). Follow up o f these patients 
with areas of increased autofluorescence surrounding geographic atrophy has shown the 
development of new atrophic patches within these regions within a year. These 
observations strengthen the theory that excessive RPE lipofuscin accumulation is involved 
in the pathogenesis o f geographic atrophy associated with age-related macular 
degeneration.
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J.5.4.2.4 Choroidal neovascularisation
In those eyes with choroidal neovascularisation, the autofluorescence has been described as 
irregular, with regions of increased and decreased autofluorescence compared to 
background levels. The intensity is less than background over disciform scars (von 
Ruckmann, A. et al\ 1997b). Increased AF around the edge o f the lesion has also been 
described often corresponding to areas o f irregular pigmentation (von Ruckmann, A. et al; 
1997a)
J.5.4.2.5 Pigment epithelial detachments
Retinal pigment epithelial detachments older than 6 months showed a mild, diffusely 
increased autofluorescence corresponding exactly with the detached area and this persisted 
for 2 months after the detachment had flattened.
1.6 Natural history and risk of visual loss with ARM
1.6.1 Drusen
The presence of drusen is the ophthalmoscopic hall-mark o f age-related maculopathy 
(ARM). Various studies have shown that increased drusen number (Holz, F. G. et al; 
1994b), larger size (Gregor, Z. et al; 1977; MPS; 1997)(MPS), increased confluence (Klein, 
R. et al; 1997; Smiddy, W. E. et al; 1984)and decreased fluorescence on fluorescein 
angiography (Pauleikhoff, D. et al; 1990a)are important factors in conferring risk for visual 
loss and AMD (Strahlman, E. R. et al; 1983) (Bressler, S. B . et al; 1990; Gass, J. D.; 1973; 
Gregor, Z. et al; 1977). In particular, the macular photocoagulation study (MPS; 1997) 
identified that the presence of 5 or more drusen (RR=2.1 ;95%CI 1.3-3.5) and 1 or more 
large drusen (RR=1.5; 95%CI 1.0-2.2) were 2 important risk factors for the development of 
CNV in the fellow eye o f those with CNV in the first eye. Pauleikhoff also demonstrated 
that fellow eyes of those with PED’s were more likely to have larger, more densely packed 
and less fluorescent drusen (i.e. more hydrophobic) than fellow eyes of CNV (Pauleikhoff,
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D. et al; 1990a). This is consistent with the proposed pathogenesis of PED’s and the neutral 
lipid theory (Bird, A. C. et al; 1986; Pauleikhoff, D. et al; 2002; Sheraidah, G. et al; 1993).
The Beaver Dam study (Klein, R. et al; 1997) and the Chesapeake Bay Waterman Study 
(Bressler, N. M. et al; 1989) demonstrated that small hard drusen are common and not 
necessarily correlated with a risk of advanced AMD. This was also confirmed by the results 
o f the AREDS study (AREDS; 2001a) where patients in category 1 (i.e. no more than 5 
small drusen (<63 pm) in each eye) had a very low risk of progression to advanced AMD 
over 5 years (0.005%). Those in category 2 (extensive small drusen or non-extensive 
intermediate drusen) had a 1.3% 5yr risk of progression and those in category 3 ,with 
extensive intermediate sized drusen or at least one large druse (125pm) had a significant 
risk o f progression of 27%. Category 4, although they had the highest risk of progression 
were not classified according to drusen size.
Smiddy and colleagues (Smiddy, W. E. et al; 1984) identified drusen associated with focal 
hyperpigmentation and more than a minimal degree o f confluence as significant risk 
factors for exudative AMD in those with bilateral drusen but interestingly drusen size was 
not considered important. In Holz’s prospective study o f 126 patients with bilateral drusen 
(Holz, F. G. et al; 1994b) again drusen size did not appear to increase the risk o f AMD but 
drusen number was found to be important as none o f the eyes with less than 10 central 
drusen developed AMD.
The more diffuse linear deposits, that cause thickening of Bruch’s membrane, do not appear 
to have a clinical correlate but they do produce changes on fluorescein angiography and 
indocyanine green (ICG) angiography causing slowing of choroidal perfusion and may be 
an important factor in the development of geographic atrophy (Pauleikhoff, D. et al; 1999). 
Further study of these patients using the Humphrey automated perimeter and fine matrix 
mapping revealed discrete areas o f scotopic threshold elevation implying functional loss in 
the regions with choroidal perfusion abnormality (Chen, J. C. et al; 1992)consistent with 
the proposal that continuous thickening o f Bruch’s membrane may act as a barrier to 
diffusion between the RPE and choriocapillaris (Pauleikhoff, D. et al; 1990b).
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1.6.2 RPE pigmentation
Focal RPE hyperpigmentation has been shown to be an important risk factor. One study 
(Smiddy, W. E. et al; 1984) found an increased risk o f 23 times of developing exudative 
maculopathy with focal pigmentation associated with drusen (95%CI ;4-259) The MPS, 
Beaver Dam and Rotterdam study also found focal RPE hyperpigmentation to be a major 
risk factor for developing CNV(MPS; 1997);(Klein, R. et al; 1997) (Klaver, C. C. et al; 
2001).
Gregor et al (Gregor, Z. et al; 1977) however found no association between pigment 
clumping, with or without drusen and the development o f AMD in his study o f 104 
patients.
1.6.3 Natural history of pigment epithelial detachments
Historically pigment epithelial detachments (PED’s) have been reported to have a good 
prognosis. In 1979, the natural history o f 50 eyes with avascular serous PED’s was reported 
on (Meredith, T. A. et al; 1979). Subretinal new vessels did not develop in any patient 
under the age o f 56 years or if the lesion was less than 1 disc diameter in size. The risk of 
visual loss increased with age with 9.1% o f those less than 55 yrs losing greater than 1 line 
o f Snellen which increased to 51.3 % in those older than 55. Patients were also more 
likely to develop vascular complications if  the lesion was subfoveal (39.4 % v 16.7%). 
Unfortunately the study involved limited numbers and follow up. A further study by Elman 
and colleagues (Elman, M. J. et al; 1986) described the natural history of PED in 110 
patients. Thirty-two percent developed a choroidal neovascular complex within an average 
o f 20 months and this was associated with an acuity o f 6/60 or worse. Risk factors for CNV 
development and poor visual acuity were (1) sensory retinal detachment (2) increased size 
o f the PED (3) a hot spot on fluorescein angiography (4) late or irregular filling and (5) 
notching. Thirty-nine percent of eyes retained an acuity o f 6/9 or better.
In a further study o f 101 patients with different types o f PED (Pauleikhoff, D. et al; 2002) 
namely polypoidal choroidal vasculopathy (PCV), vascular PED and avascular PED, all
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types were found to have a similar clinical course with respect to visual loss, enlargement 
and regression. The mean final visual acuity was 1/18 in avascular PED, 1/24 in vascular 
PED and 1/30 in the PCV group, but these were not statistically different. The size o f the 
lesions however, did show statistically significant differences, with avascular lesions being 
the smallest, vascular PED’s being intermediate and PCV associated with the largest 
PED’s. Interestingly the avascular PED’s subsequently developed geographic atrophy 
whereas the other two groups more frequently resulted in RPE tears and disciform scaring.
A further group, which are often referred to as ‘drusenoid’ PED or ‘serogranular PED’(see 
figures 11 d&e [page 133]) represents an area o f approximately Vi disc diameter of 
confluent soft drusen under the centre of the macula. These patients are at risk of 
developing GA or CNV. In a study by Roquet o f 31 patients(Roquet, W. et al; 2004), 50% 
were shown to develop GA after 7 years and those with a lesion larger than 2DD or with 
metamorphopsia as a symptom were at an increased risk o f progressing to atrophy or CNV 
after 2 years (p<0.01). Over 10 years, 75% progressed to atrophy and 25% to CNV with a 
poor visual prognosis.
1.6.3.1 RPE rips
Schoeppner et al reported a high incidence o f visual loss (37%, 59% & 80% in the 1st, 2nd 
& 3rd yrs respectively) in the fellow eye o f those patients with RPE tears in the first eye 
(Schoeppner, G. et al; 1989). The causes o f visual loss included retinal pigment epithelial 
detachments with choroidal neovascularisation and RPE tears. If the characteristics of 
drusen truly determine the subsequent lesion that develops, identifying eyes at high risk of 
developing PED’s may allow prophylactic measures to prevent their development and 
subsequent visual loss. Pauleikhoff also noted that RPE tears were only seen in larger 
volume PED’s (Pauleikhoff, D. et al; 2002) where a further increase in volume could cause 
sufficient tangential stress to rupture the RPE. If the size o f PED’s could in some way be 
limited, this complication may be avoided with its inherent loss of vision.
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1.6.4 Natural history of geographic atrophy
It was Sarks who described the clinic-pathological correlation of RPE atrophy and then 
subsequently described its evolution and rate o f progression (Sarks, J. P. et al; 1988; Sarks, 
S. H.; 1976).The process commonly occurs in eyes with drusen and pigmentary alterations 
although it may also follow flattening o f RPE detachments (Bird, A. C. et al; 1986; Elman, 
M. J. et al; 1986; Meredith, T. A. et al; 1979). The progression has been described to occur 
in three phases (Maguire, P. et al; 1986). In the initial phase, eyes show focal discrete areas 
o f RPE atrophy in the parafoveal area, mostly skirting fixation producing a horse-shoe- 
shaped lesion with no thinning of the RPE. This stage is usually associated with numerous 
drusen and retention of good visual acuity (Sarks, J. P. et al; 1988) (Maguire, P. et al;
1986). Following this, the second phase occurs in which there is foveal involvement, a 
precipitous loss in acuity often down to count fingers, coarse foveal granularity, thinning of 
the RPE and a regression of macular drusen (Schatz, H. et al; 1989). Histologically, 
regressing drusen are associated with macrophages and material not removed becomes 
crystalline which can be seen clinically (Sarks, J. P. et al; 1988). The final phase results in 
multifocal areas o f atrophy becoming confluent to produce circular areas of atrophy 
involving the entire central macula.
Sarks showed that the size o f the atrophy and the percentage o f foveal involvement 
increased annually by more than 100% at first, slowing rapidly once the GA had involved 
the previous areas o f atrophy (Sarks 1988). It was also observed that significant visual loss 
occurred at a rate o f 8% per year and that the atrophy tended to expand faster in those under 
75 compared to patients over 75 (Schatz, H. et al; 1989).
Sunness et al also reported a significant decline in visual acuity over time as areas o f GA 
continued to enlarge, even when already large at baseline (Sunness, J. S. et al; 1999a). 
Those with VA better than 20/50 had the highest rate of acuity loss. 27% of these eyes had 
acuities of 20/200 or worse at 4 years. Maguire and Vine also reported that the average 
interval from onset to legal blindness was nine years (Maguire, P. et al; 1986). The 
development of CNV in those eyes with GA is another reason for further loss in vision. 
Sunness reported rates of CNV development o f 2% by 2 years in those patients with
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bilateral GA and no CNV at baseline and 11% by 4 years (Sunness, J. S.; 1999). In those 
with GA in the study eye and CNV in the fellow eye at baseline, these figures rose to 18% 
by 2 years and 34% by 4 years. CNV did not occur at sites within the atrophy, but rather at 
the peripheral border or in the spared foveal region. The size o f central atrophy also 
appeared to be important whereby an area o f central atrophy less than 2 disc areas was 
associated with an increased risk o f developing CNV. Sarks also found that the risk o f 
CNV declined once the GA had involved all areas o f incipient atrophy (Sarks, J. P. et al; 
1988).
Improvement o f visual acuity over time in patients with geographic atrophy has also been 
reported (Sunness, J. S. et al; 2000). Six out o f 36 patients with bilateral GA experienced a 
two or more line improvement with better fixation in the worse seeing eye, which occurred 
at the same time as vision deteriorated in the better seeing eye. None of the patients 
however noted the change themselves. Unlike CNV, where the lesion can involute causing 
improvements in VA (Singerman, L. J. et al; 1985), regression does not occur in GA. Any 
improvement in vision therefore is presumably due to eccentric fixation to an area of 
surviving retina (Sunness, J. S. etal; 2000).
1.6.5 Natural history of CNV.
CNV secondary to AMD is usually associated with profound visual loss especially when 
new vessel formation results in serous and/or haemorrhagic detachment o f the RPE and the 
formation o f a disciform scar. This term ‘disciform degeneration o f the macula’ was 
initially coined by Oeller in 1905 (Gass, J. D.; 1967) and was subsequently used to describe 
disc shaped lesions occurring in the macular region o f elderly individuals. Today we use 
the term to indicate the formation o f a scar following exudation and haemorrhage at the 
macula.
Clinically CNV is classified according to the position of the lesion in relation to the fovea 
as seen during the transit phase o f the fluorescein angiography (FFA). Lesions are 
described as extrafoveal when the entire complex is located 200pm or farther from the
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centre o f the foveal avascular zone (FAZ) and probably account for no more than one 
quarter o f those cases that threaten central vision (Bressler, N. M. et al; 1987). Juxtafoveal 
complexes are required to have their posterior edge or associated blood/blocked 
fluorescence between 1 and 199pm from the centre o f the FAZ and subfoveal lesions have 
evidence o f neovascularisation under the centre o f the FAZ (Chamberlin, J. A. et al; 1989).
1.6.5.1 Classic and occult CNV
Subfoveal CNV is then further classified as either ‘classic’ or ‘occult’ according to MPS 
guidelines again as defined by the appearances on FFA (MPS; 1991).
Classic CNV is characterised by an area o f choroidal hyperfluorescence with well 
demarcated boundaries that can be discerned in the early phase o f the angiogram. In later 
phases, progressive pooling o f dye leakage occurs in the overlying subsensory retinal space 
and usually obscures the boundaries o f the CNV.
Occult CNV however is represented by two patterns o f hyperfluorescence. Stereoscopic 
angiography is advised to aid in the diagnosis. The two forms are known as ‘fibrovascular 
pigment epithelial detachment (PED)’ and Tate-phase leakage o f an undetermined source’. 
The former describes an area o f irregular elevation o f the RPE which are neither discrete 
nor as bright as classic CNV in the transit phase. They then develop an area of stippled 
hyperfluorescence within 1-2 minutes after the injection and by 10 minutes there is 
persistent staining or leakage within a sensory retinal detachment. These PED’s should not 
be confused with the typical serous detachments o f the RPE also seen in AMD. The second 
type o f occult lesion often appears as speckled hyperfluorescence with leakage and pooling 
o f dye in the overlying subsensory retinal space occurring at between 2 and 5 minutes after 
dye injection. The source o f this leakage cannot be discerned in the earlier phases o f the 
FFA and the boundaries o f the lesion are never well demarcated (MPS; 1991).
Gass initially suggested that choroidal neovascularisation in AMD grew primarily under the 
RPE, hence explaining the poor prognosis following surgery with damage to the RPE
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(Gass, J. D.; 1994). In a subsequent clinicopathological study by Lafaut and colleagues, an 
attempt was made to correlate histology with classic and occult complexes. Although the 
classic CNV’s had a major subretinal fibrovascular component and the occult membranes 
predominantly contained a fibrovascular component beneath the RPE, 10/18 classic 
membranes also contained a sub RPE component and 2/10 occult membranes contained a 
subretinal component making it difficult to make any definite correlations. Fibrin was also 
noted to occur at the lateral edges of classic membranes and to occur on the inner surface of 
occult membranes (Lafaut, B. A. et al; 2000).
The above definitions have become increasingly important since the advent of 
Photodynamic therapy (PDT) but unfortunately they do not have any direct histological 
correlation. Additionally, since most CNV’s associated with AMD have been described as 
occult and subfoveal (Bressler, N. M. et al; 1987), treatment options are severely limited at 
present.
Natural history studies have shown that visual improvement can occur in those with CNV. 
Singerman (Singerman, L. J. et al; 1985)showed that 4 out o f 20 patients with macular 
disciform degeneration in the first eye, spontaneously improved their acuity by 5 lines or 
more when the second eye underwent a decrease in vision. In a further study o f those with 
occult CNV however, the outcome was more variable. 32% cases more than doubled their 
original size and median visual acuity loss was 2.5 lines after 9-12 months o f follow up. 
Classic CNV was said to develop in 52% of those with occult CNVand in those with a 
classic component at baseline, more subretinal fibrosis developed causing further visual 
loss (Stevens, T. S. et al; 1997).
1.6.5.2 Risk to second eye
Studies have shown that AMD usually affects both eyes over time (Gass 1973, Gregor 
1977). The Framingham eye study showed that the proportion of cases that were unilateral 
decreased with age from 90% (15/16) in those less than 65 to only 40% (34/78) in those
older than 75. In patients with a unilateral advanced form of the disease it is of interest to
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be able to estimate the risk to the second eye. This risk has been calculated by several 
groups including Gregor et al (Gregor, Z. et al; 1977) who reported a 12-15% annual risk of 
developing a disciform lesion in the second eye o f 104 patients with a unilateral disciform 
in the first eye. This agrees with the incidence o f 12% found by Teeters and Bird (Teeters, 
V. W. et al; 1973). A further study (Bressler, S. B. et al; 1982) found a cumulative risk o f 
29% of developing a sub-retinal CNV in a fellow eye with macular dmsen over 3 years. 
Strahlman (Strahlman, E. R. et al; 1983) and Holz (Holz, F. G. et al; 1994b) reported much 
lower risks to the second eye of between 3 to 10% per year. These studies however had 
various follow up times and differences in the severity o f macular changes which could 
account for the diversity o f risk.
The Rotterdam study provided information on incidence of AMD in the contralateral eye of 
subjects already affected by unilateral AMD (170.6 per 1000 persons per year). The most 
predictive stage for development o f AMD was ARM stage 3, which comprises the presence 
o f either soft, indistinct drusen or soft drusen with pigmentary irregularities (Klaver 2001 
IOVS). The most important predictors of progression were more than 10% of macular area 
covered by drusen, presence o f depigmentation, and presence o f hyperpigmentation.
The AREDS study found the risk o f progression to advanced AMD in those with central 
GA or CNV in the first eye (category 4) to be 43% over 5 years. Those with non-central 
GA had a risk of 27% over 5yrs (category 3). Both groups were found to benefit from 
vitamin supplements.
1.6.6 Symmetry between eyes
Marked symmetry o f drusen between eyes has been demonstrated by various groups (Gass 
1973, Coffey AJH 1986, Lewis H 1986, Barondes 1990). Barondes showed close 
concordance (kappa 0.7 -0.9) with respect to drusen size, number, density and fluorescence 
with fluorescein angiography which was greater than would be expected by chance alone. 
This led to the conclusion that dmsen may result from metabolic malfunction specific to the
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patient rather than the non specific result o f ageing. In addition it is likely that both eyes 
have similar risk o f visual loss at least in terms o f drusen characteristics.
Geographic atrophy has been quoted to be bilateral in 48 -65 % of cases (Sarks, J. P. et al; 
1988), (Green, W. R. et al; 1985), (Bellmann, C. et al; 2002), (Wang et al BJ01998) and it 
was Sunness who described the high correlation in size and progression o f GA between 
eyes. More recently, Bellman and colleagues have used autofluorescence imaging to record 
the symmetry o f lesions in patients with geographic atrophy. Autofluorescence imaging 
allows an accurate assessment o f the area o f RPE loss. Seventy-two patients were assessed 
for number of atrophic areas, size of atrophy and the size of the convex hull around all the 
lesions within an eye. There was no statistically significant difference when these variables 
were compared between eyes. These findings are in accordance with the view that AMD is 
not merely the result o f a non-specific process and implies that both eyes are under similar 
genetic and/or environmental influences.
A further study o f symmetry o f disciform scars in 81 patients observed a significant 
correlation between eyes in terms o f final scar size (r=0.5, p<0.01) (Lavin, M. J. et al; 
1991). It was suggested that the similarity in scar sizes between eyes may reflect the effect 
o f some underlying inherited or systemic factor. In a study looking at subtypes of 
neovascular complexes, Chang et al concluded that 48/55(87%) patients with a vascularised 
PED occult lesion in the first eye developed a similar type of occult lesion in the second as 
did 49/58(84%) of the group with occult CNV without a serous PED (Chang, B. et al;
1995).
Concerning patients with Pigment epithelial detachments, Chuang and Bird reviewed the 
prevalence o f bilateral tears. They found that 10/22 patients with loss of vision in their 
second eye as a result o f an RPE tear had a similar lesion in the first eye (Chuang, E. L. et 
al; 1988). Schoeppner et al (Schoeppner, G. et al; 1989) also reported a high incidence of 
visual loss (80% after 3 years) in the fellow eye o f 43 patients with RPE tears in the first 
eye. Visual loss in the fellow eye was most frequently precipitated by pigment epithelial 
detachment, which occurred in 23 patients and 15 o f these developed a tear.
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Regarding people with bilateral involvement of AMD, the Beaver Dam Study identified 
34/4926 individuals. 15% had pure GA in both eyes, 56% had exudative macular 
degeneration in both eyes and 29% had GA in one eye and exudative changes in the fellow 
eye (i.e. a discordant phenotype). In the Blue Mountain Eye Study 80% o f the 230 gradable 
cases o f AMD or early ARM were found to be bilateral, 57% for AMD and 77% for early 
ARM. GA was bilateral in 56%, neovascular AMD in 40% and distinct soft drusen in 47%, 
with hyperpigmentation and hypopigmentation being bilateral in only 38% and 28% of 
cases respectively (Wang, J. J. et al\ 1998).
Unfortunately, as in the Beaver Dam and Blue Mountain Study, many population studies 
have small numbers with late stage maculopathy making it difficult to assess overall 
symmetry between eyes in late stage disease. Larger cohorts of patients with AMD in both 
eyes will allow a more accurate assessment o f symmetry.
1.7 Current treatments in AMD
1.7.1 Laser photocoagulation Therapy
Until relatively recently, laser photocoagulation therapy was the only effective treatment 
available for CNV. Between 1979 and 1994, the Macular Photocoagulation Study Group 
conducted a number o f clinical trials on patients with neovascular lesions in one or both 
eyes(MPS; 1986; MPS; 1990; MPS; 1991). CNV lesions were classified into those that 
were extrafoveal (200 pm  or more from the centre of the macula), juxtafoveal (more than 
1 pm but less than 200pm from the foveal centre) and sub-foveal (lesion under the foveal 
centre). The study group set out indications and guidelines for Argon and Krypton laser 
treatment o f the various neovascular lesions and defined the terms ‘classic’ and ‘occult 
lesions’(MPS; 1991). Although still used in predominantly extrafoveal lesions there are 
limitations o f this treatment. Firstly, only 10-15% o f all neovascular lesions are considered
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small enough and sufficiently delineated by fluorescein angiography to be eligible for 
treatment. Secondly, even if the laser treatment is successful -  that is, the new blood vessels 
appear closed on fluorescein angiography, at least 50% have a recurrence o f leakage within 
2 years. A further problem is that in the treatment o f subfoveal lesions, laser causes an 
immediate reduction in central vision, even though in the long term these patients suffer 
less visual loss(MPS; 1991). These problems have sparked the need to find alternative, less 
destructive treatments for AMD.
1.7.2 Photodynamic Therapy
Photodynamic therapy has now been introduced as the mainstay o f treatment for subfoveal, 
predominantly classic neovascular lesions following the treatment of AMD with 
photodynamic therapy (TAP) and verteporfin in photodynamic therapy (VIP) studies 
(Barbazetto, I. et al, 2003; TAP study Group; 1999; VIP Study Group; 2001; VIP Study 
Group; 2002). It involves the intravenous administration o f a photosensitiser dye called 
verteporfin and then laser irradiation o f the macular region. The destruction of the CNV 
lesion is confined to the new, abnormal blood vessels since it is a nonthermal process 
leading to the localised production of reactive oxygen free radicals which mediate cellular, 
vascular and immunological injury. Typically the leaking vessels remain closed for several 
weeks but often multiple treatments are necessary. The trials showed that treatment delayed 
or prevented loss of vision after two years o f follow up in patients with predominantly 
classic lesions. Some o f the limitations o f this treatment however are the limited number of 
patients with predominantly classic lesions, the high cost of the photosensitiser dye and the 
need for recurrent treatments after 3 month intervals.
1.7.3 Transpupillary Thermo therapy
Transpupillary thermotherapy (TTT) is a laser photocoagulation treatment characterised by 
large spot, long-pulse and low-irradiance infrared diode (810nm) laser exposure. It has been 
used successfully to treat occult subfoveal choroidal neovascularisation (CNV). The
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treatment is administered as a subthreshold photocoagulation with no visible endpoint and 
no ophthalmoscopically apparent chorioretinal change. This may make it difficult to assess 
whether adequate treatment has been given. It has however been observed to result in 
closure of CNV membranes and resorption of intraretinal and subretinal fluid with little or 
no damage to the overlying retina (Reichel, E. et al; 1999). The mechanism o f action, 
although currently unknown, is thought to involve the alteration o f choroidal blood 
flow(Ciulla, T. A. et al; 2001).
1.7.4 Anti VEGF Treatments
Since VEGF has been shown to be an important cytokine stimulus for the growth o f new 
vessels in the eye in both AMD and diabetic retinopathy, anti-VEGF therapy is thus a 
potential treatment for neovascular AMD. Two anti-VEGF agents are now clinically 
available for the treatment o f neovascular AMD: pegaptanib sodium (macugen), which is 
an oligonucleotide aptamer which has an ability to bind and inactivate VEGF and 
bevacizumab (Avastin), which is an antibody for metastatic colorectal cancer given 
systemically(Michels, S. et al; 2005). Unlike bevacizumab, which binds all VEGF 
isoforms, pegaptanib targets only VEGF165, the isoform responsible for pathological 
ocular neovascularization and thus an ideal target for treatment o f AMD(Ng, E. W. et al; 
2005). The aptamer (pegaptanib sodium) has also been shown to significantly reduce 
vascular permeability in animals and in human studies, 3 months after intravitreal 
administration, 80% of eyes showed stabilised or improved vision with 27% showing an 
increase in threee or more lines on the ETDRS chart(Eyetech Study Group; 2002). While 
these agents offer promising therapies, there is potential for local and systemic adverse 
sequelae since VEGF serves numerous essential functions in extraocular tissues(van 
Wijngaarden, P. et al; 2005).
1.7.5 Anecortave Acetate
Anecortave acetate is an angiostatic synthetic derivative of cortisol that is being currently 
evaluated for the treatment of exudative age-related macular degeneration (ARMD). It is 
delivered as a posterior juxtascleral depot injection (15mg) and has been shown to stabilise
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vision compared to placebo and inhibit neovascular lesion growth when given at 6 monthly 
intervals(Schmidt-Erfurth, U. et al; 2005). Reported side-effects have included cataract 
formation, decreased visual acuity, ptosis, ocular pain and subconjunctival 
hemorrhage(Schmidt-Erfurth, U. et al; 2005) and there is also a risk o f raised intraocular 
pressure.
1.7.6 Retinal Translocation
The development o f increasingly refined vitreoretinal surgical techniques has resulted in a 
variety o f surgical procedures for age-related macular degeneration (AMD). These have 
included submacular surgery with removal o f choroidal neovascular membranes and 
subretinal blood and macular translocation surgery(Conti, S. M. et al; 2005). The latter 
involves translocating the macula with respect to the retinal pigment epithelium and 
choroid and performing a 360 degree retinectomy. Problems with this treatment include the 
need for concurrent squint surgery to reposition the fovea with the risk o f anterior segment 
ischaemia and the risk o f recurrence o f subfoveal RPE atrophy following the 
procedure(Cahill, M. T. et al; 2005).
To date most of the treatments available have had minimal impact in reducing blindness 
from AMD. It may be that in the future, combination treatments will need to be given to 
provide the best chances o f success in reducing visual loss.
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2 Aims
The aims o f this descriptive study were:
1) To collect a large cohort o f ARM and AMD patients and carry out a more detailed 
phenotype analysis than has previously been performed. Techniques for 
phenotyping are to include colour photography, autofluorescence imaging and 
fluorescein angiography where clinically indicated.
2) To validate grading techniques used for the assessment of 35mm colour 
transparencies and digital colour images for phenotyping of ARM and AMD.
3) To investigate whether phenotype analysis o f patients with ARM and AMD using 
colour fundus photography, autofluorescence imaging and fluorescein angiography, 
where available, can increase our knowledge base regarding:
o The concordance and symmetry between eyes, 
o The fellow eye characteristics in those with unilateral visual loss and 
whether they relate to the type o f AMD in the affected eye. 
o The regional susceptibility o f the macula to geographic atrophy and its 
pattern o f progression, 
o The integrity o f the retinal pigment epithelium (RPE) in patients with 
choroidal neovascularisation at different stages o f development, 
o The regional variation in photoreceptor function in differing lesions in AMD
4) To investigate the relationship between smoking and the different phenotypes of 
AMD.
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3 Clinical Methods
3.1 Patient / Spouse recruitment
Patients and spouses (acting as a comparison group) presenting to medical retina clinics at 
Moorfields Eye Hospital & King’s College Hospital were invited to enter the study. Ninety 
percent o f patients were recruited by myself. The remaining 10% were recruited with the 
help o f Tunde Peto (Reading Centre co-ordinator) Sharon Jenkins (genetic study co­
ordinator) and Hendrik Scholl (visiting retinal fellow).
3.1.1 Inclusion criteria:
• Patients over the age o f 50 with West European family-origin with early or late age- 
related macular degeneration in one or both eyes.
• Spouses of patients, over the age o f 50, if  they have no signs of age-related macular 
disease on biomicroscopy examination (Comparison group).
• Patients and spouses willing to take part in the study after receiving a full 
explanation o f the nature o f the study.
3.1.2 Exclusion criteria:
• Patients and spouses not wishing to participate.
• Eyes with opaque media that did not allow gradeable colour photos.
• Presence o f retinal disease or other cause o f visual loss other than due to age-related 
macular degeneration.
Informed consent was obtained in all patients and spouses entering the study after an 
explanation o f the purpose and requirements o f the study. This study was conducted in 
accordance with the tenets o f the Declaration o f Helsinki, and with the approval o f the 
institutional ethical committee (see appendix 3).
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Each participant was asked about a family history o f retinal disease, past or current 
smoking, number o f cigarettes smoked per day and for how long. Visual acuity was tested 
using the Snellen chart at 6 metres rather than logMar acuity since the phenotyping of 
AMD according to the International Classification does not include visual acuity in the 
definition and it was felt that Snellen acuity would be quicker to assess since these were 
available in all patient cubicles and could be converted to logMar if  needed (see chart 
below). Additionally, visions could also be compared to previous visual acuities which 
would also have been measured with the Snellen chart. A full dilated ophthalmological 
examination was also carried out.
LogMar is an acronym for Log 10 o f the Minimum Angle o f Resolution (MAR). The MAR 
is taken as the stroke width o f the letters, which is l/5 th o f the vertical angle it subtends. 
Thus a 6/6 letter which subtends 5 minutes o f arc, equates to a MAR o f 1 minute and a 
logMar o f 0 (Log io (l)=0)(Thompson, D; 2005). One disadvantage o f the logMar notation 
is that for letter sizes smaller than 6/6, the logMar score is negative.
Tables have therefore been calculated to allow Snellen acuity to be converted to logMar 
acuity. An example is shown below (Edited from (Thompson, D; 2005)).
Snellen Acuity LogMar
6/4 -0.2
6/6 0
6/9 +0.2
6/12 +0.3
6/18 +0.5
6/24 +0.6
6/36 +0.8
6/60 +1.0
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3.2  D ata C o llection
3.2.1 M icrosoft access database
All data were entered into an access database designed for the purpose of the study (see 
figure 5 for entry data sheet).
For the purposes of this MD by July 2003, data from 1300 patients had been collected. The 
individual studies however were carried out at different time periods and therefore the total 
number of patients differs between studies.
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Figure 5: Microsoft Access data entry sheet
3.2.2 Q ueries
Once all data were entered into the access database, ‘select queries’ were devised to analyse 
and sort the data. Specifically patients with different phenotypes could be subdivided, i.e. 
those with GA in 1 or both eyes, those with CNV in 1 or both eyes and those with a 
discordant phenotype (those with GA in 1 eye and CNV or PED in the other eye). Cross tab
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and select queries were also used to subdivide patients into those with unilateral and 
bilateral visual loss based on visual acuities at recruitment.
3.3 Imaging:
3.3.1 Colour photography:
Digital imaging has become progressively more sophisticated over previous years and, with 
the advantages o f ease o f electronic storage, image transfer, digital analysis and software 
manipulation, this has become the imaging technique of choice.
Initially colour 30° & 50° stereoscopic fundus photographs were taken using a Zeiss FF- 
series fundus camera on 35mm Ektachrome slide transparency film by certified 
photographers. These were all then digitised by myself using a Nikon Coolpix 990 digital 
camera (Nikon, Tokyo, Japan), 35mm slide film adapter and commercially available light 
box. The settings were chosen to optimise image quality at a resolution of 1024x768 pixels. 
Each image was stored as a low-compression JPEG (compression (8:1) format with a file 
size o f about 170 KB) to allow reasonable quality but with reduced memory requirements.
Approximately 4 months after the start o f the study, the medical illustration department 
installed a digital imaging system (TOPCON Imagenet 2000 © TRC 50IX fundus camera) 
and so subsequent images were taken digitally using standard settings again by certified 
photographers.
3.3.2 Autofluorescence imaging:
Autofluorescence images were taken o f all eyes by myself (providing there was no 
significant lens opacity) using either:
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(1) A prototype confocal scanning laser ophthalmoscope (cSLO) donated by Zeiss (Zeiss, 
Jena, Germany). This takes a 40° field o f view using a confocal aperture. The confocal 
detection unit employs a pinhole aperture (400pm) to suppress light originating from 
outside the focal plane. This enhances the image contrast compared with non-confocal 
images and also ensures that the autofluorescence recorded is derived from the ocular 
fundus provided that the focus is on the retinal surface. The ametropic corrector is 
employed to correct for refractive error and to focus on the structure o f interest (the 
macula). An argon blue laser (488nm) is used for excitation and directed into the dilated or 
undilated pupil, delivered from an external source. A wide-pass filter with short- 
wavelength cut-off o f 521nm is inserted in front o f the detector to record fundus 
autofluorescence. Emitted light is then detected above the barrier filter wavelength and 
recorded as a series o f images. Several images can be recorded and digitised at 768 x 576 
resolution with an in-house programmeme written in C programmeming language utilising 
functions from the Matrox© Image Library (Matrox Imaging Products Group, Quebec, 
Canada). Thirty-two individual images were automatically aligned and averaged to reduce 
noise. As a result, a single image was obtained for each study eye. A recent study has 
shown good repeatability with moderate inter-observer reproducibility using the same Zeiss 
system for AF imaging (Lois, N. et al\ 1999).
Or
(2) The Heidelberg Retinal Angiograph scanning laser ophthalmoscope (SLO) camera
(Heidelberg Engineering, Heidelberg, Germany) -  The optical and technical principles have 
been previously published (Holz, F. G. et al\ 1999a) but in brief, two scanning mirrors
provide the horizontal and vertical scanning directions. The illumination beam has a
diameter o f 3mm and the pupil o f the eye under investigation is either dilated or undilated.
The field of view can vary between 10°xl0° to 30°x30°. The latter field of view was used 
in this study. Once again, an argon blue laser (488nm) is again used for illumination and the 
barrier filter has a short wavelength cut-off o f 500nm to suppress reflected blue argon 
excitation light by a factor o f 10'6. The optics allow ametropia compensation between -12 
and +12 D. To amplify the autofluorescence signal, 9 images are aligned and a mean image 
calculated using image analysis software. Images are then digitised and processed using a
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flexible frame processor (up to 20 frames/second) provided by Heidelberg Engineering 
(Heidelberg Eye explorer, Version 2.1.0, 11/2002 for windows 98/NT/2000/XP) and 
displayed on a computer screen. Each frame contains 51 2 X 5 1 2  pixels and is saved as a 
256 KB image file (Holz, F. G. et al; 2001). All autofluorescence images were taken either 
by myself (70%) or Sharon Jenkins (genetic study co-ordinator) (30%).
3.3.3 Fluorescein angiography:
Fluorescein images were taken according to standard protocol for the department by 
certified photographers only when clinically indicated for suspected choroidal 
neovascularisation. Five millilitres o f 20% sodium fluorescein was injected into the 
antecubital vein and images were taken using:
• A Zeiss 35mm camera (Zeiss, Oberkochen Germany) or
• Topcon IMAGEnet 2000 © digital camera
The digital images were stored as JPEG files to reduce file storage requirements.
Fundus images (35mm slide transparencies) taken prior to the recruitment date were also 
digitised by m yself using a Nikon Coolpix 995 digital camera (Nikon, Tokyo, Japan), slide 
film adapter and commercially available light box.
All images were stored digitally in an image database in folders named according to their 
unique study number. Each folder contained images divided with respect to type o f image 
(‘c ’ for colour, ‘f  for fluorescein and ‘s ’ for SLO AF) with the date taken.
3.4 Grading techniques (colour, AF)
All images were evaluated at a reading centre at Moorfields Eye Hospital by specially 
trained ophthalmologists or certified graders. Two to three readers graded each image 
independently, and in the case o f disagreement a further reader was asked to mediate. For 
the initial studies all grading was carried out equally by myself, Tunde Peto and Hendrik
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Scholl and subsequently all grading was carried out by myself and Irene Leung (certified 
grader).
3.4.1 Colour photographs
The grading system used for colour images was a modified version o f that established by 
the International ARM Epidemiological Study Group (Bird, A. C. et al; 1995). This system 
was used to assess and quantify abnormalities o f age-related maculopathy (ARM) and 
degeneration (AMD) by zone, in each eye from digital images. In order to assess its 
reliability and validate its use with digital images, the inter- and intra-observer variability 
was calculated as part o f the study (see Chapter 4.1.1).
Since the grading system had been developed for use with 35mm film images and not for 
digitised fundal photographs (Nikon 995 Coolpix) or digital images (Topcon IMAGE net 
2000 ©), it was important to evaluate the effect o f the digitisation process by comparing 
kappa values for the grading o f ARM and AMD. This analysis was performed as part o f the 
study and gave high levels o f agreement between the two methods (see chapter 4.1).
3.4.1.1 35mm film grading
For grading purposes, all 35mm images were viewed and graded using standard 
stereoscopic viewing spectacles (Pocket Stereoscopes, Cartographic Engineering Limited, 
Hampshire, UK; magnification o f x2.0) on an x-ray viewing light box (CABIN CL-5000 
Series Light Panel; colour temperature o f 5000 K). The grading process used a standard 
acetate grid template with three circular zones (diameter 1000, 3000 and 6000pm). Spokes 
help to centre the grid on the macula and a set o f graduated circles with diameters o f 63 
pm, 125 pm, 250 pm, and 500 pm  were used to estimate drusen size, pigment abnormality 
size, and total area covered by geographic atrophy and/or neovascular AMD. Data were 
collected using grading forms and entered into a database.
3.4.1.2 Digital grading
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All digital images were viewed using the commercial image processing package Photoshop 
version 6.0 at a resolution o f 1024 x 768 pixels (Adobe Systems Inc., San Jose, CA).
Images were saved as low compression JPEG (compression (8:1) formats with a file size of 
about 170 KB to allow for maximum storage. Grading was then performed on a DELL 17 
inch monitor with contrast and brightness standardized. Prior to grading, stereo pairs o f 
images could be viewed using a stereoviewer programme developed in collaboration with 
scientists at the visual science laboratory at the Institute o f Ophthalmology (London) in 
conjunction with a ‘prism viewer.’
One image from each stereo pair was then chosen for grading. The posterior pole was 
arbitrarily divided into sectors by overlaying a standard digital grid template [produced in 
Adobe photoshop version 6.0 (Adobe Systems Inc., San Jose, CA) and sized according to 
the International ARM Epidemiological Study Group and Wisconsin ARM grading system 
(designed for 30° images)] onto the 30° photograph and centred on the fovea (see figure 6). 
This grid size was chosen as this is the standard grid size used in macular studies (Bird, A. 
C. et al; 1995). The three circles making up the grid represented the central, middle and 
outer subfield with diameters o f 1000, 3000 and 6000 pm respectively. The adjacent circles 
represented drusen sizes ranging from 63-500pm.
When a 50° photograph was used, the grid size was scaled down proportionately (approx 
by 0.6) and centred on the macula to allow the same area within the arcades to be graded. It 
is acknowledged that there may have been some discrepancy between the exact size of 
grading area between images but every attempt was made to keep the sizing o f the grid 
standardised between images.
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Figure 6: Digital grid template overlying digital image adapted from the International 
ARM Epidemiological Study Group and Wisconsin ARM grading system
3.4.1.2.1 Software manipulation
In the present study, digitised images were not manipulated by any image processing 
software. Optimisation of contrast, sharpness and brightness and the use of digital zoom are 
widely available in commercial image processing software (such as Photoshop, Adobe). It 
has been shown that software manipulation of images can improve the agreement in 
grading performance of diabetic retinopathy (George 1999). It is however known that this 
process can accentuate artefacts and result in pixilation or “blockiness” of the images. For 
the purposes of the study it was presumed that software manipulation would confound the 
data in an uncontrolled manner and so was not performed, although a potential to further 
improve grading performance cannot be excluded.
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3.4.1.3 Grading categories
Both 35mm film and digital images were then graded using a coding manual (see appendix 
1) with individual scores for:
Photo quality [ranging from perfect image (grade 1) to very poor quality (grade 5) or 
image not centred (grade 6) or image missing (grade 9)],
Drusen characteristics including:
Size [small (<63pm), intermediate (63 - 125pm) large (>125pm- 500pm) very large 
(>500pm),
N um ber [absent, 1-9 to >50],
Total area [ <10% to >50% of macula area]
Density [distinct -drusen are separate one from another, subconfluent -drusen 
borders just touching and confluent -borders are overlapped].
Types such as the presence of crystalline drusen or serogranular dmse in zone 1 
were also recorded.
Hypopigmentation [presence or absence] and
H yperpigmentation [presence and type- linear, punctate, mixed] within the three zones.
Regarding late stage ARM or AMD, the presence and overall area of the lesion was 
recorded with distinction between neovascular AMD and geographic atrophy. Additional 
features o f neovascular AMD were also differentiated including serous detachm ent of the 
RPE, neuroretinal detachm ent, haem orrhagic RPE detachment, presence of a scar or 
fibrous m aterial and retinal or vitreous haem orrhage. To help with subsequent sorting 
of data, a category of ‘predominant phenotype’ was also established (see table 2).
Table 2: predom inant phenotype categories for grading purposes
Predominant phenotype 
(Grading o f  each eye)
Most advanced feature present
0 <5 Hard drusen
1 Hard drusen only (>5)
2 Soft drusen
3 Geographic Atrophy
4 Retinal pigment epithelial 
detachment
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5 Choroidal neovascularisation
7 Cannot grade- obscuring lesion
8 Cannot grade -  poor photo 
quality
3.4.J.4 Definitions used fo r  grading
As in other grading systems (AREDS 2001, report no 6, AJO), definitions were established 
for the grading terms ‘absent’, ‘questionable’, ‘present’, and ‘cannot grade.’ The term 
‘absent’ was used when the abnormality under consideration was either ‘not present’ or the 
grader was less than 50% certain that the abnormality existed in the area under 
consideration. The term ‘Questionable’ was used to mean that the grader was at least 50% 
but less than 90% certain that the abnormality was present within the area under 
consideration. The term ‘present’ was used when the grader was at least 90% certain that 
the abnormality existed within the area being graded and lastly, ‘cannot grade’ was used 
when either an obscuring lesion or poor photographic quality did not allow assessment o f 
any abnormality in the area under consideration.
The definitions o f hard drusen, soft drusen, areas o f hyperpigmentation, areas of 
hypopigmentation have been previously established by the International ARM 
Epidemiological Study Group (Bird, A. C. et al\ 1995).
Definitions for subtypes o f AMD were according to the International Classification (see 
grading manual). Choroidal neovascularisation and pigment epithelial detachment were 
both graded as neovascular AMD with the individual features classified separately. Any 
lesions with a subretinal neovascular complex, intraretinal or subretinal hypertrophic scar, 
neurosensory retinal detachment, hard exudates or retinal haemorrhages (Bird, A. C. et al\ 
1995) were classed as CNV and those with a retinal pigment epithelial detachment were 
categorised as PED.
Geographic atrophy was defined as an area o f RPE hypopigmentation with clearly visible 
choroidal vessels occupying an area greater than that of a circle of 175pm in diameter. 
Choroidal vessels and the edges o f  the atrophy were considered difficult to detect in areas
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smaller than this (Bird, A. C. et al\ 1995). If choroidal neovascularisation was seen in an 
eye with previous geographic atrophy, it was graded as CNV. If there was evidence o f 
previous CNV such as any fibrous tissue with adjacent areas o f atrophy, this was also 
classified as neovascular AMD.
3.4.1.5 Validation o f  colour fundal image grading techniques
3.4.1.5.1 Inter- and intra-observer variability in grading ARM and AMD
The grading system used for the phenotype analysis o f colour images was a revised version 
o f that devised by the International ARM Epidemiological Study Group. It had been 
adapted for the study and it was therefore necessary to investigate its reliability, and inter- 
and intra-observer variability between graders.
Both eyes o f 25 patients with ARM or AMD in at least one eye, with stereoscopic pairs o f 
35mm colour fundus photographs , were randomly selected from the study database.
The images were graded according to the modified grading system from the International 
ARM Epidemiological Study Group by three graders, as described previously (see 
Methods).
Data were collected using grading forms and entered into a database. All stereoscopic 
fundus colour slides were graded separately and then re-graded by each grader with a time- 
delay of at least two weeks.
Finally a master-grading was established and where any disagreement between graders 
existed, the images were reviewed, and a consensus reached. If any uncertainty remained, 
final arbitration was carried out by a further retinal specialist (ACB), and these results were 
used for the master-grading.
Paired gradings from two respective graders (for estimating the inter-observer variability) 
and both gradings from each grader (for estimating the intra-observer variability) were
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compared by means o f tables, percentages of agreement/disagreement and kappa statistic 
(see methods). For abnormalities graded with a binary response (for example, 
absence/presence o f geographic atrophy), agreement and K-statistic were un-weighted and 
for abnormalities with extended scales (for example, area covered by geographic atrophy), 
a weighted variant was also calculated assigning a weight o f 1 for perfect agreement, 0.75 
for one-step disagreement, and 0 for all other disagreements. Kappa ( k ) statistic was 
interpreted using the ranges suggested by Brennan and Silman and Landis and Koch 
(Brennan, P. et al\ 1992; Landis, J. R. et al\ 1977) (see statistics section). For features with 
extremely low prevalences, K-statistic was not performed.
3.4.1.5.2 Comparison o f  digitised and 35 mm fdm  colour grading
In order to validate the use o f digitised images for the phenotyping study, it was necessary 
to carry out a pilot study (Scholl, H. P. et al\ 2004b). Gold standard 35 mm stereoscopic 
slide transparencies were compared to digitised non-stereoscopic images when grading for 
abnormalities in ARM and AMD. Kappa values were calculated to determine agreement 
between observers and between the digitised and 35mm film images.
Three observers utilised the modified grading system (see appendix 1) to grade 50 eyes of 
25 patients randomly selected with stereoscopic colour fundus photographs taken with the 
Zeiss FF-series 30-degree fundus camera. Each 35 mm colour slide was then digitised 
using a Nikon Coolpix 990 digital camera (Nikon, Tokyo, Japan) according to previously 
described techniques (see methods).
These digitised images were also graded separately by three retinal specialists (HPNS, TP, 
and SD) using the standard digital grid template adapted from the Wisconsin age-related 
maculopathy grading system (see Methods section). Data were entered on grading forms 
and entered into a final database. To assess intra-observer variability, all colour slides and 
digitised images were re-graded by each grader after a time-delay of at least two weeks.
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Finally a mastercopy was established for both the stereoscopic colour slides and the 
digitised fundus images. When the three assessments differed in any category, the graders 
reviewed the images to reach a consensus. If  any uncertainty or disagreement remained, 
final arbitration was carried out by a further retinal specialist (ACB).
Inter-observer variability was estimated from gradings from pairs of graders and intra­
observer variability calculated from the two gradings o f each grader. For each category, the 
percentages o f agreement/disagreement and kappa statistic were calculated. Once again 
abnormalities analysed as either absent or present, agreement and K-statistic were 
unweighted, whereas for those with extended scales (for example, area covered by 
geographic atrophy), a weighted variant was also calculated assigning a weight o f 1 for 
perfect agreement, 0.75 for one-step disagreement, and 0 for all other disagreements. For 
abnormalities with extremely low prevalences (1:50 or below) such as subgroups o f larger 
drusen, serogranular drusen, hypopigmentation, and retinal haemorrhage K-statistic was not 
performed.
3.4.2 Fluorescein angiograms
All images were taken digitally using Topcon digital imaging software (IMAGEnet 2000 
©) and viewed in Photoshop version 6.0. Early transit and late images were chosen for 
grading purposes. Fluorescein angiograms, when available were used to determine the 
presence o f pigment epithelial detachment and to evaluate the extent of classic or occult 
choroidal neovascularisation using definitions provided by the Macular Photocoagulation 
Study (MPS, Arch Ophth 1991) (see appendix 2). When assessing the integrity of the RPE 
layer in CNV lesions FFA and AF image were directly compared to assess the areas of 
leakage. This utilised comparison software integrated within the Topcon digital imaging 
programme (IMAGEnet 2000 ©) (see later).
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3.4.3 Autofluorescence images
These images were also viewed in Photoshop version 6.0 on a DELL 17 inch monitor with 
contrast and brightness standardised.
A classification system was developed (see Appendix 1) to encompass the various features 
o f autofluorescence imaging o f AMD (In particular, to evaluate the areas o f increased and 
decreased AF in the macular region in addition to the pattern o f background 
autofluorescence). Changes were divided into unifocal, multifocal, homogeneous or 
heterogeneous areas o f abnormal AF including the presence of specific patterns such as 
reticular, focal or lace-like (see figure 15 [page 147-8]), as discussed by the International 
Fundus Autofluorescence Classification Group (In press-see section 8), were also noted.
This grading system was used to identify autofluorescence patterns in patients with 
unilateral visual loss. The worst eye in each case was evaluated to determine the 
characteristic AF patterns in GA, CNV and PED. Additionally the fellow eye in each case 
was assessed for patterns that may confer increased risk o f visual loss.
3.5 Concordance and symmetry of phenotype between eyes
To date, symmetry has not been assessed in late stage ARM or AMD. As part o f this study, 
the concordance between eyes in those with bilateral AMD was assessed in terms o f the 
lesion causing visual impairment. The analysis was confined to those with bilateral AMD, 
rather than including those with unilateral AMD (who would inherently be classed as 
‘discordant’), as this latter group represents an intermediate time point where the second 
eye is not yet affected.
Three hundred and seventy-five patients out o f the 790 that had been recruited to the study 
at the time o f analysis were included. They were all graded with bilateral late stage disease 
from digital colour fundus photographs according to the modified version of the
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International Classification in conjunction with the assessment of fluorescein angiograms 
where available (n=196).
The grading was carried out by myself and Irene Leung (certified grader), on all patients to 
determine the predominant AMD phenotype in each eye. In the event o f disagreement, a 
third observer (TP) was asked to arbitrate. For the purposes o f this study, late stage disease 
was defined as those patients with either GA, PED or CNV in both eyes or any combination 
of these phenotypes and ‘queries’in Microsoft Access were used to identify patients.
Concordance rates for the phenotype were calculated for ‘neovascular AMD’, PED and 
CNV independently and for GA (or non-neovascular AMD). In view of the fact that FFA 
was not carried out on all patients, a definite diagnosis o f PED or CNV could not always be 
determined. This was the basis for carrying out the analysis using the terms ‘neovascular’ 
and ‘non-neovascular’ in addition to the individual phenotypes using predominantly the 
grading from colour images. The justification for this was based on the international 
classification for ARM where no FFA images were used (Bird, A. C. et al; 1995).
A concordant phenotype was defined as a patient with the same phenotype in both eyes, for 
example those with GA in both eyes or CNV in both eyes. Patients graded with GA in one 
eye and PED or CNV in the other were considered to be discordant for phenotype.
In order to assist in the diagnosis o f a previous PED or to determine if  a patient with 
geographic atrophy had any evidence o f previous CNV, or vice versa, historical data were 
obtained from the hospital notes.
The numbers of discordant phenotypes (i.e. GA in one eye and CNV or PED in the fellow 
eye) and concordant phenotypes (GA, CNV or PED in both eyes) from the digital grading 
were recorded and analysed using Microsoft Excel. Kappa ( k ) statistic (see section on 
statistics 3.11) was then used to calculate the observed concordance between eyes above 
that expected due to chance assuming independence between eyes (Brennan, P. et al\ 1992).
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3.5.1 Symmetry of autofluorescence patterns in bilateral GA
With the advent o f the scanning laser ophthalmoscope (SLO) and autofluorescence 
imaging, areas o f geographic atrophy have become more readily detectable allowing 
quantitative analysis to be carried out. Those patients with bilateral GA and 
autofluorescence images were assessed for symmetry and to compare the area and pattern 
o f atrophy between right and left eyes.
Fifty consecutive patients (100 eyes) with bilateral GA as graded from the colour 
photographs with autofluorescence images available of sufficient image quality to allow 
analysis, were assessed. Three patients were excluded from the study since only 1 eye had 
been imaged. Autofluorescence images o f both eyes were obtained for each patient (see 
section 3.3.2).
Planimetric techniques were then used by a single reader (SJ) to encircle the darkened areas 
o f atrophy on each image (100 eyes) which are more readily seen on AF images compared 
to colour images especially in the presence o f extensive drusen (see figure 4m-p [page 
148]). A mouse driven arrow was used in conjunction with software devised ‘in house’ by 
scientists at the Institute of Ophthalmology (University of London). The area was 
calculated in ‘square steridians’ after adjusting for the size o f the image. Square steridians 
were chosen so that images could be standardised by setting the number of pixels between 
the fovea and the centre o f the disc to fifteen degrees. This is the measurement accepted as 
the standard angle between disc and fovea.
All data was analysed by myself with the total area o f atrophy (see fig 7) was calculated in 
each eye (see table 16 (page 132}) including and excluding any areas of peripapillary 
atrophy to see if these areas differed between eyes. The pattern of decreased 
autofluorescence was also classified as ‘multifocal’ or unifocal’ (see figure 7c&d [page 
91]) depending on the number o f atrophic patches in each eye.
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The areas and pattern o f atrophy were compared between eyes using the Pearson’s 
correlation coefficient (r) and kappa statistic ( k ) respectively (seee statistics section). The 
mean difference in size between right and left areas o f atrophy was also tested using the 
paired student t-test and the results displayed with 95% confidence intervals (see table 16 
{page 132}).
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Figure 7
(a&b) AF images to show planimetry technique to assess area and symmetry o f  bilateral GA (c) AF image o f 
GA showing ‘multifocal’ areas o f  decreased AF (d) and a predominantly ‘unifocal’ area o f decreased AF in 
GA. Note the areas o f  increase AF surrounding the areas o f  atrophy which represent areas susceptible to 
further atrophy
a
O
cXp
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3.6 Characteristics of the fellow eye in patients with 
unilateral visual loss
Patients with unilateral visual loss are o f particular value to the study of AMD as they allow 
an accurate assessment o f the premorbid phenotype in those with a proven susceptibility to 
advanced disease.
3.6.1 Colour fundus characteristics
195 patients with unilateral visual loss from AMD (affected eye worse than 6/24 and fellow 
eye better than 6/9- difference o f 3 lines) and 30° colour fundus photographs of both eyes 
available for grading, were identified from the study at the time of analysis. Patients with 
loss o f central vision due to other causes including amblyopia, retinal vascular disease or 
significant cataract were excluded from the initial recruitment.
The images o f the worse affected eye were graded to determine the cause o f visual loss 
with reference to the fluorescein angiograms. They were graded as either choroidal 
neovascularisation (CNV), avascular pigment epithelial detachment (PED), geographic 
atrophy (GA) or soft drusen.
The fellow eyes were graded for the number, density, area o f total drusen (%) and type o f 
drusen (using the modified international classification) and also for the presence o f any 
other lesion relating to AMD.
These characteristics were then analysed with regard to the nature of the lesion in the worse 
affected eye. For data conforming to a 2x2 contingency table, statistical analysis was 
carried out using Fisher’s exact test (see statistics section. When analysing the area of 
drusen, data were treated as ranked categorical data and analysed using the chi-squared test 
for trend. Calculations were performed using ‘Medcalc®’ statistical software (Belgium).
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3.6.2 Autofluorescence fundus characteristics
At the time of analysis, 135 patients from the study were identified with unilateral visual 
loss and autofluorescence images o f both eyes available for grading purposes. AF images 
from 40 spouse comparisons were also available for grading. Unilateral visual loss was 
once again defined as a visual acuity o f worse than 6/24 in the affected eye and better than 
6/9 in the fellow eye. This corresponds to a difference o f three lines between the eyes.
Images of affected and fellow eyes from each patient (270 eyes) in addition to the right eye 
of each spouse comparison (n=40) were then graded by one reader (SD) to determine the 
AF characteristics using a pilot grading system developed for the study (see appendix 1).
The autofluorescence characteristics o f the fellow eye were then compared with regard to 
the cause o f visual loss in the affected eye (i.e. GA, CNV or PED) and to that o f 40 
clinically identified spouse comparisons (Right eye).
3.7 Identification of foveal location
It was found during the course o f the study, that in patients with late stage AMD, the fovea 
was very difficult to identify just by assessing the photograph visually. Additionally data on 
the precise mapping o f the foveal location relative to the centre o f the optic disc were 
limited. Since the accurate position o f the fovea was deemed important for many aspects o f 
this thesis, a separate study was undertaken to establish foveal location in normal subjects. 
Data on the fovea’s mean location in 211 young healthy eyes relative to the optic disc were 
collated from digital colour fundus photographs, in both disc diameters and degrees. Those 
patients with data from both eyes allowed assessment o f symmetry between eyes.
Digital fundus photographs o f 150 consecutive patients (211 eyes) from the hospital image 
database, with at least one healthy fovea were analysed using Topcon Imagenet 2000© 
measurement software. All data were collected and analysed by myself. Younger patients 
(subjects less than 45 years) were chosen due to the ease of locating the foveal reflex
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produced by the increased reflectivity o f the internal limiting membrane. One hundred 
patients had 35 degree field fundal photographs and 50 patients had 50 degree field images.
Using the Topcon imagenet 2000© measurement facility, the disc diameter (D), horizontal 
(H) and vertical (V) distance from the centre o f the optic disc to the fovea and the total 
width o f the photograph were measured in mm for each patient (see figure 8). Mean values 
and standard deviations for the horizontal and vertical distance from the centre of the optic 
disc to the fovea were calculated and expressed in terms of disc diameters and degrees. For 
those 61 patients with data available from both eyes, the average values were used and the 
oblique distances (O) between the fovea and centre o f the disc in each eye were also 
calculated. Comparisons between eyes were made using a paired t-test.
M--------------------------------------------------------------------------------------------------------------------------- ►
Figure 8: schematic diagram detailing measurements taken to calculate foveal location
3.8 Study of susceptibility of the macula to GA
To determine the relative susceptibility o f regions o f the macula to atrophy and allow the 
construction o f a contour map, the normative data obtained for the location o f the fovea in
35° or 50°
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healthy eyes (see section 4.6) was utilised. This was particularly important due to the 
difficulty in locating the fovea in the elderly retina affected by geographic atrophy.
Inclusion /  exclusion criteria
Digital colour fundus photographs o f 113 consecutive patients (200 eyes) from the study 
with an area o f visible geographic atrophy o f sufficient quality to carry out the analysis 
were included in the study. Forty-two patients with GA present in one or both eyes were 
excluded due to poor quality photographs or disciform scars with surrounding atrophy. In 
addition, images where the edges o f the atrophy could not be clearly determined from the 
colour image were excluded unless an autofluorescence image was available to assist in 
localisation.
Longitudinal data from a subset o f patients (n=21) was also analysed to establish 
progression o f geographic atrophy over time.
3.8.1 Foveal marking and resizing images
Prior to analysis, each image was viewed using Adobe Photoshop version 6.0 and the fovea 
marked. This was performed by inserting a small square over the fovea (in those 
retrospective images where the fovea was identifiable) or using a partially transparent 
rectangle to measure a set distance between the centre o f the disc and the fovea (see figure 
9 [page 96]) as calculated from the normative data derived from the previous study. The 
images were then resized so that there were 500 pixels between the disc and fovea to allow 
comparison between images taken at different time points. Finally each image was 
compressed and saved as a JPEG (100-150KB).
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Figure 9
Schematic representation of how the fovea was located using a digital rectangle overlay of 
known dimensions
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3.8.2 Contour map construction
To produce a contour map o f the susceptibility o f the macula to GA, a Microsoft Excel 
spreadsheet was used to provide a grid for each colour image. The background was then 
replaced with a fundus image so that the areas o f atrophy could be marked. The grid was 
adjusted so that 30 pixels separated the fovea from the centre o f the disc. The pixels 
overlying the marked fovea location and centre o f the disc were then filled in and marked 
with an arbitrary number: ‘2 ’ for the fovea and a ‘-1’ for the centre o f the disc to allow 
comparison between images. Pixels overlying the areas o f atrophy in each image were then 
marked with a ‘l ’(see figure 10 [page 98]).
If the areas of atrophy could not be clearly identified on the colour image, the 
autofluorescence image (Zeiss or Heidelberg SLO) was used to assist in the detection of 
atrophy (see figures 4m-p [page 42]).
Aggregate contour maps for the distribution o f atrophy were produced for i) the whole 
patient cohort (n=133) and ii) the patients on whom longitudinal data were available 
(n=21); right and left eyes. They were constructed by matrix summation o f complimentary 
pixels for all images (see figure 16a [page 156]). The pixel matrices were aligned for the 
foveal centre.
Patients with longitudinal data (n=21) were included in the overall susceptibility map but 
the pixels overlying the initial areas o f atrophy were first weighted by assigning these 
pixels with a ‘ 1’ and subsequent areas o f atrophy were assigned a fraction of ‘ 1’ depending 
on the number o f images the areas o f atrophy were present in.
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[Figure 10(15)]
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3.8.3 Progression o f atrophy
For those patients with one or more retrospective images, o f sufficient quality to analyse 
and taken at least 1 year prior to the latest image, progression o f atrophy was also analysed 
(n=21, 26 eyes). Images previously taken using 35mm Ektachrome slide transparency film 
were digitised using a Nikon 990 digital camera as previously described.
When the foveal location could not be determined from retrospective images, the mean 
values from our normative data were applied to locate the foveal centre. An Excel spread 
sheet, was again employed to map the areas o f progression o f atrophy from subsequent 
fundus photographs. In order to assist in the alignment of images over time, the fovea 
location, the centre o f the disc and coloured markers placed over vessel bifurcations were 
transposed between images.
Individual contour maps were then constructed and analysed for each patient with 
longitudinal data to determine whether specific patterns o f progression were seen over time. 
These were classified as circumferential (i.e. in one direction around the fovea either 
clockwise or anticlockwise), centrifugal (i.e. where the atrophy progressed towards the 
periphery in all directions) or centripetal (where the atrophy extended towards the fovea 
from its initial site).
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3.9 Analysis of the RPE in Neovascular AMD using AF 
imaging.
The ability to assess the integrity o f the RPE in neovascular AMD may be important for 
two reasons. Firstly, it may influence the behaviour o f the choroidal new vessel complex 
(Yamagishi, K. et al\ 1988) (Blaauwgeers, H. G. et al; 1999) and secondly, visual outcome 
may be determined by whether or not the RPE maintains its physiological function. In 
geographic atrophy, AF has been shown to be decreased either because there is RPE loss or 
photoreceptor loss since AF reflects its metabolic activity that is driven by photoreceptor 
outer segment renewal, and areas o f increased AF are observed at the junctional zone 
(Holz, F. G. eta l\ 1999a).
In this part o f the study the AF findings in patients with different stages o f CNV were 
evaluated and compared to the FFA images.
Fundus AF images o f sixty-five eyes (65 patients), with choroidal neovascularisation 
(including PED) at various stages o f disease, were analysed from the study image database.
Eligibility criteria included (1) patients with choroidal neovascularisation or pigment 
epithelial detachment (PED) due to AMD in at least one eye and (2) AF, colour and FFA 
imaging in the cases o f recent onset o f CNV o f sufficient quality to allow evaluation.
The patients were then divided into three groups according to the timing o f the AF imaging. 
Group 1 consisted o f twenty patients who had AF imaging undertaken at the same time as 
CNV or PED was diagnosed using FFA. Group 2 consisted of a further 8 patients who had 
AF imaging performed 1-6 months following the diagnosis o f CNV. The remaining 37 
patients had AF imaging o f late stage CNV with established disciform scars and are 
referred to as group 3. FFA was not performed in this latter group at the time o f AF 
imaging.
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In those with recent onset CNV (Group 1), the FFA images were directly compared to the 
auto-fluorescence images using Topcon IMAGEnet 2000 © software (see next section) so 
that areas o f fluorescence could be mapped exactly to corresponding areas on the AF 
images (see figure 11 a&b [page 102]). Patterns o f AF within and around the lesions were 
analysed and overall areas o f abnormality on both FFA and AF were measured (see next 
section). Additionally, the nature o f  the lesion (i.e. classic, occult CNV and avascular PED) 
was determined from the early and late fluorescein images according to the MPS guidelines 
(MPS; 1991) in group 1 only.
In group 2, where the AF images were taken between 1-6 months after the FFA, areas o f 
abnormality were not measured but areas o f previous leakage on FFA were mapped to the 
AF images using IMAGEnet 2000 © software.
In group 3, with established disciform scars, colour and AF images were analysed for 
various patterns.
The colour images o f all patients were graded to confirm the diagnosis o f CNV by two 
trained graders with an arbitrator in the event o f disagreement.
3.9.1 Topcon image analysis programme
In order to compare AF images directly with either digital fluorescein angiograms (FFA) or 
digital colour images, the Topcon Imagenet 2000 © image analysis software was used.
When comparing FFA images to AF images, a mid-venous phase angiogram was selected 
so that the site o f leakage could be identified and compared directly to the AF image. It was 
also important that the AF image was taken just prior to FFA to avoid artefactually 
increased AF.
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Figure 11
Planimetry technique for comparison o f  (a) FFA and (b) AF images o f AMD using Topcon imagenet 2000© 
measurement facility. Note the area o f  hyperfluorescence on the fluorescein angiogram corresponds to a 
darkened area on the AF image
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The two images to be compared were imported into the Topcon IMAGEnet 2000 © 
‘compare images’ programme. At least 6 reference points at vessel bifurcations were then 
selected on both images to allow comparison and compensation for varying magnification. 
The size o f various regions and areas o f abnormality could then be measured by a single 
observer (SD) using a cursor driven measurement facility on one image with the 
corresponding area automatically shown and measured (in cm2) on the second image for 
spatial comparison (see figure 1 la& b [page 102]). Linear measurements between vessel 
bifurcations were also made as an internal control to ensure adequate adjustment of 
magnification differences between images. For each measurement, an average o f 3 
measures was determined.
These images were then exported to Adobe Photoshop version 6.0 and saved as JPEG or 
TIFF images.
3.10 Influence of smoking on type of AMD lesion
In order to analyse the influence o f smoking on the type o f AMD lesion (i.e. neovascular or 
non-neovascular) smoking data ascertained as part o f the study were analysed for all those 
patients graded with evidence o f AMD. For the purposes o f the analysis, AMD was defined 
as either ‘neovascular’ where choroidal neovascularisation, disciform scar or serous 
detachment of the retinal pigment epithelium were present in one or both eyes or ‘non 
neovascular’ where there was no evidence o f neovascular AMD in either eye but only 
geographic atrophy in one or both eyes.
A full smoking history was taken including data on number o f cigarettes smoked per day, 
age when smoking began and age o f stopping smoking in ex-smokers. Pack years were also 
calculated from the total time subjects had smoked, multiplied by the usual daily cigarette 
intake, and divided by 20.
A total o f 711 patients were included in the study analysis (578 -  graded as neovascular,
133 -  graded as non neovascular).
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Data were analysed using multiple logistic regression analysis (see statistics section). Age 
and gender were considered to be the main confounding factors for the study. Odds ratios 
and their 95% confidence intervals were calculated for the likelihood o f neovascular AMD 
as the dependent variable using smoking status (categorical variable- 0= non smoker, 1= ex 
smoker, 2= current smoker), age (continuous variable) and gender (categorical variable - 
f= 0, m= 1) as independent variables, as demonstrated by the model below.
Loge(p/1 ~p)= a  + p i smoking status + P2 age + p3; 
where:
p = proportion o f patients with neovascular AMD 
a  = is the y intercept
p i, p2, etc are the regression coefficients o f the variables in the model
A further regression analysis and a chi-squared test for trend (‘M edcalc®’ statistical 
software -Belgium) were also performed using the pack year data.
3.11 Statistics
Three statistical software packages were used for analysis.
• Medcalc® (Belgium )- This was used primarily for t-tests (to test null hypothesis 
with continuous data), chi squared test and test for trend (for categorical data), 
kappa statistic (see below), Pearson’s correlation coefficient calculations (where 
variables are continuous), Bland & Altman plots and Fisher’s exact calculations 
(where expected values were <5 since this test does not require any distributional 
assumptions).
• SPSS 9.0 (SPSS Inc, statistical software, Chicago, USA) - This programme was 
utilised to carry out multiple regression analysis.
• STATA 7.0 (STATA corp , statistical software, Texas, USA)- This package was 
used to assess inter and intra-observer variability for grading and to compare 35mm 
and digitised images (carried out by Catey Bunce; Moorfield’s Eye Hospital).
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3.11.1 Kappa statistic ( k )
The k  statistic is generally used to assess the extent o f observer variability in clinical 
measures. It assesses ‘agreement’ when considering data arising from nominal or ordinal 
scales and discriminates between actual agreement and that due to chance. It relies on the 
comparison between the observed and the expected amount o f agreement, the latter 
representing that due to chance and dependent on the prevalence o f the attribute being 
measured (Brennan, P. et al; 1992).
Values for k  will usually lie between zero and 1, zero indicating only chance agreement and 
1 indicating perfect concordance. Negative values would suggest situations where 
discordance exists. Intervening values o f kappa have been given different arbitrary 
strengths o f agreement as shown in the table 3 below (Brennan, P. et al; 1992; Landis, J. R. 
et al; 1977).
Table 3: Kappa statistic interpretation according to Landis 1977 and Brennan 1992
k statistic Stren gth  o f  agreem ent
<0.2 Poor
0.21-0.40 Fair
0.41-0.60 M oderate
0.61-0.80 G ood/ Substantial
0.81-1.00 Very good/ Almost perfect
In this study k  was used to assess inter- and intra-observer variability, when evaluating the 
effect o f digitising 35mm film fundal photographs and additionally to compare agreement 
between eyes when assessing concordance and symmetry of phenotype.
Page 105
Detailed Clinical Phenotyping of Age-Related M acular Degeneration
Dr S Dandekar
3.11.2M ultiple logistic regression analysis
This technique was used to assess the relationship between the risk o f neovascular AMD 
(binary dependent variable) and various independent variables such as smoking, age and 
gender (see section 3.10).
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3.11.3 Bland and Altm an plots
Comparison data o f measurements between AF and FFA images were displayed using a 
graphical method described by Bland and Altman. This plots the difference between 
measurements against the mean o f the two measurements and is used to assess the 
agreement between two methods o f clinical measurement (Bland, J. M. et al; 1986).
3.12 Functional assessment of areas of increased 
autofluorescence
Areas o f increased AF are seen in eyes affected by both AMD and ARM (Lois, N. et al; 
2002; Solbach, U. et al; 1997; von Ruckmann, A. et al; 1997a; von Ruckmann, A. et al; 
1997b). In geographic atrophy, regions o f increased AF have been demonstrated around 
areas o f atrophy and are thought to precede the development o f retinal pigment epithelial 
and photoreceptor loss (Holz, F. G. et al; 2001). Regarding drusen and autofluorescence, 
studies have been less conclusive as to the association between the distribution o f AF, types 
o f drusen and the thickening o f Bruch’s membrane (Solbach, U. et al; 1997) (Lois, N. et al; 
2002), (Okubo, A. et al; 1999). This implies that Bruch’s membrane changes and AF 
changes may be two independent measures o f ageing and ARM in the retina (Lois, N. et al; 
2002). Since fundus auto fluorescence is believed to represent the metabolic activity o f the 
RPE, it therefore provides ‘in vivo’ assessment o f changes in the RPE/Bruch’s membrane 
complex and photoreceptor function (von Ruckmann, A. et al; 1997b).
Recently it has been shown that involvement of the rod system may precede that of the 
cone system in AMD (Curcio, C. A. et al; 2000; Curcio, C. A.; 2001; Jackson, G. R. et al; 
2002). A study was therefore carried out predominantly by Hendrik Scholl in association 
with colleagues at the Institute o f  Ophthalmology to investigate the relative involvement o f 
the rod and cone system and the functional implications o f increases in AF using photopic 
and scotopic fine matrix mapping (FMM) in patients derived from the cohort o f patients.
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The data pertaining to this section were predominantly collected by Hendrik Scholl and 
colleagues at the Institute o f Ophthalmology (except for patient recruitment, 
autofluorescence imaging and some data interpretation which were carried out by myself) 
and therefore represents a context report o f the work o f others. It is included in this thesis as 
although I was not the main investigator, I certainly contributed to the study and I feel that 
it presents important data that help to explain findings in other sections.
The inclusion criteria for patients were those with areas o f increased AF at the posterior 
pole and a visual acuity o f 20/40 or better to allow fixation in the study eye. Patients with 
more than mild nuclear sclerosis on slit lamp examination were also excluded so as to 
provide good quality images.
All study patients underwent the following protocol for the study: (1) Best corrected visual 
acuity with ETDRS charts, (2) Humphrey standard visual field examination using the 30-2 
programme (data not shown), (3) photopic fine matrix mapping (FMM), (4) pupil dilatation 
with 1.0% tropicamide and 2.5% phenylephrine, (5) dark adaptation for 45 min, (6) dark- 
adapted 30-2 Humphrey visual field examination as described elsewhere (Chen, J. C. et al; 
1992) (data not shown), (7) scotopic FMM, and (8) AF image recording.
3.12.1 Fine matrix mapping (FMM )
Fine matrix mapping under photopic and scotopic conditions was carried out in association 
with colleagues at the Institute o f Ophthalmology to investigate the relative involvement of 
the rod and cone system and the functional implications o f increases in AF in patients with 
age-related macular degeneration.
Depending on the location o f the area o f increased fundal AF, either a FMM of the centre 
o f the macula or a FMM of the nasal superior, nasal inferior, temporal superior, or temporal 
inferior quadrant o f the macula was obtained each o f which included the fovea at one o f the 
comers o f the FMM. The technique o f FMM has been described previously (Chen, J. C. et
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al; 1990; Chen, J. C. et al; 1992; Chuang, E. L. et al; 1987; Fitzke, F. W. et al; 1989; 
Guymer, R. H. et al; 1997; Schachat, A. P. et al; 1995; Wu, D. et al; 1995). Briefly, the 
technique uses a modified Humphrey field analyser. For the photopic FMM measurements, 
standard Humphrey size III target white flashes were used on a standard Humphrey bowl 
illumination o f 31.5 apostilbs. For scotopic FMM measurements, Humphrey size III target 
blue flashes were presented with the bowl illumination switched off. Four red light- 
emitting diodes in a small diamond configuration served as the fixation target. Accuracy o f 
fixation was monitored using an infrared camera. For the FMM perimetry, retinal 
luminance sensitivity was tested at 100 test locations and subtended a visual angle of 9 x 9 
degrees at the posterior pole. Subsequent processing o f the data then produced a three 
dimensional contour plot showing the size and location of luminance sensitivity gradients 
across the grid (contour steps: 0.1 log units). These data were used to calculate the mean 
and the maximum threshold elevation from baseline. The higher the elevation from 
baseline, the greater the loss o f function compared with normal values (Chen, J. C. et al; 
1992).
These contour plots were then superimposed onto the AF images by aligning anatomical 
landmarks using custom image analysis software. Fundal AF images were recorded using 
the cSLO (Zeiss prototype SM 30-4024, Zeiss, Jena, Germany), as previously described 
(see above) (Lois, N. et al; 2002; von Ruckmann, A. et al; 1995; von Ruckmann, A. et al; 
1997a).
Fine matrix mapping results were compared with age-matched data that have been 
published previously (Guymer, R. H. et al; 1997; Schachat, A. P. et al; 1995; Westcott, M. 
C. et al; 1997). The individual threshold or luminance sensitivity data (reciprocal o f 
threshold) were compared over areas o f normal, increased and decreased AF.
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4 Results & Analysis of data
4.1 Characteristics & analysis of patients recruited to the 
study.
At the time o f analysis, 1059 European subjects (940 patients and 119 spouses) had been 
recruited (90% by m yself and the remaining 10% by my colleagues Sharon Jenkins,
Hendrik Scholl and Tunde Peto) with colour fundus photographs, auto fluorescence (AF) 
images and data regarding family history and smoking history.
923 o f the 1059 subjects recruited to the study had colour fundus images o f both eyes of 
reasonable quality, available for grading (839 patients, 84 spouses).
The remaining 136 subjects did not have colour fundus images available from both eyes. 
These ‘missing im ages’ were attributable to either a lack of photographic services on the 
day o f recruitment (n=13), poor quality images at the time o f photography regarded not 
suitable for grading (n=59), patients not willing to wait for images to be taken on the day of 
recruitment (n=38) or loss or misplacement o f  35mm film images prior to digitisation 
(n=26).
4.1.1 Case- Com parison group definition
Once the colour fundus images had been graded, it became evident that a large proportion 
of subjects who had initially been recruited as the spouse ‘comparison group’ with fundi 
which appeared normal on biomicroscopy, had evidence of soft drusen (>63 pm) in one or 
both eyes. For the purposes o f this analysis, all those from the comparison group graded 
with soft drusen >63pm in one or both eyes were therefore reclassified as ‘patients’ and 
only those with hard drusen <63pm  in both eyes were analysed as the ‘comparison group’ 
(see figure 4 i&j [page 42]).
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Using this case —definition, 923 subjects were analysed in total; 879 as patients and 44 as 
spouse comparisons.
4.1.2 Dem ographic data
The demographic data (particularly sex and age data) for the 923 subjects with colour 
images o f both eyes who were recruited to the study are presented here.
4.1.2.1 Sex
O f the 879 patients, 65% were female and o f the 44 from the comparison group, 43% were 
female (see table 4). This difference in proportions was statistically significant (p=0.005: % 
test).
4.1.2.2 Age
The median age o f the 879 patients was greater than that of the 44 from the comparison 
group [77 (95%CI:76-77) v 72 (95%CI: 69-74)]. There was no difference however between 
the median age o f the females (77) and males (76) that participated in the study (Mann- 
Whitney U test; p=0.97). Table 4 presents the gender and age breakdown o f patients and 
spouse comparisons.
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Table 4: Age of study subjects recruited
Age-group Study Patients
(n-879)
Comparison
Group
(n=44)
Female Median Age 77 (95%CI:76- 70 (95%CI:62-
77) 73)
50-59 yr 22 2
60-69 yr 93 7
70-79 yr 262 7
80-89 yr 179 3
90+ yr 14 0
Total 570 (65%) 19 (43%)
Male Median Age 76 74
(95%CI:75-78) (95%CI:69-78)
50-59 yr 12 1
60-69 yr 49 6
70-79 yr 137 12
80-89 yr 105 4
9 0 + yr 6 2
Total 309 (35%) 25 (57%)
4.1.3 Smoking data
The proportion o f smokers, ex-smokers and current smokers amongst the patient group and 
controls is given in table 5 {page 113}. The proportion o f controls who are current smokers 
is approximately twice that o f patients and there is a higher proportion o f ex-smokers and 
non-smokers (not significant) in the patient group. These results may well be skewed by the 
presence o f small numbers in the control group. A more detailed analysis of smoking data 
and the influence on the type o f AMD lesion seen is shown in Chapter 2.3.1.
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Table 5: Smoking status amongst patients and comparison group
Non smoker Ex smoker Current smoker
Patients (n=879) 357 (41%) 415 (47%) 107(12%)
Comparison Group (n=44) 17(38.5% ) 17(38.5%) 10 (23%)
X2 test (2X2 table) =0.012, DF=1 
group, p=0.91
difference o f  frequency o f non smokers between patients and comparison
4.1.4 Family history data
The proportion o f patients and spouse comparisons with a self-reported family history of 
AMD was 22% and 7% respectively (statistically significantly different - see table 6). In 
those patients graded with bilateral AMD this figure rose slightly to 25%.
Table 6: Proportion of patients and comparison group with positive family history
Positive Family History
Patients (n=879) 199 (22%)
Patients with bilateral AMD
(n=395)
100 (25%)
Comparison Group (n=44) 3 (7%)
X  test = 4.769, DF = 1, p = 0.029 (difference between patients and 
comparison group- 2x2 table)
4.2 Clinical phenotype of study subjects
Both eyes o f 879 patients and 44 spouse comparisons were graded for the various 
abnormalities seen in ARM and AMD. Each patient was also assigned a predominant 
phenotype for each eye to represent the most advanced stage of macular abnormality 
present (see table 2 {page 83}).
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Table 7 represents the predominant phenotype data for each eye o f the 879 patients. The 
numbers in bold correspond to the patients with the same predominant phenotype in each 
eye, i.e. symmetry between eyes at the time o f grading.
Table 7: Predominant phenotype graded for each eye in patient cohort (n=879)
Left Eye
Right eye Hard
drusen
(1)
Soft
drusen
(2)
GA
(3)
PED
(4)
CNV
(5)
Poor
quality
(8)
Total
Hard
drusen (1)
0 11 1 0 11 0 23
Soft drusen 
(2)
17 154 17 5 111 0 304
GA
(3)
2 25 87 1 38 0 153
PED
(4)
1 4 0 5 4 0 14
CNV
(5)
11 114 48 5 205 1 384
Poor
quality (8)
0 0 0 0 0 1 1
Total 31 308 153 16 369 2 879
Out of the 879 patients, 21 % were graded with drusen only in both eyes, 10% with GA in 
both eyes, 0.6% with PED in both eyes and 23% with CNV or a disciform scar in both 
eyes. All the 44 spouse comparisons were graded with bilateral hard drusen only. Kappa 
statistic was calculated for the overall ‘agreement’ or ‘symmetry’ between eyes in excess of 
that due to chance ( k  = 0.264; SE = 0.025, 95% Cl = 0.214-0.313).
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Table 8 represents the bilaterality o f the various lesions in ARM and AMD in the cohort of 
patients analysed. The number o f unilateral cases is also given with the proportion of those 
with only drusen in the fellow eye given in brackets.
Table 8: Bilaterality of ARM/AMD lesions in patient cohort
Lesions No o f cases No (%) with bilateral 
involvement
No (%) with
unilateral
involvement
Any AMD (not 
drusen only)
697 391 (56%) 306 (44%)
Neovascular AMD 563 219(38% ) 344 (62%)
CNV 547 205 (37%) 342 (63%)
(247 (72%)of these 
CNV-drusen)
PED 25 5 (20%) 20 (80%)
(10 (50%) o f these 
PED-drusen)
Atrophic AMD 219 87 (40%) 132 (60%)
(45 (34%) o f these 
GA-drusen)
Any drusen 
(soft or hard)
484 182 (38%) 302 (62%)
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4.3 Validation of fundal image grading techniques
The prevalences o f the various attributes o f ARM and AMD that were graded from the 50 
eyes as part o f the validation study were determined from the final master grading (see 
table 9).
Table 9: Prevalence of ARM/AMD attributes in the study eyes
Zone 1 Zone 2 Zone 3
(central 1000pm) (outer 3000-
____________________________________________________________________________ 6000pm)______
Drusen < 63 pm * 39 45 48
(hard drusen)
Drusen 63-125 pm * 9 32 28
(intermediate soft drusen)
Drusen 125-250 pm * 4 ,3 ,1  1 3 ,7 ,7  1 3 ,1 0 ,6
(large semisolid drusen) 
distinct, subconfluent, confluent
Drusen 250-500 pm * 0 ,0 ,3  5 ,3 ,1 0  1 ,3 ,2
(large semisolid drusen) 
distinct, subconfluent, confluent
Drusen > 500 pm * 0, 0, 1 0, 0, 4 0, 0, 1
(large semisolid drusen) 
distinct, subconfluent, confluent
Crystalline drusen * 5 6 3
Serogranular drusen * 1
Hyperpigmentation 21 19 5
(presence)
Hypopigmentation 0 2 6
(presence)
Geographic atrophy 11 12 6
(presence)
Neovascular AMD 11 10 5
(presence)
Neovascular AMD 7 6 4
(scar/fibrous)
Neovascular AMD 1 3 0
(retinal haemorrhage)
For large and serogranular drusen, hypopigmentation and retinal haemorrhage, the 
prevalence was extremely low (including values o f 1:50 or less). Geographic atrophy and 
neovascular AMD were more prevalent in zones 1&2 compared to zone 3 (see table 9). In
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zone 1, the predominant features were a subretinal scar present in 7 eyes, a serous retinal 
detachment in 2 eyes and a serous RPE detachment in a further 2 eyes.
4.3.1 Inter-observer variability
Photo quality
Weighted agreement between the three graders on photo quality was fair to moderate and 
ranged between 62% and 75% ( k  = 0.30 -  0.47).
Drusen Characteristics
Section A o f table 10 {page 119} presents the comparison o f gradings for the various 
drusen characteristics. W eighted agreement, weighted kappa values and p-values are 
presented for the categories with an asterix (*). The p-value represents the probability that 
the observations made are due to chance alone. For hard drusen and intermediate soft 
drusen, the agreement was fair to substantial for all zones and ranged between 70% and 
89% ( k  = 0.27 -  0.63) for hard drusen and between 76% and 94% ( k  = 0.31 -  0.69) for 
intermediate soft drusen. For large semisolid drusen (larger than 125 pm), agreement 
ranged from 87% to 100%, but the prevalence for individual types was extremely low (see 
table 9 {page 116}; with values o f 1/50 and 0/50) and hence K-statistic was not performed 
since in these circumstances it does not provide useful information. For the larger drusen, 
the raw data were investigated for all 81 comparisons (3 graders, 3 zones and 9 types of 
large drusen) and showed that the (unweighted) exact agreement was below 40/50 in only 9 
cases with the smallest value being 33/50. Perfect agreement was achieved in 5 cases.
The agreement for crystalline drusen in zones 1-3 was fair to almost perfect and ranged 
between 95% and 100% ( k  = 0.25 -  0.81). For serogranular drusen in zone 1, agreement 
ranged between 96% and 100%.
Pisment abnormalities
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Section B o f table 10 {page 119} shows the unweighted agreement or concordance and 
unweighted kappa values for the grading o f pigment abnormalities in the 50 eyes. For the 
presence o f hyperpigmentation, the concordance was poor to substantial ranging between 
50% and 92% ( k  = 0.14 -  0.75). This was also true for the type o f hyperpigmentation with 
a range o f agreement o f 48% and 88% ( k  = 0.13 -  0.78). For hypopigmentation, where the 
prevalence was low in the graded cases, agreement ranged between 78% and 100%.
Ase-related macular degeneration (AMD)
Section C o f table 10 {page 119} presents the agreement between the gradings of the late 
stages o f ARM or AMD. For the presence of geographic atrophy in zones 1-3, unweighted 
agreement was moderate to almost perfect ranging between 88% and 98% ( k  = 0.60 -  0.95) 
and weighted agreement for the area covered by geographic atrophy was substantial to 
almost perfect (93% - 99%; weighted k  0.79- 0.97).
For the presence o f CNV, the unweighted agreement was substantial to almost perfect 
ranging between 84% and 100% ( k  = 0.62 -  1.00). However, for individual features o f 
CNV, the comparison between different pairs o f gradings resulted in substantial variability 
from only poor to almost perfect agreement ( k  = 0.09 -  1.00; agreement between 72% and 
100%).
A high concordance o f grading was seen for the presence o f scars and retinal haemorrhage, 
with unweighted agreements o f between 90% and 100% ( k  = 0.65 -  1.00) and between 
96% and 100% respectively. W eighted agreement for the area covered by CNV was also 
high with agreement ranging between 86% and 100% and weighted kappa values between 
0.67 and 1.00.
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Table 10: Inter-Observ er Agreement
Zone 1 Zone 2 Zone 3
Observer
1 - 0
Observer
2 -1
Observer
2 - 0
Observer 
1 -0
Observer
2 -1
Observer
2 - 0
Observer Observer 
1 - 0  2 - 1
Observer
2 - 0
A Drusen < 63 pm * 89% 75% 87% 80% 78% 70% 80% 83% 81%
(hard drusen) 0.63 0.27 0.46 0.63 0.56 0.45 0.62 0.63 0.60
p<0.0001 p=0.005 p<0.0001 p<0.000
i
p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001
Drusen 63-125 pm * 93% 92% 94%
I
89% 85% 88% 84% 77% 76%
(intermediate soft drusen) 0.41 0.31 0.38 0.69 0.54 0.56 0.64 0.47 0.36
p=0.003 p=0.022 p=0.006 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p=0.0003
Drusen 125-250 pm * 98%, 96%, 94%, 97%, 92%, 92%, 89%, 92%, 87%,
(large semisolid drusen) 99%, 95%, 95%, 95%, 94%, 94%, 97%, 92%, 92%,
distinct, subconfluent, confluent 99% 97% 98% 98% 95% 90% 100% 93% 94%
Drusen 250-500 pm * 100%, 98%, 98%, 99%, 93%, 94%, 100%, 95%, 95%,
(large semisolid drusen) 99%, 97%, 100%, 99%, 95%, 95%, 99%, 94%, 95%,
distinct, subconfluent, confluent 100% 96% 96% 97% 93% 95% 96% 92% 96%
Drusen > 500 pm * 100%, 100%, 100%, 100%, 97%, 97%, 99%, 98%, 97%,
(large semisolid drusen) 100%, 98%, 100%, 100%, 98%, 98%, 100%, 98%, 100%,
distinct, subconfluent, confluent 100% 98% 98% 99% 96% 96% 99% 98% 97%
Crystalline drusen * 99% 98% 99% 99% 95% 93% 100% 97% 97%
0.81 0.59 0.56 0.78 0.50 0.25 0.79 0.44 0.55
p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p=0.005 pO.0001 p<0.0001 p<0.0001
Serogranular drusen * 98% 96% 98%
B Hyperpigmentation 86% 54% 50% 84% 72% 64% 92% 88% 80%
(presence) 0.75 0.22 0.14 0.68 0.49 0.35 0.66 0.45 0.25
p<0.0001 p=0.017 p=0.086 p<0.0001 p<0.0001 p=0.0004 p<0.0001 p<0.0001 p=0.007
Hyperpigmentation 88% 52% 80% 72% 48% 56% 88% 80% 82%
(type) 0.78 0.18 0.25 0.47 0.13 0.25 0.56 0.22 0.33
p<0.0001 p=0.041 p=0.007 pO.0001 p=0.079 p=0.004 p<0.0001 p=0.01 p=0.0002
Hypopigmentation 100% 78% 78% 100% 78% 78% 100% 88% 88%
(presence)
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C Geographic atrophy 98% 92% 90% 98% 90% 88% 98% 92% 94%
(presence) 0.94 0.75 0.70 0.95 0.71 0.67 0.90 0.60 0.72
pO.OOOl p<0.0001 p<0.0001 p<0.0001 pO.OOOl pO.OOOl pO.OOOl pO.OOOl pO.OOOl
Geographic atrophy * 99% 93% 93%
(area covered) 0.97 0.79 0.80
pO.OOOl pO.OOOl p<0.0001
Neovascular AMD 100% 84% 84% 100% 84% 84% 100% 96% 96%
(presence) 1.00 0.63 0.63 1.00 0.62 0.62 1.00 0.78 0.78
pO.OOOl p<0.0001 p<0.0001
ooo©VC
l pO.OOOl pO.OOOl pO.OOOl pO.OOOl pO.OOOl
Neovascular AMD 100% 74% 74% 96% 72% 74% 98% 92% 94%
(features) 1.00 0.10 0.10 0.80 0.09 0.12 0.85 0.31 0.38
pO.OOOl p=0.147 p=0.147 p<0.0001
T
f
©IIQ
. p=0.051 pO.OOOl p=0.0002 pO.OOOl
Neovascular AMD 98% 90% 92% 100% 94% 94% 100% 96% 96%
(scar/fibrous) 0.93 0.65 0.71 1.00 0.74 0.74 1.00 0.73 0.73
p<0.0001 p<0.0001 pO.OOOl © o o o pO.OOOl pO.OOOl ** o 8 © pO.OOOl pO.OOOl
Neovascular AMD 100% 96% 96% 100% 96% 96% 100% 98% 98%
(retinal haemorrhage)
Neovascular AMD * 100% 86% 86%
(area covered) 1.00 0.67 0.67
pO.OOOl pO.OOOl pO.OOOl
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4.3.2 Intra-observer variability
Table 11 {page 122} presents the concordance between the master grading from initial 
gradings and the master grading from the re-gradings (obtained after a time-delay o f  at least 
two weeks) for the three graders. Minimal and maximal agreement, minimal and maximal 
kappa values, and the maximal and minimal p-value (indicating the smallest and highest 
statistical significance, respectively) obtained from the comparison are provided for each 
zone separately. As for the inter-observer variability (Table 10 {page 119}), weighted 
agreement and weighted kappa values are given for the drusen characteristics and the area 
covered by GA and CNV. For all other categories in Table 11 {page 122} unweighted 
(exact) agreements and unweighted kappa values are given. As for the inter-observer 
variability, K-statistic was not performed for attributes with extremely low prevalences such 
as larger drusen, serogranular drusen, hypopigmentation, and retinal haemorrhage (Table 9 
{page 116}).
Drusen characteristics & pigment abnormalities
Agreement was moderate to almost perfect for small hard drusen, and fair to almost perfect 
for intermediate soft drusen. Agreement for large semisolid drusen (larger than 125 pm) 
ranged between 84% and 100%. Agreement for both the presence and the type of 
hyperpigmentation was fair to substantial.
Aee-related macular degeneration (GA and CNV)
Agreement was moderate to almost perfect for the presence o f GA, and substantial to 
almost perfect for the area covered by GA. The agreement was moderate to almost perfect 
for the presence o f CNV, and substantial for the area covered by CNV. Agreement on the 
individual features o f neovascular AMD was lower although the agreement on the presence 
of scarring was moderate to almost perfect.
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Table 11: Intra-Observer Agreement
Zone 1 Zone 2 Zone 3
Drusen < 63 pm * (m in) 82%, 96%  (max) 72%, 76% 78%, 81%
(hard drusen) 0.45, 0.83 0.43,0.55 0.60, 0.64
pO.OOOl, pO.OOOl pO.OOOl pO.OOOl
Drusen 63-125 pm * 88%, 98% 87%, 96% 81%, 93%
(intermediate soft drusen) 0 .13 ,0 .75 0.51,0.81 0.50, 0.78
p=0.154, pO.OOOl pO.OOOl pO.OOOl
Drusen > 125 pm * 
(large semisolid drusen)
84%, 100% 92%, 100% 90%, 100%
Crystalline drusen * 92%, 100% 92%, 99% 90%, 100%
0.46, 0.94 0.67, 0.85 0.23, 0.95
Serogranular drusen *
p=0.0004, pO.OOOl 
96%, 100%
pO.OOOl p O .0 4 8 , pO.OOOl
Hyperpigmentation 62% , 82% 70%, 82% 84%, 86%
(presence) 0.30, 0.68 0.39, 0.69 0.36 ,0 .54
p=0.006, pO.OOOl p 0 .0 0 0 5 , pO.OOOl p=0.0005, pO.OOOl
Hyperpigmentation 54%, 68% 64%, 76% 78%, 88%
(type) 0 .21 ,0 .46 0.30, 0.61 0.27, 0.46
p= 0 .017, pO.OOOl p 0 .0 0 1 4 , pO.OOOl p=0.002, pO.OOOl
Hypopigmentation
(presence)
88%, 100% 86%, 98% 82%, 90%
Geographic atrophy 92% , 95% 88%, 97% 94%, 96%
(presence) 0.52, 0.78 0.65, 0.77 0.69, 0.81
Geographic atrophy * 
(area covered)
pO.OOOl
90% , 96%  
0 .61 ,0 .88  
pO.OOOl
pO.OOOl pO.OOOl
Neovascular AMD 82%, 90% 88%, 96% 94%, 99%
(presence) 0.42, 0.72 0.46, 0.82 0.63 ,0 .90
p=0.0008, pO.OOOl p 0 .0 0 0 5 , pO.OOOl pO.OOOl
Neovascular AMD 80%, 94% 86%, 96% 92%, 98%
(features) 0 .36 ,0 .76 0.49, 0.84 0.18, 0.66
pO.OOOl pO.OOOl p=0.004, pO.OOOl
Neovascular AMD 86%, 96% 88%, 98% 94%, 96%
(scar/fibrous) 0.46, 0.87 0.50, 0.92 0.54, 0.78
p 0 .0 0 0 3 ,  pO.OOOl p=0.0002, pO.OOOl pO.OOOl, pO.OOOl
Neovascular AMD 
(retinal haemorrhage)
Neovascular AMD * 
(area covered)
96%, 96%
87%, 92%  
0.65, 0.77 
pO.OOOl
98%, 100% 96%, 100%
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4.3.3 Com parison of digitised images and 35mm film grading 
results
The comparison o f the gradings between the two mastercopies from the colour slides and 
digitised images from the 50 eyes used in the study are presented in Table 12 {page 125}. 
For binary scales exact (unweighted) agreement, kappa values and p-values are given and 
for abnormalities with extended scales (as e.g. for drusen characteristics), agreement and 
kappa values are weighted.
Section A o f Table 12 presents the comparison or concordance for drusen characteristics 
between gradings. For small hard and intermediate soft drusen, the agreement for all zones 
was moderate to substantial and fair to substantial, respectively. For large semisolid drusen 
(larger than 125 pm), the weighted agreement was consistently above 90% for all 27 
subgroups.
The agreement for crystalline drusen in zones 1-3 was fair to almost perfect. Agreement 
was perfect for serogranular drusen (only graded for zone 1).
In section B o f Table 12, the comparison for the grading o f pigment abnormalities are 
presented as unweighted agreement and unweighted kappa values. For the presence and 
type of hyperpigmentation, the concordance was only poor to fair. For the presence of 
hypopigmentation however, the concordance was higher (88% to 100%).
Section C o f Table 12 presents the agreement between abnormalities o f late stage disease 
(AMD). For the presence o f GA, unweighted agreement was substantial to almost perfect. 
Weighted agreement for the area covered by GA was also substantial.
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For the presence o f CNV or scars, the concordance was almost perfect and for the features 
o f CNV, agreement was fair to moderate. For the presence o f retinal haemorrhage, 
agreement was between 96% and 98%. Weighted agreement for the area covered by CNV 
was also almost perfect.
To investigate possible sources o f disagreement in more detail, the raw data were reviewed 
and analysed. For the grading o f small hard drusen, using the grading from the 
stereoscopic colour slides as the gold standard, we found that the digitised grading 
underestimated the number o f drusen in all 3 zones (9 z l , 20 z2, 15 z3).
When grading for the presence o f hyperpigmentation, 14, 26, and 42 cases in zone 1, 2, 
and 3, respectively, had evidence o f  pigmentation on the digitised images but not on the 
colour slides. Conversely hyperpigmentation was seen on stereoscopic colour slides but not 
on the digitised images, in only 7, 2, and 0 cases in each zone respectively.
When grading for the presence o f GA, this lesion was graded as ‘absent’ in three cases in 
zone 1 and 2 and in one case in zone 3 from the digitised images when small areas o f GA 
were seen on the 35mm colour slides.
The presence o f CNV from the grading o f the digitised images was missed in two cases 
from zones 1 and 2 and in one case from zone 3; CNV was also graded as ‘present’ from 
the digitised images and ‘absent’ from the conventional colour slides in one case in zones 1 
and 2. For the grading o f CNV features, a tendency to miss neuroretinal detachments on the 
digitised images was also observed (two cases).
As part of a separate study, carried out by medical retinal specialists at Moorfield’s Eye 
Hospital, 35mm transparencies o f AMD were compared to digital images taken with the 
TOPCON imagenet 2000 © digital camera with comparable results (unpublished).
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Table 12: Percentage agreements, kappa values and p-values for comparison o f fundal features between the 
m aster copies o f the 35mm colour slides and digitised images (* weighted kappa values) in each zone.
Zone 1 Zone 2 Zone 3
» Drusen < 63 pm * 91% 86% 77%
r \  (hard drusen) k=0.56 k=0.72 k=0.56
p<0.0001 p<0.0001 p<0.0001
Drusen 63-125 pm - yj'Vo SSJ%
(interm ediate soft drusen) k=0.31 k=0.64 k=0.62
p= 0.005 p<0.0001 p<0.0001
Drusen 125-250 pm * 98%, 98%, 100% 95%, 94%, 94% 91%, 93%, 94%
(large sem isolid drusen)
distinct, subconfluent, confluent
Drusen 250-500 pm * 100%, 100%, 100% 97%, 94%, 97% 97%, 97%, 97%
(large sem isolid drusen)
distinct, subconfluent, confluent
Drusen > 500 pm * 100%, 100%, 100% 100%, 100%, 92% 98%, 98%, 98%
(large sem isolid drusen)
distinct, subconfluent, confluent
Crystalline drusen  * 99% 98% 97%
k=0.82 k=0.72 k=0.35
p<0.0001 p<0.0001 p=0.0001
S erogranu lar drusen * 100%
q  H yperpigm entation 56% 32% 12%
D (presence) k=0.27 k=0.00 k=0.02
p= 0.004 p= 0.494 p= 0.243
H yperpigm entation 50% 28% 10%
(type) k=0.15 k=0.05 k=0.03
p= 0.086 p=0.191 p= 0.143
H ypopigm entation 100% 98% 88%
(presence)
r \  G eograp h ic atrophy 94% 94% 96%
(presence) k=0.81 k=0.82 k=0.80
p<0.0001 p<0.0001 p<0.0001
G eograp h ic atrophy * 93%
(area covered) k=0.78
p<0.0001
N eovascu lar AMD 94% 94% 98%
(presence) k=0.82 k=0.81 k=0.88
p<0.0001 p<0.0001 p<0.0001
N eovascu lar AMD 90% 88% 96%
(features) k=0.34 k=0.22 k=0.49
p=0.0003 p= 0.005 p<0.0001
N eovascu lar AMD 96% 96% 98%
(scar/fibrous) k=0.83 k=0.81 k=0.85
p<0.0001 p<0.0001 p<0.0001
N eovascu lar AMD 98% 96% 98%
(retinal hem orhage)
N eovascu lar AMD * 95%
(area covered) k=0.83, p<0.0001
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Inter- and intra-observer variability between graders
Tables 11 and 12, present the respective inter- and intra-observer agreement for the three 
graders for grading o f the digitised colour photographs. Once again agreement and k -  
statistics are weighted for abnormalities with extended scales. Section A o f Tables 11 and 
12 presents the comparison for the grading o f drusen characteristics between and within 
observers, respectively. Agreement for small hard drusen was fair to substantial between 
observers and moderate to almost perfect within observers. For intermediate soft drusen, 
agreement was fair to substantial between observers and moderate to almost perfect within 
observers. The agreement between and within observers for larger drusen ranged from 82% 
to 100%, and 90% to 100%, respectively.
Agreement for pigmentary changes (Section B, Tables 11 and 12) was poor to moderate for 
the presence o f hyperpigmentation between observers and poor to substantial within 
observers. The concordance for the presence o f hypopigmentation ranged between 86% and 
98% between observers and 84% and 100% within observers.
Agreement was moderate to almost perfect for the presence o f GA between observers 
and substantial to almost perfect within observers (Section C, Table 12 {page 125} and 13 
{page 127}). For the area covered by GA, agreement was substantial to almost perfect 
between observers and almost perfect within observers. For the presence o f CNV, 
agreement was moderate to almost perfect between observers and substantial to perfect 
within observers. For the grading o f features o f CNV, agreement was poor to almost perfect 
between observers and fair to substantial within observers. For the area covered by CNV, 
weighted agreement was fair to substantial between observers and substantial within 
observers.
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Table 13: Inter-Observer Agreement
Zone 1 Zone 2 Zone 3
A Drusen < 63 pm * 83%, 94% 74%, 85% 75%, 90%
(hard drusen) 0.40, 0.73 0.52, 0.72 0.53, 0.79
p=0.0001, pcO.0001 pcO.0001 pcO.OOOl
Drusen 63-125 pm * 88%, 93% 79%, 90% 75%, 88%
(intermediate soft drusen) 0.37, 0.52 0.52,0.71 0.48, 0.70
p=0.008, p<0.0001 pcO.0001 pcO.OOOl
Drusen > 125 pm  * 93% , 100% 82%, 100% 89%, 100%
(large semisolid drusen)
Crystalline drusen * 92%, 95% 92%, 97% 90%, 95%
0.26, 0.45 0.29, 0.38 0.02, 0.56
p=0.0001,p<0.0001 p=0.004, pcO.0001 p= 0 .153, pcO.OOOl
Serogranular drusen * 90%, 98%
B Hyperpigmentation 66%, 68% 54%, 64% 44%, 76%
(presence) 0.47, 0.50 0.25, 0.35 0.05, 0.15
p<0.0001 p=0.006, p=0.0001 p=0.211, p=0.041
Hyperpigmentation 46%, 64% 44%, 74% 20%, 56%
(type) 0 .28 ,0 .37 0.09,0.35 -0.08, 0.14
p=0.0005, p<0.0001 p=0.1, pcO.0001 p=0.955, p=0.03
Hypopigmentation 96%, 98% 92%, 96% 86%, 94%
(presence)
C Geographic atrophy 88%, 94% 88%, 94% 94%, 98%
(presence) 0 .55 ,0 .79 0.58, 0.79 0.60, 0.89
p<0.0001 pcO.0001 pcO.OOOl
Geographic atrophy * 91%, 98%
(area covered) 0.70, 0.93 
pcO.OOOl
Neovascular AMD 78%, 92% 80%, 92% 94%, 98%
(presence) 0 .41 ,0 .70 0.44, 0.70 0.64, 0.90
p=0.0003, p<0.0001 p=0.0002, pcO.0001 pcO.OOOl
Neovascular AMD 70%, 96% 70%, 98% 96%, 98%
(features) 0.18, 0.73 0.13, 0.85 0.48, 0.66
p=0.014, p<0.0001 p=0.053, pcO.OOOl pcO.OOOl
Neovascular AMD 84%, 92% 88%, 94% 94%, 98%
(scar/fibrous) 0.34, 0.67 0.44, 0.74 0.55, 0.79
p=0.005, p<0.0001 p=0.0004, pcO.OOOl pcO.0001
Neovascular AMD 92%, 96% 92%, 98% 94%, 100%
(retinal haemorrhage)
Neovascular AMD * 68%, 88%
(area covered) 0.27, 0.62 
p=0.002, pcO.OOOl
Taken from: Scholl et al. Ophthalmology. 2004 (Scholl, H. P. et al\ 2004b)
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Table 14: Intra-Observer Agreement
Zone 1 Zone 2 Zone 3
A Drusen < 63 pm * 
(hard drusen)
91%, 95% 
0.76, 0.80
p<0.0001
73%, 90% 
0.45, 0.81 
pcO.0001
78%, 87% 
0.59, 0.76 
pcO.OOOl
Drusen 63-125 pm * 
(intermediate soft drusen)
89%, 96% 
0.44, 0.75 
pcO.0001
89%, 95% 
0.79, 0.84 
pcO.0001
85%, 95% 
0.67, 0.88 
pcO.OOOl
Drusen > 125 pm * 
(large semisolid drusen)
92%, 100% 90%, 100% 75%, 100%
Crystalline drusen * 94%, 99% 
0.16, 0.88 
p=0.124, pO.OOOl
95%, 99% 
0.30, 0.83 
p=0.001, pcO.0001
95%, 99% 
0.15, 0.88 
p=0.156, pcO.OOOl
Serogranular drusen * 94%, 100%
B Hyperpi gmentati on 
(presence)
54%, 84% 
0.32, 0.73 
p=0.0003,p<0.0001
54%, 76% 
0.21,0.44 
p=0.004, pcO.OOOl
40%, 84% 
0.08, 0.43 
p=0.188, pcO.0001
Hyperpigmentation
(type)
56%, 82% 
0.27, 0.71 
p=0.005, p<0.0001
54%, 68% 
0.13,0.41 
p=0.035, pcO.OOOl
42%, 72% 
0.10,0.44 
p=0.056, pcO.0001
Hypopigmentation
(presence)
88%, 100% 84%, 96% 86%, 96%
C Geographic atrophy 
(presence)
96%, 100% 
0.85, 1.00
p<0.0001
96%, 98% 
0.85, 0.94 
pcO.OOOl
96%, 98% 
0.73, 0.89 
pcO.OOOl
Geographic atrophy * 
(area covered)
95%, 97% 
0.83, 0.92 
pcO.0001
Neovascular AMD 
(presence)
84%, 92% 
0.65, 0.70 
pcO.0001
88%, 94% 
0.72, 0.77 
pcO.OOOl
94%, 100% 
0.74, 1.00 
pcO.OOOl
Neovascular AM D 
(features)
80%, 90% 
0.33,0.56 
p=0.002, pcO.0001
80%, 90% 
0.34, 0.53 
p=0.002, pcO.OOOl
94%, 98% 
0.49, 0.74 
pcO.0001
Neovascular AMD 
(scar/fibrous)
92%, 96% 
0.67, 0.81 
pcO.0001
96%, 98% 
0.84, 0.92 
pcO.OOOl
96%, 100% 
0.66, 1.00 
pcO.OOOl
Neovascular AMD 
(retinal haemorrhage)
94%, 98% 94%, 100% 98%, 100%
Neovascular AMD * 
(area covered)
87%, 93% 
0.67, 0.75 
pcO.0001
Taken from: Scholl et al. Ophthalmology. (Scholl, H. P. et al\ 2004b)
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4.4 Concordance and symmetry between eyes in bilateral 
A M D
Three-hundred and seventy-five patients (47%) out o f a total of 790 patients recruited and 
graded at the time o f analysis, had evidence o f late AMD affecting both eyes. The 
remaining 415 patients were graded as having either drusen in both eyes (n=T32;17%), GA 
in one eye and soft drusen in the other (n= 41; 5 %), CNV or PED in one eye and soft 
drusen in the other (n=222;28 %), or hard drusen only in one eye and CNV in the other 
(n=20; 2.5%).
4.4.1 Concordance o f late AM D
O f these 375 patients (750 eyes), 67% were female. The median age at entry into the study 
was 78 years for both sexes (range 56 - 93). Using data from the image grading, a 
concordant phenotype was observed in 281/375 patients (75%); 194 (52%) patients were 
graded as having CNV, 82 with GA (22%) and 5 with PED (1%) in both eyes (see table 15 
{page 130}). In view o f the availability o f fluorescein angiography in only 196 cases and 
the difficulty in differentiating between PED and CNV from colour photographs alone, the 
recalculated concordance rate with the CNV and PED phenotypes combined as neovascular 
AMD was 77% (290/375 patients) which included 208 patients with bilateral neovascular 
disease and 82 patients with bilateral GA.
The Kappa value for concordance between eyes for all three categories o f disease namely 
CNV, GA and PED as determined from the images was 0.48, (SE 0.05, 95%CI: 0.38-0.57; 
p<0.001) and when the PED and CNV categories were combined as neovascular disease 
the kappa value increased to 0.49; (SE=0.049, 95%CI: 0.39-0.59; p<0.001).
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From the grading, 143/750 (19%) eyes (33 patients both eyes, 44 Left eyes, 33 Right eyes) 
had features o f CNV present with evidence o f atrophic areas within or adjacent to the 
lesion. Using retrospective data (missing for 20 eyes), these areas of atrophy were shown to 
be the result o f secondary atrophy occurring after formation of a disciform scar in 93 eyes 
(65%), from the resolution o f PED in 12 eyes (8%) and from CNV occurring at the edge of 
an area o f GA in 18 eyes (13%). This changing phenotype is likely to explain part o f the 
observed discordance. For the purposes o f the study these cases were graded as 
neovascular AMD in keeping with the International Classification.
Table 15: No of patients with a concordant and discordant phenotype between eyes 
according to digital grading.
Right Eye (Grading)
Phenotype GA PED CNV Total
Left Eye GA 82 1 37 120
(Grading) PED 0 5 4 9
CNV 47 5 194 246
Total 129 11 235 375
k =  0.48; Stanclard Error= 0.047; 95% Cl = 0.38-0.57 (p<0.001)
4.4.2 Symmetry of GA from AF images
O f the 50 patients analysed, 32 (64%) were female and the median age was 76 (range 61- 
93). Twenty-one patients (42%) had evidence o f peripapillary atrophy in one or both eyes 
that was measured in a similar fashion by drawing around the optic disc but not including 
the optic disc itself. The relevance o f peri-papillary atrophy to the aetiology o f AMD is at 
present unknown. The purpose o f the study was to see if  any differences existed between 
the eyes. In glaucoma, a study has shown that the area and extent o f peripapillary atrophy is
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significantly greater and more prevalent in eyes with a disc hemorrhage compared to 
contralateral control eyes(Ahn, J. K. et al\ 2004).
The average areas o f atrophy were calculated including and excluding the peripapillary 
atrophy for right and left eyes (see table 16 {page 132}). Correlation coefficients 
comparing right and left eyes for the atrophic area including and excluding peripapillary 
atrophy were 0.67 (p<0.0001) (95%CI 0.47-0.80) and 0.63 (p<0.0001) (95% Cl 0.43-0.77) 
respectively (see figure 12a&b [page 134]). The paired t-test showed no significant 
difference o f these average values between right and left eyes with and without the peri­
papillary atrophy (see table 16 {page 132}).
When analysing the pattern o f GA, 42% eyes had evidence o f a unifocal atrophic lesion 
(3% horse shoe in shape) and 58% eyes demonstrated a multifocal pattern (see table 17 
{page 132}). Kappa statistic was calculated for the agreement between the pattern of 
atrophy between eyes giving a value o f 0.67 (95% Cl; 0.46 to 0.88) which represents 
substantial agreement according to Landis and Koch (Landis, J. R. et al; 1977) (see table 
3).
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Table 16: Com parisons for m easurem ents o f areas o f atrophy between right and left eyes (sq 
steridians)
Area o f  atrophy 
including peri­
papillary atrophy
Area o f  atrophy 
excluding peri­
papillary atrophy
No o f patients 50 50
Mean o f Right Eyes 146.96 (SD 141.5) 136.1 (SD 135.7)
Mean o f Left Eyes 140.54 (SD 118.3) 125.1 (SD 110.7)
Mean difference 6.42 10.96
Paired t-test (RvL) DF=49, t=0.419,
p=0.68
DF=49, t=-0.714, 
p=0.48
Pearson’s correlation 
coefficient ( r )
(RvL)
0.665 (p<0.0001) 0.629 (pcO.0001)
Table 17: Comparison of shape of atrophic area between right and left eyes.
L shape
R shape unifocal multifocal Grand Total
unifocal 17 5 22
multifocal 3 25 28
Grand Total 20 30 100
Kappa = 0.67 (95%CI : 0.46-0.88)
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Figure 12a: Graph to show correlation o f areas o f atrophy (sq steridians) between the left 
and right eye o f each patient including the peripapillary atrophy (r = 0.6650, P<0.0001)
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Figure 12b: Graph to show correlation o f areas o f atrophy (sq steridians) between the left 
and right eye o f each patient excluding the peripapillary atrophy (r =. 0.6294 P<0.0001)
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4.5 Characteristics of the fellow eye in patients with 
unilateral visual loss
4.5.1 Colour fundus image characteristics
O f the 195 patients analysed, 80 (41%) were male. The median age was 76 years. The 
cause o f visual loss was graded as choroidal neovascularisation in 156 patients (CNV 
group), geographic atrophy in 26 (GA group), avascular pigment epithelial detachment in 3 
(PED group) and soft drusen in 10 patients (Drusen group). The median ages, visual 
acuities and gender ratio o f the individual groups are given in table 18 {page 134}. The 
comparative fellow eye characteristics for the two largest groups (CNV & GA) are shown 
in table 19 {page 137}. The fellow eyes o f  the PED and drusen groups were only compared 
to a limited degree due to small numbers.
Table 18: Demographics of patient cohort segregated by cause of visual loss
Feature causing loss o f  vision
GA (n=26) CNV (n=156) PED (n-3) Drusen (n=10)
Age (Median) 74 76 78 76
Median Visual 
acuity 
(worse eye)
6/36 -  6/60 3/60 6/36 6/36
Sex
Male
Female
10(38%) 
16 (62%)
67 (43%) 
89 (57%)
0
3 (100%)
3 (30%) 
7 (70%)
Fellow eye characteristics of GA v CNV group :
Total area of Drusen. There was a statistically significant trend for the fellow eyes o f the 
GA group to have a greater area o f the macula covered by drusen and a greater tendency for
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the CNV group to have a smaller area covered by drusen. This was confirmed using the chi 
squared test for trend (p<0.001) (see table 19 {page 137}).
Confluent and Distinct Drusen. When drusen o f all sizes in all zones were combined, 
there were significantly more GA fellow eyes with both confluent drusen (Fisher’s exact 
test p=0.012) and distinct drusen (Fisher’s exact test p<0.0005) when compared to the 
CNV group (see table 19 {page 137} & 24 {page 152}).
Small hard drusen (<63 pm). When considering all zones, there were 17 patients in the 
CNV group with only small hard drusen (<63 pm), fourteen o f whom had no more than 10 
drusen in each zone. This was in contrast to the GA group where no patients had only small 
hard drusen in the fellow eye. This difference however was not statistically significant. 
Large drusen (125 to >500pm). In zones 2&3, Drusen o f size 125-250pm, whether 
distinct or confluent were significantly more prevalent in the fellow eye o f the GA group 
compared to the CNV group as indeed were the larger distinct drusen, (250-500pm) in zone 
3 (p=0.0001). Drusen over 500pm were not seen in zone 1 in either group but were 
statistically more prevalent in the GA group in zone 2 (p=0.021).
Crystalline Drusen. Crystalline or refractile drusen (see figure 13a&b [page 136]) were 
seen in a significantly greater frequency in GA fellow eyes compared to the CNV group in 
all zones but the difference was not statistically significant in zone l(see table 20 {page 
138}).
Serogranular Drusen. These large drusen present in zone 1 (see figure 13d&e [page 136]) 
or drusenoid PED’s as they are sometimes called, were again proportionately more frequent 
in the GA fellow eyes compared to the CNV group (8% v 2%) but the difference was not 
statistically significant.
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Figure 13
(a&b) Colour photographs o f crystalline or refractile drusen (c) AF image o f  crystalline drusen showing 
central dark area surrounded by halo o f  increased AF (d&e) examples o f  a serogranular drusen (or drusenoid 
PED)
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Other AMD lesions. 54% of the GA group had evidence of GA in the fellow eye as well, 
but not involving fixation. This was compared to 11% of CNV group with GA in the fellow 
eye (p<0.00001).
Table 19: Fellow eye characteristics of those with visual loss due to CNV & GA
Feature causing visual 
loss
GA
(n=26)
CNV
(n=156)
P value 
(NS- not significant)
Fellow eye
Drusen Area (all zones)
0% 0 (0%) 1 d % ) Chi squared
<10% 2 (8%) 77 (49%) test for
10-24% 10(38% ) 60 (38%) Trend (*2 =
25-49% 11 (42%) 17(11%) 32.363; DF=1)
>50% 3 (12%) 1 (1%) P 0 .0 0 0 1
Any Zone
<63u hard drusen only 0 (0%) 17(11%) NS
Confluent Drusen 23 (89%) 98 (63%) P=0.01*
Distinct Drusen 17(65% ) 44 (28%) P<0.0005*
Extrafoveal GA 14 (54%) 17(11%) P0.00001*
Extrafoveal CNV 2 (8%) 10 (6%) NS
* Fisher’s exact test
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Table 20: Drusen characteristics of fellow eye by zone (GA & CNV eyes)
Zone 1
presence in fellow eye of:
GA as cause o f  
visual loss 
(n=26)
CNV as cause o f 
visual loss (n=T56)
Fisher’s exact test 
(NS= not significant)
<63 25 (96 %) 143 (92 %) NS
63-125 19 (73 %) 96 (62 %) NS
125-250 distinct 2(8 %) 7 (4 %) NS
125-250 confluent 7(27 %) 43(28 %) NS
250-500 distinct 0 (0 %) 2(1 %) NS
250-500 confluent 4 (1 5 % ) 9 (6 %) NS
>500 distinct 0 (0 %) 0 (0 % )
>500 confluent 0 (0 %) 0 (0 %)
crystalline 2 (8 %) 2(1 %) NS
serogranular 2 (8 %) 3 (2 %) NS
Zone 2
<63 25 (96%) 150 (96%) NS
63-125 24 (92%) 121 (78%) NS
125-250 distinct 12 (46%) 23 (15%) P < 0.001
125-250 confluent 19 (73%) 76 (49%) P < 0.05
250-500 distinct 3 (12%) 5 (3%) NS
250-500 confluent 9 (35%) 34 (22%) NS
>500 distinct 0 (0%) 1 (0.6%) NS
>500 confluent 3 (12%) 2 (1%) P < 0.05
crystalline 12 (46%) 8 (5%) P = 0.000001
Zone 3
<63 26(100% ) 147 (94%) NS
63-125 19 (73%) 94 (60%) NS
125-250 distinct 11 (42%) 18(12%) P < 0.0005
125-250 confluent 19(73% ) 47 (30%) P < 0.00005
250-500 distinct 6 (23%) 2(1% ) P = 0.0001
250-500 confluent 6 (23%) 15 (10%) NS
>500 distinct 0 (0%) 0 (0%)
>500 confluent 1 (4%) 3 (2%) NS
crystalline 4(15% ) 1 (0.6%) P < 0.005
4.5.1.1.1 Fellow eye o f avascular pigment epithelial detachment group
Only three cases o f unilateral visual loss were due to pigment epithelial detachment. This 
low figure was partly due to the difficulty in diagnosing PED from colour images without 
fluorescein angiography in all cases. The PED fellow eyes were more likely to have larger 
and confluent drusen sized between 250-500pm  (66% v 15% in GA group and 5% in CNV 
group, the latter comparison being statistically significant p=0.01) in zone 1, but no eye had
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evidence o f drusen over 500pm. There were also no crystalline or serogranular drusen 
present in any o f the PED fellow eyes.
4.5.1.1.2 Fellow eye o f  drusen causing visual loss
Surprisingly, in 9/10 patients, there was no evidence o f any other lesion other than drusen 
in both the eye with visual loss and the fellow eye (FFA only available in 3 cases). In the 
tenth patient there was evidence o f GA in the fellow and interestingly only drusen in the 
worse affected eye. All eyes had evidence o f small <63pm drusen in all zones and 6/10 
eyes had intermediate sized drusen (63-125pm) in all zones.
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4.5.2 Autofluorescence im age characteristics
O f the 135 consecutive patients with unilateral visual loss, aged between 57 and 92 (median 
76), 83 were females (61%). The median VA in the better eye was 6/9 and in the worse 
affected eye was 3/60. The AF images o f the worse affected eye and the fellow eyes were 
graded in conjunction with the colour fundus photographs in order to determine the cause 
o f visual loss and to determine any corresponding changes in the fellow eye relating to 
specific AF changes.
4.5.2.1 Affected Eye
4.5.2.1.1 Colour Photographs
According to the colour photographs, 109 /135 patients were graded with CNV, 18 with 
GA, 2 with PED and 6 with drusen in the worse affected eye. The fellow eye was then 
analysed according to the cause o f  visual loss in the affected eye.
4.5.2.1.2 Autofluorescence Images
Main area o f  altered AF
Each o f the phenotypes causing visual loss were analysed separately to identify specific 
autofluorescence changes (see table 21 (page 143}). CNV was most commonly associated 
with a unifocal, heterogeneous lesion o f altered AF (60%)(see figure 14a [page 142]). GA 
was associated with either multifocal (56%) (see figure 7c [page 91]) or unifocal (44%)
(see figure 7d), homogeneous areas o f decreased AF in all 18 cases . Only 2 eyes were 
graded with PED and both were noted to have a unifocal, heterogeneous area o f altered AF. 
O f the six eyes graded with drusen, 67% had evidence of homogeneous areas o f decreased 
AF (unifocal or multifocal).
Patterns o f  increased AF
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The most frequent patterns o f increased AF associated with CNV were ‘focal’ areas (see 
figure 15a&b [page 147])(25%) in and around the main lesion followed by a partial or 
complete ‘band of increased AF’ in 21% (see figure 15c&d [page 147]).
In GA, a ‘reticular’ pattern o f increased AF was the commonest seen present in 33% of 
cases (see figure 15e&f [page 148]) followed by a ‘mixed’ pattern in 22% o f the group. A 
‘lace-like’ pattern (see figure 15g&h [page 148]) was seen in 17% and 3% of the GA and 
CNV group respectively.
In the 2 cases with PED, 1 showed a ‘focal’ pattern and the other a ‘band’ pattern of 
increased AF and in those eyes with drusen, a ‘mixed’ pattern was seen in 33% cases.
Patterns o f  background AF
In all phenotypes the commonest background pattern o f autofluorescence was a 
homogeneous pattern. A diffusely irregular pattern was also seen in 33% of the GA group.
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Figure 14
AF images and corresponding colour images to demonstrate AF classification (a& b) unifocal heterogeneous 
lesion predominantly associated with CNV (c&d) multifocal homogeneous lesion predominantly associated 
with GA
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Table 21: AF characteristics for eyes with GA, CNV, PED and Drusen causing visual 
loss
Affected Eyes AF characteristics GA as 
cause o f 
visual loss 
(n= 18)
CNV as cause 
o f visual loss 
(n=109)
PED as cause 
o f  visual loss 
(n=2)
Drusen as 
cause o f 
visual loss 
(n=6)
Main Lesion- 
abnormal AF
Unifocal,
homogeneous area 
o f decreased AF
8 (44%) 15(14% ) 0 3 (50%)
Multifocal, 
homogeneous areas 
of decreased AF
10(56% ) 7 0 1
Unifocal, 
heterogeneous, 
areas o f altered AF
0 65 (60%) 2(100% ) 0
Multifocal, 
heterogeneous, 
areas of altered AF
0 21 (19%) 0 1
Normal darkened 
area at fovea
0 0 0 0
Too Poor Quality to 
Grade
0 1 0 1
Pattern of 
increased AF No increase
2(11% ) 14(13% ) 0 1
Focal Increases 2(11% ) 27 (25%) 1 (50%) 0
Reticular pattern 6 (33%) 18(17% ) 0 1
Lace-like pattern 
(Inc)
3(17% ) 3 (3%) 0 0
Partial/full band o f 
increased
1 (6%) 23 (21%) 1 (50%) 0
Mixed 4 (22%) 22 (20%) 0 2 (33%)
Poor Quality 0 2 0 2 (33%)
Background AF Homogeneous 11 (61%) 72 (66%) 2(100% ) 3 (50%)
Diffusely Irregular 6 (33%) 25 (23%) 0 1
Focal increases 1 0 0 0
Poor Quality 0 12(11% ) 0 2 (33%)
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4.5.2.2 Fellow Eye
Areas o f  predominantly decreased AF
A summary o f autofluorescence findings in the fellow eye o f the various phenotypic groups 
is given in table 22 {page 145}. In those fellow eyes with GA in the worse affected eye, the 
most frequent patterns o f predominantly decreased AF were ‘multifocal, heterogeneous’ 
areas o f altered AF (44%) and ‘multifocal homogeneous’ areas o f decreased AF (28%). 1 
eye demonstrated a ‘normal pattern’ at the fovea.
This was in contrast to the fellow eyes o f the CNV group, where the majority o f the group 
(26%) had a ‘normal pattern’ o f  decreased AF at the fovea and 8 o f which (7%) had no 
evidence o f  increased AF either. The second most frequent pattern in the CNV fellow eye 
group (24%) were ‘multifocal, heterogeneous’ areas of altered AF. O f the comparison 
group 80% had a ‘normal pattern’ o f  decreased AF at the fovea only.
The most frequent patterns o f decreased AF in the PED and drusen groups were ‘unifocal, 
heterogeneous’ (see figure 14a&b [page 142]) and ‘multifocal, homogeneous’(see figure 
14c&d) respectively.
Patterns o f  increased AF
All eyes from the GA group had evidence o f abnormally increased AF. The most common 
pattern in this group being ‘focal increases’ o f AF (50%) followed by a ‘reticular pattern’ 
in 22%. In the CNV group, a ‘reticular pattern’ was the most frequent (27%) with ‘no 
increased A F’ as the second most representative pattern (26%). ‘Focal increases’ o f AF 
were also the most common pattern noted in the drusen group (i.e. like GA group) and ‘no 
increase in A F’ was the most frequent pattern in the comparison group (55%).
Background AF pattern
As in the affected eyes, a homogeneous background was the most frequent pattern in the 
fellow eye o f all phenotypic groups including the comparison eyes.
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Table 22: AF characteristics of fellow eyes of those with visual loss and comparison
eyes
Fellow Eyes AF
characteristics
GA in 
affected 
eye 
(n=18)
CNV in 
affected eye 
(n= 109)
PED in
affected 
eye (n=2)
Drusen in 
affected eye 
(n=6)
Com parison 
G roup Eyes
Unifocal, 
homogeneous 
area of 
decreased AF
0 10 0 1 0
Multifocal, 
homogeneous 
areas of 
decreased AF
5 (28%) 18 0 3 (50%) 2
Areas of 
predominantly 
decreased AF
Unifocal, 
heterogeneous, 
areas of altered 
AF
2(11% ) 20 2(100% ) 0 2
Multifocal, 
heterogeneous, 
areas o f altered 
AF
8 (44%) 26 (24%) 0 1 2
Normal
darkened area at 
fovea
1 28 (26%) 
(8 had no 
increased 
AF either)
0 1 32 (80%)
Too Poor 
Quality to 
Grade
2 7 0 0 2
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Fellow Eyes 
cont’d
AF
characteristics
GA in 
affected eye 
(n=18)
CNV in 
affected 
eye
(n=109)
PED in 
affected 
eye (n=2)
Drusen in 
affected eye 
(n=6)
Com parison 
G roup  Eyes
No increase 0 (0%) 28 (26%) 0 1 22 (55%)
Focal Increases 9 (50%) 25 (23%) 0 3 (50%) 5(13% )
Reticular pattern 4 (22%) 29 (27%) 0 0 12(30%)
Pattern of
Lace-like
pattern
0 3 0 0 0
increased AF Patchy pattern 
(see figure 
15i&j [page 
148])
1 7 0 1 0
Mixed 2 (both 
included 
lacelike)
13(10 
retie & 
focal)
1 (50%) 
(lacelike & 
focal)
1 (retie & 
focal)
0
Poor Quality 2 4 1 0 1
Homogeneous 15(83% ) 82 (75%) 1 (50%) 5 (83%) 34 (85%)
Background AF
Diffusely
Irregular
1 (6%) 16(15% ) 0 0 5(13% )
Focal increases 0 0 0 0 0
Poor Quality 2 11 (10%) 1 (50%) 1 1
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Figure 15: (a)-(d)
AF and corresponding colour images to demonstrate various AF patterns in the affected and fellow eye (a&b) 
focal (c&d) band
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Figure 15: (e)-(j)
AF and corresponding colour images to demonstrate various AF patterns in the affected and fellow eye 
(e&f) reticular (g&h) lace-like (i&j) patchy
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4.5.2.2.1 Corresponding lesions
Data were also analysed to determine what the various autofluorescence features 
corresponded to when compared to the colour images. The most frequent corresponding 
lesions are given in Table 23 {page 150}.
In the affected eye, homogeneous areas o f decreased AF were more commonly associated 
with GA and heterogeneous areas with CNV. In the fellow eye, homogeneous and 
heterogeneous areas o f decreased AF were associated with patches o f atrophy. Unifocal 
areas o f decreased AF in the fellow eye did not always correspond to any detectable lesion 
on the colour image.
Considering the patterns o f increased AF, a ‘reticular pattern’ appeared to be most 
commonly associated with scattered drusen in both the affected and fellow eyes. A ‘focal’ 
pattern was noted to correspond most frequently with parafoveal drusen in fellow eyes and 
‘lacelike’ changes were most commonly associated with RPE pigment change. ‘Bands o f 
increased A F’ were more frequently seen at the edge o f lesions in the affected eye only.
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Table 23: C orresponding lesions to AF characteristics in affected and fellow eyes
Affected Eye Fellow Eye
Pattern o f AF Commonest
Corresponding
lesion
%  o f cases 
with pattern
Commonest
Corresponding
lesion
% o f cases 
with pattern
Decreased
AF
Unifocal
homogeneous
Area o f  GA 
(14)
54% No
corresponding 
lesion (9)
82%
Multifocal
homogeneous
Area o f GA
(9)
50% Area o f GA 
(12)
67%
Unifocal
heterogeneous
Area ofC N V  
(53)
79% No
corresponding 
lesion (15)
63%
Multifocal
heterogeneous
Area o f CNV 
(20)
91% Area o f GA 
(15)
43%
Increased
Reticular Scattered drusen
(5)
20% Scattered drusen 
(23)
70%
AF Focal Edge o f lesion 
(10)
33% Large Parafoveal 
drusen (14)
38%
Lacelike RPE change 
(4)
67% RPE change 
(3)
100%
Band Edge o f lesion 
(17)
68% N/A 0
Patchy N/A 0 RPE change
(3)
33%
l
Mixed Scattered Drusen 
(12)
43% RPE change (6) 
Scattered drusen 
(6)
35%
35%
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4.6 Location of the fovea
For the 150 subjects in the study (211 eyes), the median age was 29 (age range was 1 month 
to 43). The average horizontal distance between the fovea and the centre o f the disc, as 
calculated from the entire group was 2.76 +/- 0.33 DD or 16.07 +/- 1.25 degrees. The 
average vertical distance to the fovea for the whole group was 0.31 +/- 0.21 DD or 1.83 +/- 
1.19 degrees.
When comparing measurements on the subjects with 35 degree field images to those with 
50 degree field images, there was no significant difference between the groups except for 
the horizontal measurements made in degrees where the 50 degree field measurements were 
significantly higher than the 35 degree field measurements (see table 24 {page 152}).
In those patients where data were available for both eyes (n=61), the results unexpectedly 
showed that there was a statistically significant difference between eyes in both the mean 
horizontal and vertical measurements especially in degrees (see table 25 {page 153}). To 
test whether a tortional component could be playing a role in this discrepancy, the oblique 
distance (O) between fovea and centre o f  the disc was also compared between eyes (see 
figure 8 [page 94]). The difference between the oblique measurements in Disc Diameters 
was not statistically significant between eyes. Although the Degree measurements were 
statistically different, they were not clinically significant with the difference only 
representing 0.2 degrees (see table 26 {page 153}).
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Table 24: Horizontal and Vertical distances for foveal location in disc diam eters and
degrees (& com parison between 35 and 50 degree images)
Mean Distance
Whole sample 
(n=150)
35 degrees 
Images (n=100)
50 degrees
Images
(n=50)
Comparison 
between 35° 
and 50° images 
(t-test)
Horizontal Disc Diameters 2.76 +/- 0.33 
(12%)
2.79 +/- 0.33 
(12%)
2.69+/-0.31 
(12%)
Difference 
-0.0995 
95% Cl : - 
0.2111 to 
0.0121 
t= l .762 
DF=148 
P = 0.0802 
Not Sig
Degrees 16.07 +/- 1.25 
(8%)
15.53+/-0 .86 
(6%)
17.16+/-1.19 
(7%)
Difference : 
1.6306
95% Cl : 
1.2947 to 
1.9665 
t=-9.592 
DF=148 
P <  0.0001
Vertical 
(below disc)
Disc Diameters 0.31 +/-0.21 
(68%)
0.31 + /-0 .20 
(65%)
0.32 +/- 0.22 
(69%)
Difference
0.0147
95% Cl : - 
0.0562 to 
0.0856 
t=-0.410 
DF=148 
P = 0.6827 
Not sig
Degrees 1 .83+/-1 .19  
(65%)
1.72+/-1 .10  
(61%)
2.06+/- 1.34 
(65%)
Difference : 
0.3424
95% Cl : - 
0.0632 to 
0.7480 
t= -1.668 
DF=148 P = 
0.0974 
Not sig
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Table 25: Com parison of foveal location between right and left eyes
Difference between Right and 
Left Eyes 
(paired t-tests)
Whole sample (n=61)
Right Left Difference
Horizontal Disc
Diameters
2.79 +/- 
0.36
2.74 +/- 
0.34
Mean difference : 0.0545 
Standard deviation : 0.2372 
9 5 %  Cl :-0.0062 to 0.1153 
t= 1.795 DF=60 
P = 0.0776
Degrees 16.31 +/- 
1.40
15.94+/-
1.53
Mean difference : 0.3744 
Standard deviation : 0.5895 
95 % Cl : 0.2234 to 0.5253 
t=4.960 DF=60 P <  0.0001
Vertical 
(below disc)
Disc
Diameters
0.18+ /-
0.19
0.42 +/- 
0.19
Mean difference : -0.2404 
Standard deviation : 0.2745 
9 5 %  Cl :-0.3107 t o -0.1701 
t=-6.840 DF=60 P< 0.0001
Degrees 1.04+/- 
1.17
2.43 +/- 
1.13
Mean difference : -1.3883 
Standard deviation : 1.6251 
9 5 %  Cl :-1.8045 t o -0.9721 
t=-6.672 DF=60 P <  0.0001
Table 26: Com parison of foveal location between right and left eyes in those with
bilateral data
Sample with bilateral data (n=61)
Right Left Difference
Mean Oblique 
measurement (DD)
2.81 2.78 Mean difference -0.0288 
+/-0.2309
95 % Cl -0.0879 to 
0.0304
t=-0.973 DF=60 P = 
0.3343
Not statistically significant
Mean Oblique 
measurement (Degrees)
16.39 16.16 Mean difference -0.2255 
+/-
0.5377
95 % Cl -0.3632 to - 
0.0878
t=-3.275 DF=60 P = 
0.0018
Statistically significant but 
not clinically significant
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4.7 Regional susceptibility o f the macula to GA
Entire cohort
O f the 133 patients (200 eyes) analysed, 66% were female and the median age was 76. The 
final analysis included 101 right eyes and 99 left eyes. Sixty-seven patients contributed 
both eyes to the analysis. Where only right or left eyes were included in the study, the 
fellow eye was excluded either due to ill-defined atrophy with no autofluorescence image 
(15 cases), blurred images (8 cases), CNV with surrounding atrophy (19 cases) or drusen 
with no visible GA (24 cases).
On analysis o f the final aggregate o f  the entire cohort o f eyes, the results show increasing 
susceptibility o f  geographic atrophy towards the fovea in both eyes with a series o f 
concentric circles o f increasing frequency towards the centre (see figure 16a [page 156]). 
There did not appear to be a definite predilection for one region, but the most susceptible 
part in both eyes was located in a parafoveal location within 2 degrees o f the centre o f the 
fovea (see figure 16a).
In order to determine more accurately where the atrophic process had started and how it 
progressed, those with longitudinal data were analysed separately.
Patients with longitudinal data
A separate aggregate matrix was carried out for the 26 eyes (12 R; 14 L, 21 pts) with 
longitudinal data with images spanning between 2 and 11 years, to establish if  a more 
susceptible area existed in early atrophy.
The results showed a temporal and infero-temporal displacement o f the centre o f the 
contour map relative to the fovea in the right and left eyes respectively (see figure 16 b&c 
[page 157]), suggesting a particular susceptibility to the atrophic process in these regions of 
the macula.
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4.7.1 Progression o f atrophy
Out o f the 26 eyes (12 R; 14 L) with longitudinal data, 15 eyes (9R, 6L) were classified 
with a circumferential pattern o f progression, 10 eyes (3R, 7L) with a centrifugal pattern 
and 1 (L) with centripetal and centrifugal extension.
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Figure 16
Figure 16a: Macular susceptibility contour map of entire cohort of patients (n=133)
Left and Right Eyes Combined
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Figure 16
Figure 16 b&c: Contour maps of right and left eyes of patients with longitudinal data
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4.8 Analysis o f the RPE in Neovascular AMD using AF 
imaging.
O f the total 65 patients analysed, 27 were male and 38 female. The median age was 78 
(range 58 - 90). The median ages o f the three groups were 78, 75 and 78 respectively. One 
eye from each patient was analysed; 35 left eyes and 30 right eyes. In group 2, where the 
AF images were taken a few months after the diagnosis o f CNV or PED, the average 
interval was 4 months (range 1-6 months). In group 3, all the patients had established 
disciform scars and had lost vision in that eye more than a year prior to presentation. The 
median Snellen visual acuity in the three groups was 20/60, 20/100 and 20/600 
respectively.
Vessel to vessel  measurem ents
Vessel to vessel measurements, which were taken as an internal control, compared well 
between autofluorescence and fluorescein images in all cases and the difference was not 
statistically significant (mean difference; -0.008 mm, 95%CI: -0.056, 0.040; p= 0.73).
This indicated that magnification differences were adequately adjusted for using the digital 
Topcon IMAGEnet 2000 ©software.
Total area o f  lesion (G roup 1 only)
The main area o f abnormal autofluorescence was more widespread than the main area of 
abnormal fluorescence on FFA in 18 o f the 20 cases, (mean difference in size = +1.63 mm2; 
95%C1= 0.58, 2.68; p=0.004). This is demonstrated with the Bland Altman plot (see figure 
17 [page 159]). In three o f these cases where the main abnormal area extended beyond the 
edges o f the AF image the area was only measured up to the limits o f the frame. It would be 
expected therefore that the difference in total area between the AF and FFA image would 
be even larger than quoted in these 3 cases.
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Figure 17: Bland Altman plot (see section 3.11.3) showing the difference between the 
extent of the AMD lesion as measured from the AF image versus the FFA image plotted 
against the average of these measurements. The size of the lesion was larger on the AF 
image in the majority of cases.
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Figure 18
Comparison between 
FFA and AF images in 
group 1
(a): FFA of a neovascular 
lesion with areas of 
hyperfluorescence especially 
temporally and some 
subretinal blood superiorly 
and nasally (b) 
Corresponding AF image 
showing an area o f increased 
AF at the edge of the area of 
leakage (area marked A) 
seen on the FFA image The 
area marked B represents an 
abnormal area o f AF but 
there are areas o f more 
normal AF centrally.The 
area marked C indicates the 
optic disc. This latter 
measurement was not used 
in the study, (c): FFA image 
o f a neovascular lesion with 
a greater than 50% classic 
component (d): 
Corresponding AF image 
showing a ring o f increased 
AF surrounding areas o f 
normal AF within the 
complex (e): FFA image of 
an avascular pigment 
epithelial detachment (f) 
Corresponding AF image 
showing normal AF from the 
elevated retinal pigment 
epithelium and a dark rim 
corresponding to subretinal 
fluid ’A’ represents the 
‘normal’ area o f AF 
corresponding to the 
pigment epithelial 
detachment ‘B&C’ 
represent corresponding 
abnormal areas on the FFA 
image and ‘D’ marks the 
optic disc (g): FFA image 
o f a neovascular lesion with 
100% occult component and 
multiple areas of 
hyperfluorescence (h): AF 
image showing 2 areas o f 
decreased AF where areas o f 
leakage are seen on the FFA 
(see areas labelled ‘A&B’) 
There are also some normal 
patches of AF within the 
lesion (marked ‘C ’) with 
increased AF towards the 
edge of the lesion Area ‘D ’ 
marks the optic disc.
•3 *t o
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Figure 19
Comparison between FFA and AF images in group 2 (a): FFA image o f  a neovascular lesion showing an area 
o f  intense hyperfluorescence centrally, (b): AF image taken 6 weeks after the FFA image showing an area of 
decreased AF (area labelled A) corresponding to the area o f intense hyperfluorescence and surrounding areas 
o f normal AF. The linear patterns o f  decreased AF correspond to exudates, (c): FFA image o f a neovascular 
lesion showing a small focus o f  intense hyperfluorescence adjacent to a subretinal haemorrhage, (d): AF 
image taken 1 month after the FFA image showing an area of decreased AF (area labelled A) corresponding 
to the area o f intense hyperfluorescence and a surrounding band o f  increased AF with adjacent linear patterns 
o f decreased AF corresponding to exudates temporally and haemorrhage nasally.
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Figure 20
Comparison between fundus photographs and AF images in group 3 (a): Fundus photograph showing 
exudative disciform lesion, (b): Corresponding AF image showing a heterogeneous pattern o f decreased and 
increased AF within the lesion, (c): Fundus photograph showing disciform scar with surrounding atrophy o f 
the pigment epithelium, (d): Corresponding AF image showing a homogeneous pattern of decreased AF with 
no normal AF within the lesion.
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Spatial correlation o f  leakage on FFA
In groups 1 and 2, the areas o f hyperfluorescence on FFA were mapped to the AF images.
In group 1, these mapped to an area o f normal AF in 16 cases (see figure 18a-f [page 160]) 
with an adjacent area o f increased AF in 13 o f these cases (see figure 18a-d, g,h [page 
160]). In 4 cases the hyperfluorescence on FFA corresponded to an area of decreased AF 
(see figurel8 g&h). In group 2, the areas o f previous leakage on FFA mapped to areas of 
decreased AF in all 8 cases (see figure 19 a-d [page 161]). In 4/8 cases an area o f increased 
AF was present adjacent to fluorescein hyperfluorescence (see figure 19 c&d). FFA was 
not performed in group 3 patients.
4.8.1 Patterns o f AF
In group 1, 18/20 cases, demonstrated patches o f normal autofluorescence that could be 
seen within the lesion. In 13 o f these, normal AF could be seen at the fovea and 3 had a 
Snellen acuity o f 20/30. Five o f  the 20 eyes were classified as having a lesion with 
between 0-50% classic component (see figure 18a [page 160]), 6 patients were graded with 
a lesion >50% classic (see figure 18 c), 7 were graded with a 100% occult lesion (see figure 
18g) and 2 patients had an avascular pigm ent epithelial detachment (see figure 18e). O f 
the seven cases with no focal increase in AF adjacent to FFA hyperfluorescence, 3 were 
100% occult, 2 had an avascular PED and 2 were classified as < 50% classic.
In group 2, 7/8 cases demonstrated some areas o f normal AF within the lesion-see fig 19 b 
(4 including the fovea). One case with normal AF at the fovea had an acuity o f 20/30.
In group 3, focal increases o f AF were seen in 27/37 cases (see figure 20 a&b [page 162]). 
Twenty nine cases consisted o f a fibrous scar and 8 were graded as an exudative lesion with 
a serous detachment. In this group, 31/37 cases had no normal AF (see figure 20a-d [page 
162]) and 6/37 cases showed patches o f normal AF within the lesion but none at the fovea.
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No case had a visual acuity o f better than 20/50. Two patterns o f AF were seen in this 
group; 23/37 cases had widespread areas o f  decreased homogeneous AF throughout the 
lesion (see figure 20d [page 162]). In 9 o f these, surrounding secondary atrophy o f the RPE 
was demonstrated on the colour image (see figure 20c). The second pattern was a more 
heterogeneous, mottled pattern with areas o f increased and decreased AF (see figure 20b). 
This pattern was seen in 14 cases and 6 had areas o f atrophy on the colour image.
In all three groups, areas o f decreased auto fluorescence corresponded to areas o f atrophy 
(see figures 20 c&d) (n=21), areas o f subretinal blood (n=6) (see figure 19c&d [page 161]) 
or areas o f exudates (n=T2) (see figure 19 a-d). In one case where the blood was 
predominantly sub RPE, the intensity o f auto fluorescence appeared relatively preserved.
Pigment epithelial detachments
Two cases were graded as having avascular PED from group 1. On AF imaging the sub 
RPE fluid appeared to show normal autofluorescence corresponding to the fundoscopic 
visible area o f pigment epithelial detachment with the typical normal appearance o f decay 
o f AF intensity towards the foveal centre. In one case a dark rim could be seen surrounding 
the elevated area (see figure 18 e& f [page 160]).
Page 164
Detailed Clinical Phenotyping o f the A geing Retinal M acula
Sam antha S. Dandekar
4.9 Influence o f smoking on type of AMD
The smoking status o f the study participants by age and gender is given in Table 27 {page 
166}. This table indicates that 65% o f the AMD study population (n=711) were female and 
46% of them had never smoked. O f the males, 28% were non-smokers and 59% ex­
smokers.
Table 28 {page 166{displays the smoking status and AMD group of subjects. It shows that 
approximately 60% o f the cohort o f  AMD patients were either current or ex-smokers and 
the remaining 40% were non-smokers.
Multiple logistic regression analysis adjusting for both age and gender, did not show an 
association between smoking status or increasing number o f pack years and type o f AMD 
lesion graded (see Table 29 {page 166}). The odds o f ‘ex-smokers’ compared to ‘non 
smokers’ developing neovascular rather than non neovascular AMD when adjusted for age 
and gender was 0.86 (95%CI: 0.58 to 1.30) and that o f current-smokers compared to ‘non 
smokers’ was 1.88 (95%CI: 0.91 to 3.89). W hen pack year data were analysed using the chi 
squared test for trend (data available on 686 pts), again no difference was seen between the 
neovascular and non-neovascular groups in the number o f pack years smoked (see Table 30 
{page 167}).
With the numbers o f  smokers and nonsmokers recruited, this study should have been 
adequately powered (80%) to detect a clinical difference o f an excess prevalence o f CNV in 
smokers compared to never smokers o f 8% or more or an excess prevalence in never 
smokers compared to smokers o f 8% or more. This calculation was based on the sample 
size and power calculation comparing 2 binomial proportions assuming a=0.05 in a two 
tailed test (Rosner, B.; 1995).
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Table 27: Age, gender and smoking status of patients with late AMD
Female
Age Group Current smoker Ex smoker Non smoker Grand Total
50-59 4 3 1 8
60-69 6 22 30 58
70-79 35 93 93 221
80-89 13 71 79 163
90-99 0 3 9 12
Grand Total (12.5%) 58 (41.5%) 192 (46%) 212 462
Male
Age Group Current smoker Ex smoker Non smoker Grand Total
50-59 1 5 2 8
60-69 4 17 8 29
70-79 16 62 36 114
80-89 11 60 21 92
90-99 1 3 2 6
Grand Total (13%) 33 (59%) 147 (28%) 69 249
Table 28: Smoking status according to AMD type
AMD type current smoker ex smoker non smoker
Grand
Total
neovascular (89%) 81 (79%) 268 (81%)229 (81 %)578
non neovascular (11%) 10 (21%) 71 (19%) 52 (19%)133
Total with late 
AMD (100%) 91 (100%) 339 (100%) 281 (100%)711
Table 29: M ultiple logistic Regression table to assess the influence of smoking on the 
type of AMD lesion (Adjusted for Age and G ender)
Variable b-
Regression
coefficient
p value OR for
neovascular
AMD
95%CI
(lower)
95%CI
(upper)
Age .0096 .4690 1.0097 .9837 1.0363
G ender (female- ref) 
Male
-.0321 .8753 .9684 .6481 1.4469
Smoking Status
Ex smoker cf non 
smoker
-.1467 .4790 .8636 .5754 1.2961
Current Smoker cf 
non smoker
.6315 .0882 1.8805 .9098 3.8870
Pack years of 
smoking (n= 686)
1.2954 .2220 .9996 .9918 1.0074
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Table 30: Influence of pack years of smoking on AMD lesion type
Pack years 
(range) 0 <20 20-40 40-60 >60
Pack 
years not 
known
Grand
Total
neovascular 229(81%) 154(83%) 91(83%) 45(79%) 40(77%) 19(76%) 578
&
non
neovascular 52(19%) 32(17%) 19(17%) 12(21%) 12(23%) 6(24%) 133
Q
s
<
Total with 
late AMD 281 186 110 57 52 25 711
Chi-Square test for trend=0.465, DF=1, p=0.5 NS
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4.10 Functional assessment o f areas o f increased 
autofluorescence in AMD
O f the 436 patients reviewed from the database, 38 ARM patients met the inclusion criteria 
with adequate image quality and a vision o f at least 20/40. O f these, seven participated in 
the study (4 female and 3 male), (mean age, 75 years; range, 68-80 years) (Scholl, H. P. et 
al\ 2004a). The predominant fundal features o f the seven study eyes included: extrafoveal 
CNV (two eyes), extrafoveal GA (two eyes), and soft drusen (three eyes) (see Table 31 
{page 169}). Median visual acuity amongst the seven study eyes was 20/25 (range, 20/40- 
20/20).
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Table 31: Dem ographics, visual acuity and predom inant fundal features of the seven study subjects
Patient Age Sex Eye FM M Study eye Fellow eye
VA
(ETDRS)
VA
fellow
eye
n\ 68 M L
upper nasal 
macular 
quadrant
Extrafoveal CNV; s/p laser 
treatm ent
few drusen 20/20 6/5
#2 77 M R
lower nasal 
macular 
quadrant
Juxtafoveal CNV with 
disciform  scar
Few RPE 
pigmentary 
changes; no 
drusen
20/40 6/6
#3 69 F R
lower
temporal
m acular
quadrant
Secondary GA after 
longstanding PED; s/p 
prophylactic drusen laser; 
cellophane retinopathy
Large disciform 
m acular scar 
after RPE tear
20/25 6/60
#4 78 F L
central
m acular
FFM
Extrafoveal GA; RPE 
hyperpigm entations; drusen
Subfoveal CNV 
with disciform 
scar and PED
20/25 6/24
#5 80 M L
central
m acular
FFM
Extensive drusen at the 
posterior pole including a 
large juxtafoveal druse
Subfoveal CNV 
with disciform 
scar
20/25 HM
#6 79 F R
upper
temporal
m acular
quadrant
Large soft and small hard 
m acular drusen
Subfoveal CNV 
with large 
disciform scar
20/20 HM
#7 73 F L
lower
temporal
m acular
quadrant
Interm ediate and large soft 
and sm all hard drusen
Subfoveal CNV 
with PED
20/20 6/36
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Figure 21
Photopic (a, c, e, g; left column) and scotopic (b ,  d ,  f, h; right column) fine matrix mapping (FMM) in a 33- 
year old normal subject. The first four figures (a-d) show data derived from FMM that was centered on the 
fovea and the second four figures (e-h) from a FMM that was placed on the nasal upper quadrant with the 
fovea on the lower temporal com er o f  the test grid. To allow orientation o f the luminance sensitivity contour 
plots on the FMM images and the three dimensional threshold surface plots, the letters A-D have been added 
to figure 21c. In all AF contour maps shown, A corresponds to the right lower comer, B to the left lower 
comer, C to the left upper comer, and D to the right upper com er, respectively. (See Scholl et al (Scholl, H. P. 
et al; 2004a) for scotopic FMM centred on the fovea from an age-matched normal subject)
21a Photopic- Normal subject I  b Scotopic- Normal subject
C D
e Photopic- Normal subject ■  f Scotopic-
Taken from Scholl et al 2004 (Scholl, H. P. et al; 2004a)
Normal subject
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Figure 21 [page 170] shows the results o f photopic (a,c,e and g) and scotopic (b,d,f and h) 
fine matrix mapping in a normal subject (not age-matched). Two sets of fine matrix 
mapping were performed: The first was centred on the fovea (a-d) and the second placed on 
the nasal upper quadrant with the fovea on the lower temporal comer of the test grid (e-h). 
The sensitivity profiles are shown with contour steps o f 0.1 log unit (ldB).
The data derived from both the scotopic and photopic FMM testing in all o f the seven study 
eyes are summarised in Table 32. The global estimates of the FMM, the mean (background) 
and the maximum threshold elevation from baseline are given. The higher the threshold 
elevation from baseline, the greater the loss o f function compared with established normal 
values. Sensitivity data (reciprocal o f threshold) for a representative four o f the seven 
patients and their correspondence to AF findings are also described below.
Table 32: D ata derived from  both the scotopic and photopic FM M  testing in all 7 
study eyes showing the mean (background) and the m axim um  (discrete) threshold 
elevation from  baseline (log units) and  com parison values from  norm al subjects.
P h o to p ic  F F M Scotopic  F F M
P atien t
T ype  o f  lesion in 
S tu d y  eye
B a c k g ro u n d  
th r e s h o ld  (log)
M a x im u m  
e leva tion  (log)
B ack g ro u n d  
th re sh o ld  (log)
M a x im u m  
eleva tion  (log)
Normal Subject
0.27
(not aged matched)
0.51
(not age matched)
1.04 
(age matched)
2.36 
(age matched)
#1 Extrafoveal CNV 1.87 3.05 3.13 3.60
#2 Juxtafoveal CNV 1.92 3.11 3.46 3.63
#3 Secondary GA 1.08 2.31 2.84 3.60
#4 Extrafoveal GA 0.97 1.28 2.53 3.58
#5 Drusen 1.44 2.06 2.62 3.58
#6 Drusen 1.39 1.64 1.99 3.59
#7 Drusen 0.46 0.65 Not performed Not performed
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4.10.1 Patient w ith choroidal neovascularization
Patient #2 is an example o f an extrafoveal occult CNV that developed 15 months prior to 
the study in the right eye. Visual acuity had been stable since then without any intervention. 
The fundus showed a disciform scar with foveal sparing surrounded by a halo o f  RPE 
atrophy. AF imaging showed centrally decreased AF surrounded by a ring o f increased 
FAF at about 1000 pm  eccentricity. Inferior to fixation there was an additional small area 
o f increased AF. Photopic FMM (fig. 22a) revealed severely reduced sensitivity in the 
foveal region and moderately reduced sensitivity in the central area with mainly decreased 
AF. The ring o f increased AF and the more eccentric portion showed only mildly reduced 
photopic sensitivity. Scotopic FMM (figure 22b [page 173]) revealed complete sensitivity 
loss in both the central area o f decreased AF and the surrounding ring o f increased AF.
4.10.2 Patients w ith geographic atrophy
Patient #3 received prophylactic laser treatment for confluent soft drusen in the right eye 
five years prior to the study (12 spots; 200 pm, 0.2 sec; 80 mW). She then developed a 
longstanding RPE detachment (PED). Subsequently she developed secondary GA. AF 
imaging showed a central area o f decreased AF with a radius o f about 1000 pm  surrounded 
by a ring o f increased AF. Photopic FMM revealed normal foveal sensitivity, mildly to 
moderately reduced sensitivity over the adjacent area o f  decreased AF, but normal 
sensitivity over the area o f increased AF and also normal photopic sensitivity eccentric to 
the area o f increased AF (Fig. 23a). Scotopic FMM showed a complete loss o f  sensitivity 
over both the central area o f decreased AF and the surrounding ring o f increased AF 
(Figure 22b [page 173]). Eccentric to the area o f increased AF the scotopic sensitivity was 
moderately reduced by about one log unit.
Patient #4 also exhibited a small patch o f  GA superior to fixation in the left eye. Although 
photopic FMM did not reveal reduced sensitivity (see Table 32 (page 171}), scotopic 
FMM showed extremely reduced sensitivity including the fovea, the area o f decreased AF 
(GA) and the areas o f increased AF.
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Figure 22
(a& c) Photopic and (b & d ) scotopic F M M  (e) colour fundus image (f) AF image from patient #2 (extrafoveal 
C N V )
22a Photopic
D
^ \  ;  \  I
AA
B
b Scotopic
Taken from Scholl et al 2004 (Scholl, H. P. et al; 2004a)
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Figure 23
(a& c) Photopic and (b & d ) scotopic F M M  (e) colour fundus image (f) AF image from patient #3 (secondary 
GA after longstanding RPE detachment and previous prophylactic laser treatment)
23a Photopic 23b Scotopic
Taken from Scholl et al 2004 (Scholl, H. P. et al; 2004a)
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Figure 24
(a&c) Photopic and (b& d) scotopic FMM (e) colour fundus image (f) AF image from patient #5 (large soft 
foveal druse)
24a Photopic 24b Scotopic
Taken from Scholl et al 2004 (Scholl, H. P. et a l; 2004a)
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4.10.3 Patients w ith drusen
Patient #5 exhibited extensive drusen at the posterior pole including a large soft foveal 
druse. AF imaging revealed a central area o f increased FAF corresponding to the large soft 
foveal druse (figure 24 [page 175]). There were some additional small patches o f increased 
AF at the posterior pole that also corresponded to the drusen distribution. Photopic FMM 
revealed a mildly reduced sensitivity over the test field o f about 0.5 log units (figure 24). 
The sensitivity decrease over the area o f increased AF was slightly larger. Scotopic FMM 
revealed considerably reduced sensitivity over the area o f increased AF. This sensitivity 
decrease extended beyond the area o f increased AF by about 1-2 deg inferiorly and 
temporally. The rest o f the test field showed moderately reduced scotopic sensitivity.
Another patient with drusen (#6) showed many large soft and small hard drusen at the 
posterior pole o f the right eye. AF imaging showed an area o f reticular increased AF in the 
superior portion o f the macula that poorly corresponded to drusen distribution. Photopic 
FMM revealed mildly reduced sensitivity o f  about 0.5 log units that was equally distributed 
over the test field. Scotopic FMM showed moderately reduced sensitivity over the areas 
with reticular increased AF. Outside the area o f abnormal AF, the scotopic sensitivity was 
near normal.
Page 176
Detailed Clinical Phenotyping o f the A geing Retinal M acula
Sam antha S. Dandekar
5 Discussion
5.1 Characteristics o f patients recruited to the study
When recruiting for the study, the gender distribution favoured females. We would expect 
this to be due to increased longevity but surprisingly there was no difference in the median 
age between the sexes. An alternative explanation for this gender difference in 
ascertainment may include differences in health seeking behaviour (Evans, J. R.; 2001) and 
a willingness to volunteer in females. Pooled data from 3 population studies, showed no 
significant differences in the prevalence o f AMD between the genders (Smith, W. et al; 
2001).
The spouse comparisons were predominantly male. This was again due to ascertainment 
bias due to the recruitment o f spouses in most cases. The small number o f the ‘comparison 
group’ identified from the colour grading o f  images and the fact that the median age o f this 
group was lower than that o f the ‘patients’ makes it difficult to make any definite 
comparisons between the two groups. The comparison group therefore have the potential 
to become patients over time, making interpretation o f these results more difficult.
Bilaterality o f the various lesions in ARM and AMD were also calculated. In those 705 
cases with any AMD, 56% had bilateral involvement. Although this figure compares well 
with that found in the Blue M ountain Eye Study where 57% (39/69) o f those with AMD 
were found to be bilateral (Wang, J. J. et al; 1998), and is slightly higher than the 42% rate 
found in the Beaver Dam Study (Klein, R. et al; 1992), we would expect our bilateral rate 
to be significantly higher in view o f the referral bias inherent in clinic samples compared to 
population studies. This finding confirms the wide range o f phenotypes recruited to the 
study and this cohort may therefore be more representative o f the general population than 
o f a typical tertiary referral centre.
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W hen analysing the different types o f AMD, 38% o f the neovascular AMD cases were 
bilateral as were 40% o f the GA cases. The corresponding values in the Blue Mountain 
Study were 40% and 56% respectively. Differences however exist in the way that AMD 
cases were classified in the two studies. In the Blue Mountain study any case with both GA 
and CNV in the same eye was classified with both phenotypes whereas according to the 
international classification used with our cohort, any patient with GA in an eye that 
subsequently developed CNV was reclassified as neovascular AMD for that eye.
The proportion o f those with unilateral CNV and drusen graded in the fellow eye was 
almost twice as many as those with unilateral GA and dmsen in the other eye (73 v 34%) 
implying that GA may be more symmetrical in terms o f  progression o f disease. A large 
proportion o f patients however, (n=87) graded with unilateral GA had evidence o f 
neovascular AMD in the fellow eye. This could either be due to neovascular changes 
occurring at the edge o f  an atrophic lesion (Sunness, J. S. e ta l ; 1999b)or secondly, the GA 
graded in the first eye could have resulted from secondary atrophy following a previous 
neovascular lesion.
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When analysing the family history data, as expected, spouse comparisons were less likely 
to report a positive family history than patients. Additionally, those with bilateral AMD 
reported a slightly higher rate o f  a positive family history compared to those with unilateral 
disease (25% v 22%).
One o f the most important findings o f  this part o f the study was the unreliability o f 
biomicroscopy as a way to classify patients and spouse comparisons. It is only after 
accurate grading o f fimdus images that the appropriate classification o f subjects can occur.
5.2 Validation of grading techniques
The grading system used in this study represents an adapted version o f that established by 
the International ARM Epidemiological Study Group (Bird, A. C. et al; 1995), and has 
been shown to be reliable and reproducible in the validation study. Since it represents a 
consensus o f various groups conducting research on ARM and AMD including the 
Wisconsin Grading System (Klein, R. et al; 1991), the results o f this study can be 
compared to other studies such as the Beaver Dam Eye Study, the Framingham Eye Study 
or the Age-Related Eye Disease Study. The former studies however were population-based 
as opposed to an ARM  study population. This results in considerably different prevalences 
o f ARM and AMD and since k  statistic measurements are dependent on the prevalence of 
the attribute being measured, very different values would be obtained (Thompson, W. D. et 
al; 1988), (Brennan, P. et al; 1992)
Important differences exist between the more recent AREDS classification (AREDS; 
2001b) and the grading system used in this study. Firstly, although a similar grid was used, 
zones were not graded separately and secondly, drusen were only segregated by type and 
not semi-quantitatively as in this study. Despite these differences, similar inter-observer 
agreement was obtained for the presence o f subretinal scarring in neovascular AMD (97%) 
and for the presence o f  GA (93%) respectively (AREDS; 2001b). In the current study 
agreement ranged between 90% and 98% for both types o f AMD.
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In this study, the inter- and intra-observer variability for the grading o f drusen and for the 
presence o f hyper- or hypopigmentation was similar. The intra-observer variability 
however, was slightly higher for the presence o f GA, the area covered by GA, the presence 
o f CNV and for the area covered by CNV. It was concluded that at least part o f the 
disagreement between graders for features o f AMD in this study can be explained by the 
disagreement within graders.
One problem with the interpretation o f the ‘K-statistic’ is due to the dependence on the 
prevalence o f the attribute being measured (Thompson, W. D. et al; 1988). This is because 
when there is a very low (or very high) underlying prevalence o f a particular feature, this 
results in a very high level o f expected agreement and the K-statistic becomes unreliable. 
This occurred when grading larger drusen, serogranular drusen, hypopigmentation, and 
retinal haemorrhage. In these cases, more emphasis was then placed on these raw data 
rather than the kappa statistic.
In conclusion, the revised version o f the grading system established by the International 
ARM Epidemiological Study Group used in this study has been shown to be reproducible 
with inter -observer variability rates comparable to other studies. The system includes an 
extensive subclassification o f the features o f  both ARM and AMD for describing the 
phenotype, and may therefore be used for future correlations between the phenotype and 
genotype of ARM and AMD patients.
5.2.1 How do conventional 35m m  colour slides compare to 
digitised images?
The comparison between gradings showed good agreement for drusen characteristics with 
a slight tendency to underestimate drusen number on digitised images. This might be 
explained by the lower spatial resolution o f the digitised images when compared to the 
original colour slides. The agreement for the grading o f hyperpigmentation abnormalities 
was relatively poor and this is likely to be due to artefacts that occurred when the colour
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slides were digitised. Use o f this method is therefore not recommended for grading, where 
pigmentary abnormalities are deemed an important part o f the study.
Interestingly, another recent study has compared 35mm film and 35° digital stereoscopic 
fundal images for grading age-related maculopathy and concluded similar findings with the 
lowest k scores found for the number o f small drusen and for pigmentary changes (van 
Leeuwen et al 2003, Ophthalmology).
The agreement or concordance for the grading o f late-stage AMD (geographic atrophy and 
choroidal neovascularisation) was high for all features graded in the study. The only 
exceptions were the individual features o f CNV. There was a tendency for neuroretinal 
detachments to be missed on the digitised images and this might be explained by poorer 
stereopsis. There was also a tendency to miss small areas o f GA on the digitised images 
and a failure to detect the presence o f CNV in three cases from the digitised images and in 
one case CNV was detected from the digitised image but not the 35mm colour slide. 
Resolution o f the image may be one explanation but another study investigating the effects 
o f image compression and stereopsis, using images o f drusen and AMD, showed that low 
compression (30:1) JPEG images were almost indistinguishable from uncompressed TIFF 
images and that these were highly comparable to the original fundus photographs. 
Additionally, even high compression (80:1) JPEG images conveyed a stereoscopic quality 
similar to that o f the original photographs especially for lesions like retinal pigment 
epithelial detachments (Lee et al 2000, Retina).
When all the data of inter- and intra-observer variability had been taken into account it was 
concluded that grading from digitised images resulted in reproducible results comparable to 
those from grading stereoscopic colour slides.
Comparison to other studies
Recently, studies by Lee and co-workers (Lee 2000, Retina) and van Leeuwen et al (van 
Leeuwen 2003) compared standard 35 mm fundus photographs and digitised and digital 
images respectively in patients with ARM. Even though the study population differed in 
the former study since it was not restricted to ARM, they found a high weighted agreement
Page 181
Detailed Clinical Phenotyping o f the Ageing Retinal M acula
Sam antha S. Dandekar
between the grading from stereoscopic colour slides and low compression JPEG images. 
The second study gave weighted kappa results for the number o f small hard drusen ( k ; 
0.41) and drusen type ( k ; 0.79) similar to that found in this study and also high kappa 
values for atrophic and neovascular end-stage ARM ( k ; 0.87 and 0.94 respectively).
Digital fundus photography has already become a sensitive tool for detecting diabetic 
retinopathy (Lin 1999). With the level o f agreement between stereoscopic colour slides and 
digitised images obtained in this study, together with the results o f other studies, there is 
increasing evidence to suggest that digital imaging will become a valuable tool for grading 
abnormalities in studies o f ARM and AMD.
The fact that three cases o f GA and two cases o f CNV were missed in our study using 
digitised images does cause some concern but with increasing technology and image 
resolution, the advantages o f storage, transfer o f images and software manipulation, digital 
fundus imaging is likely to continue to improve. Additionally, using other diagnostic 
modalities such as digital fluorescein angiography and autofluorescence imaging would 
assist in determining the presence o f  lesions o f AMD in a purely digital system.
5.3 How Concordant or symmetrical is AMD between eyes?
5.3.1 Bilateral late AM D
Assessing the degree o f symmetry between eyes and the extent to which the individual 
phenotypes occur independently o f each other may assist in determining the influence o f 
genetic and environmental factors in AMD.
It is known that other inherited eye disorders show heterogeneity o f phenotype within 
families although not usually between eyes o f the same individual. For example, in Sorsby 
macular dystrophy, a monogenic disorder caused by mutations in the TIMP3 gene, a
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phenotype not dissimilar to GA has been demonstrated to occur in some affected 
individuals in a family (Clarke, M. et al; 2001) whilst others show a more typical CNV-like 
phenotype. This shows that the effect o f the primary causative mutation can be modified by 
other factors. Often it is impossible to determine whether such modifiers are genetic, 
environmental or stochastic in nature.
In order to determine the influence o f genetic factors in the development o f AMD, twin 
studies have proven useful. Hammond et al (Hammond, C. J. et al; 2002) demonstrated a 
high heritability for the presence o f soft drusen and >= 20 hard drusen at the macula, by 
comparing concordance in MZ v DZ twins, but such patient resources are rare. This study 
has taken advantage o f the inherent bilaterality o f signs available to the ophthalmologist 
due to the presence o f two eyes in each patient. Clearly, both eyes would share very similar 
genetic, developmental and environmental factors. Any phenotypic differences therefore 
could only be attributable to somatic mutation, skewed X-inactivation, micro­
environmental differences or unknown stochastic factors.
Our results demonstrate that the symmetry or concordance between eyes o f 75%-77% 
(kappa= 0.48) undoubtedly exceeds that expected by chance alone if  the eyes were affected 
independently. Interestingly, this figure is less than that previously recorded for early AMD 
or drusen in which concordance has been described in 90% of patients (Gass, J. D.; 1973) 
and also for the size, number, density and fluorescence o f  drusen where kappa values o f 
between 0.7 and 0.9 have been quoted (Barondes, M. et al; 1990). This difference in 
concordance may suggest that the earlier signs o f ARM are a better reflection o f the 
common genetic and environmental influences acting upon both eyes whilst the later 
manifestations o f the disease are further downstream in the pathological process and may 
be affected by as yet unknown stochastic factors affecting the eyes separately, at different 
times during the patient’s life. Early signs o f drusen may therefore be more informative in 
studies designed to discover susceptibility genes and environmental factors.
When the entire cohort o f patients (n=879) were analysed according to the predominant 
phenotype in each eye, a kappa value for overall concordance between eyes was calculated
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as 0.264. This represents ‘fair agreement’ (Brennan, P. et al; 1992; Landis, J. R. et al; 
1977), and is lower than the value obtained for drusen symmetry (kappa= 0.71-0.89) 
(Barondes, M. et al; 1990) and AMD symmetry (see chapter 4.4).
When considering the retrospective data o f the eyes with features o f CNV and adjacent 
areas o f atrophy in those with bilateral AMD, 65% o f the atrophic areas resulted from 
secondary atrophy following contraction o f a disciform scar indicating that GA follows 
CNV in many cases. In a further 13%, CNV occurred at the edge o f a previous GA lesion. 
This changing phenotype can cause difficultly in determining the initial lesion occurring in 
an eye and is likely to explain some o f the 25% discordance observed in this study. It also 
emphasises the importance o f examining all available historical data. It is not yet known 
whether environmental factors such as smoking may influence these changes.
Other locally acting factors such as ocular dominance, differences in blood flow or 
differing refractive error may have contributed to the observed discordance between eyes 
but such data were not collected in this study and no evidence at present exists to confirm 
these theories.
The development o f CNV in an eye with GA has been well documented by Sunness et al. 
She reported a rate o f 11% by 4 years in those with bilateral GA and in those with CNV in 
the fellow eye, 34% developed CNV by 4 years (Sunness, J. S. e ta l ; 1999b). The 
development o f atrophy in those eyes with CNV is less clearly defined.
In conclusion, this study demonstrates statistically significant symmetry between lesions 
causing visual impairment in 75%-77% patients with late stage AMD as graded from 
digital photos. Although this does not confirm a genetic rather than environmental 
influence, it is in keeping with the concept that genes may confer risk to the different 
manifestations o f late ARM or AMD. In 23-25% cases however, patients were discordant 
for phenotype between eyes suggesting that other locally acting factors may modify the 
phenotype in a significant proportion o f  cases. Only with subsequent large collaborations
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and accurate phenotyping in sibling, family and twin studies can the role o f genetics be 
confirmed in the determination o f phenotype in AMD but, these data do suggest that early 
AMD rather than the late stages may be under greater genetic influence and since the kappa 
values only represent moderate symmetry for late AMD, other factors acting independently 
on the eyes maybe modifying the phenotype.
5.3.2 Sym metry o f AF in bilateral GA
The results show a high correlation for area o f atrophy between right and left eyes in those 
with bilateral GA. This was demonstrated with and without the inclusion o f peripapillary 
atrophy with no significant difference between the mean areas o f atrophy in right and left 
eyes (see table 16 {page 132}). This is in accordance with a similar study measuring the 
extent o f GA between eyes (Bellmann, C. et al\ 2002) and serves to emphasise the non - 
random nature o f atrophy o f  the pigment epithelium at the posterior pole.
Furthermore the distribution o f atrophy showed marked symmetry or concordance between 
eyes as shown by a kappa value o f 0.67 (95% Cl; 0.46 to 0.88) representing substantial 
agreement. The pattern o f atrophy was more commonly multifocal (58% eyes).
The observed peripapillary atrophy does not appear to have any relevance to the extent of 
GA in each eye, except to say that it occurred in 42% of patients analysed and appeared to 
be symmetrical. In glaucoma it has been associated with disc haemorrhage and disease 
progression (Jonas, J. B.; 2005), but this may be related to refractive error. We do not have 
sufficient data in this study to assess the effect o f peripapillary atrophy on disease 
progression in AMD.
High rates o f symmetry have been shown in AMD (see 1.6.6), all implying that individual 
determinants, including possible genetic or environmental factors, may play a role in the 
pathogenesis o f the disease. Additionally, the pattern and evolution o f the atrophic process 
may be predetermined for each individual and that random, non-specific ageing changes are
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less likely to be important in disease progression. This study also suggests that later on in 
the course o f disease when both eyes are affected, the atrophy is likely to become 
symmetrical.
5.4 What can the fellow eye tell us about the cause of visual 
loss from AMD?
5.4.1 Colour photograph features
This study show distinct differences in those with unilateral visual loss between the drusen 
characteristics o f the fellow eye o f the GA and CNV group. These include the presence o f 
an increased number o f confluent, distinct and crystalline drusen in the fellow eye o f the 
GA group. Furthermore the overall total area covered by drusen was significantly greater in 
the GA fellow eyes compared to the CNV group.
These findings support the hypothesis that GA is more likely to follow the regression of 
pre-existing drusen. Gass (Gass, J. D.; 1973) and Sarks (Sarks, J. P. et al; 1988) observed 
that GA was often associated with the fading o f drusen, but also recognised that it could 
occur following the resolution o f a serous retinal pigment epithelial detachment.
One criticism o f the current study is that it appears that GA is more frequently seen in both 
eyes compared to CNV. This bias may well be due to the selection criteria used for the 
study in that atrophy is less likely to cause unilateral visual loss due to the nature o f the 
lesion. Similarly, eyes with CNV in the fellow eye would be more likely to have bilateral 
visual loss and would therefore not be included in the analysis. Assumptions on the 
bilaterality o f GA compared to CNV cannot therefore be made from this study but need to 
be assessed from the entire cohort o f patients.
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The fewer drusen seen in the CNV fellow eyes and the existence of 14 patients (9%) with 
<10 (63 pm) hard drusen only in each zone, is in keeping with the theory that CNV may not 
be necessarily related to the presence o f pre-existing drusen and can occur as an event in an 
apparently otherwise healthy eye.
In a previous similar study comparing drusen characteristics in patients with exudative 
(n=89) and non-exudative AMD (n=38) (Bressler, N. M. et al; 1988), those younger than 
75 were more likely to have confluent drusen in the fellow eyes o f the exudative group 
(OR=6.0; CI=1.07,33.89). No difference however was found between drusen characteristics 
in those older than 75 years. Several differences between the two studies may explain these 
disparate results. Firstly, the non-exudative group included those with bilateral drusen and 
/or geographic atrophy in both eyes and therefore provided a different comparison group to 
that in our study. Additionally, there were smaller numbers o f patients and the average age 
o f the non-exudative group was 5 years younger than the exudative group. The latter factor 
however was adjusted for in the analysis. The small difference in median ages between the 
two groups (74v76) in the current study is unlikely to account for the changes seen.
The increased frequency o f crystalline drusen in the GA fellow eyes, especially in zones 2 
& 3, suggests that this type o f drusen represents a stage o f resolution associated with 
geographic atrophy. In histological studies, Sarks has described drusen with glistening foci 
o f calcification within areas o f atrophy (Sarks, S. H.; 1976). Although serogranular drusen 
or drusenoid PED’s were also more frequent in the GA group compared to the CNV group, 
the difference was not statistically different making it difficult to implicate this type o f 
drusen as a risk factor for GA.
Pauleikhoff (Pauleikhoff, D. et al; 1990a) analysed the fellow eye o f 150 patients with 
visual loss due to PED and CNV and concluded that larger, more densely packed and less 
fluorescent drusen on fluorescein angiography were more likely to be present in the fellow 
eye when an avascular pigment epithelial detachment was the cause o f visual loss in the 
first eye. This is consistent with the proposed neutral lipids theory of PED’s (Sheraidah, G. 
et al; 1993) (Holz, F. G. et al; 1994a; Pauleikhoff, D. et al; 1990c). Our results showed
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evidence o f larger, more confluent drusen in the PED fellow eyes compared to the CNV 
group in zone 1 but not compared to the GA fellow eyes. In view o f the small numbers of 
PED’s in our study, it is difficult to make any firm comparisons between the PED and CNV 
group from our data.
Although visual impairment occurs with drusen alone, six of these nine individuals had 
visual acuities o f 6/36 or worse, which is unusual. It is likely that some underlying atrophy 
or CNV not seen on colour photography or biomicroscopy was the cause o f visual loss in 
these patients. Fluorescein angiography, only available in 3 o f these patients, did not show 
evidence o f underlying CNV.
These findings suggest that there are likely to be differences between the frequency and 
types o f drusen (i.e. crystalline drusen) in the fellow eye o f those with visual loss due to 
GA and those due to CNV. Deposition o f waste material from RPE and lipids are known to 
cause thickening o f Bruch’s membrane, (Okubo, A. et al; 1999) (Pauleikhoff, D. et al; 
1990a) and are likely to reflect the magnitude o f metabolic activity determined by outer 
segment renewal. Resolution o f drusen would therefore be expected to occur in geographic 
atrophy as the photoreceptor population falls. Further evidence to support this mechanism 
comes from histological(Sarks, J. P. et al; 1988) and autofluorescence findings (Holz, F. G. 
et al; 1999a) prior to the development o f GA.
5.4.2 AF im age features
A ffected Eve
This part o f the study demonstrated that certain autofluorescence patterns are seen with 
different phenotypic types o f AMD. Specifically GA appears as a multifocal or unifocal 
pattern o f decreased AF and CNV produces a more unifocal, irregular or heterogeneous 
pattern. These patterns are in keeping with the descriptions o f autofluorescence in AMD by 
Von Ruckmann and colleagues (von Ruckmann, A. et al; 1997a) and consistent with the
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theory that reduced lipofuscin generation after photoreceptor cell death in areas o f atrophy 
produces areas o f decreased autofluorescence (Delori, F. C. et al; 1995a; von Ruckmann,
A. et al; 1997a). Three out o f the 6 eyes, graded with drusen as the cause o f visual loss, 
interestingly had evidence o f a unifocal area o f decreased AF. This may represent an area 
o f underlying atrophy more easily detected from the AF image having been missed on the 
colour image and could explain the decrease in vision in these eyes (see figure 4 m-p [page 
42] and figure 13 [page 136]). FFA’s were not available in these cases.
It has also been shown that ‘reticular’ and ‘lacelike’ patterns o f increased AF are more 
prevalent in GA eyes compared to CNV eyes where smaller, more ‘focal’ increases are 
more commonly seen. The reason for this is unclear but may represent more scattered 
drusen and RPE pigment changes in GA eyes compared to CNV eyes. Solbach et al also 
described areas o f increased AF corresponding to drusen and RPE pigment in eyes with 
early AMD (Solbach, U. et al; 1997),but Lois et al were not able to attribute focal changes 
in AF to detectable soft drusen other than to large foveal soft drusen (Lois, N. et al; 2002). 
Different drusen groups are likely to have differing autofluorescence properties depending 
on their size and relative disruption to the RPE layer. The ‘reticular’ pattern o f increased 
AF seen in this study may represent a generalised disruption o f RPE metabolic activity as a 
result o f small scattered drusen rather than being related to the drusen themselves. 
Furthermore, melanolipofuscin is likely to account for the high levels o f autofluorescence 
seen in the ‘lacelike’ pattern at the level o f the RPE (von Ruckmann, A. et al; 1997a).
Fellow Eye
When assessing the fellow eyes o f  the various phenotypes, all the GA fellow eyes had 
evidence o f abnormally increased AF (particularly focal increases) and all but one eye had 
abnormal areas o f decreased AF (2 eyes could not be graded due to poor quality). In 
contrast to this, 26% o f the CNV fellow eyes did not show any abnormal increased AF and 
the same number had no abnormal area o f decreased AF. This finding supports the theory 
proposed by Holz that areas o f increased AF represent regions o f enhanced susceptibility to
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further photoreceptor loss and atrophy (Holz, F. G. et al; 1999a). Since GA has been shown 
to be symmetrical and bilateral in a number o f cases (Bellmann, C. et al; 2002)(see ch 
2.4.2), it can be argued that these ‘focal’ areas o f increased AF in the fellow eye (also seen 
in 50% o f PED fellow eyes) are likely to increase the risk o f geographic atrophy and visual 
loss. The fellow eye o f those with CNV showed an increased prevalence o f ‘reticular’ 
change compared to the GA fellow eyes but a similar proportion o f comparison eyes also 
demonstrated this change which implies lower risk o f visual loss.
In another comparative study o f autofluorescence images o f patients with nonexudative 
AMD and fellow eyes o f exudative AMD with and without retinal vascular contribution, it 
was shown that AF was increased in the latter groups predominantly due to increased 
hyperpigmentation. These differing results could be attributed to a different excitation and 
barrier filter wavelength to that used in our study causing excitation o f different 
fluorophores in the RPE (Spaide, R. F.; 2003).
The background pattern o f  AF appeared to be homogeneous across all phenotype groups 
including the comparison group and is therefore less informative to differentiate between 
types o f AMD.
In summary, AF changes appear to be characteristic for GA and CNV and areas o f atrophy 
may be more readily detected in those eyes with only drusen according to the colour 
images. Additionally, it is proposed that eyes with areas o f ‘focal’ increases in AF may be 
at increased risk o f GA or PED compared to those eyes with more o f a ‘reticular’ AF 
pattern which occurs in CNV fellow eyes as well as healthy comparison group eyes.
5.5 Location o f the Fovea
From this study, the position o f  the human fovea in relation to the optic disc was located at 
an average horizontal distance o f  2.76 +/- 0.33 DD or 16.07 +/- 1.25 degrees and average 
vertical distance o f 0.31 +/- 0.21 DD or 1.83 +/- 1.19 degrees below the disc.
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This compared favourably with studies by Kabanarou using psychophysical mapping 
techniques (Kabanarou, S. A et al; 2003) and with that o f Barr and colleagues (Barr, D. B. 
et al; 1999) using projected colour fundus photographs. The former quoted horizontal 
measurements o f  between 15.9° +/- 1.52 (SD) and 16.6° +/- 0.8 and the latter obtained a 
result o f 2.8 DD+/- 0.39. Vertical measurements were also similar to that obtained in the 
current study (range 1.54° +/- 0.8 to 1.98° +/- 0.7 inferior to fixation.) (Barr, D. B. et al;
1999)'(Kabanarou, S. A et al; 2003).
The standard deviation for the horizontal and vertical distances in degrees was smaller 
when compared to that o f disc diameters (8% v l2%  and 65% v 68%) implying that the 
former measurement is the more accurate and should be used when the angle subtended by 
the image is known.
On the whole, mean differences between the 35 and 50 degree images were not statistically 
significant, although the mean horizontal distance calculated in degrees from the 50 degree 
images was significantly higher implying that the 35 degree images are more accurate.
The statistically significant difference in the measurements between right and left eyes in 
those patients with bilateral data (especially those in degrees and vertical measurements) 
was unexpected. The calculated oblique measurement (O) from the fovea to the centre o f 
the disc however, showed that there was no significant difference between disc-diameter 
measurements and although the degree measurements were significantly different, they 
were not clinically significant. This suggests that a torsion effect may explain some o f this 
discrepancy. Why, on average, the left eye should show greater extorsion than the right 
during the taking o f these images remains unexplained.
Limitations o f this study include lack o f data on the refractive error of patients. In a study 
by Barr et al (Barr, D. B. et al; 1999) however, looking at the effect of refractive error on 
disc to macula measurements, there was a trend towards a greater Disc-Macula to Disc- 
Diameter ratio in myopia and a lower ratio in hypermetropia, but none of the inter-group 
correlations achieved statistical significance.
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The study concluded that the fovea is located 1.83 +/- 1.19 degrees (or 0.31+/- 0.21 DD) 
inferior and 16.07 +/- 1.25 degrees (2.76 +/- 0.33 DD) temporal to the centre o f the disc. 
Where possible degree rather than disc diameter measurements should be used and 35 
degree colour fundus images are preferable to 50 degree colour images. Any differences 
between eyes may be attributed to an unexplained torsional component.
These data were then used to locate the fovea in subsequent studies particularly when this 
was difficult to assess due to the extent o f  disease.
5.6 W here is the macula most susceptible and how does GA 
progress?
The evolution o f geographic atrophy has previously been described as starting with focal 
areas o f RPE atrophy in a parafoveal location which subsequently spread to produce a 
horse-shoe-shaped and then circular lesion (Sarks, J. P. et al; 1988),(Maguire, P. et al;
1986) but no specific region within the parafoveal area has been identified as being more 
susceptible to the atrophic process.
Explanations for preferential involvement o f the macula region in AMD include lipofuscin 
accumulation (Dorey, C. K. et al; 1989), increased retinal illumination (Katz, M. L. et al; 
1982), and differences in metabolic rate between the fovea and more peripherally (Gass, J. 
D.; 1967).
This part o f the study demonstrated that when the entire cohort o f patients with GA were 
analysed, there was an increasing predilection for the atrophic process towards the fovea. 
Within the central region, the most susceptible areas were within 2° o f the centre o f the 
fovea.
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When the 26 eyes with longitudinal data were examined separately, a different pattern 
emerged. Here the contour map showed displacement o f increased susceptibility towards 
the temporal and infero-temporal region in relation to the fovea in both right and left eyes.
When analysing the progression o f atrophy in these patients, it appeared that the most 
frequent pattern seen was in a circumferential direction. This is consistent with the 
development o f a horse-shoe pattern in GA as described by Sarks (Sarks, J. P. et al; 1988).
These results suggest a greater propensity for the temporal and infero-temporal macula to 
the atrophic process at the earlier stages o f disease followed by a circumferential spread to 
involve the parafoveal macula regions. Macular susceptibility then appears to reduce 
equally in all directions away from the fovea towards the vascular arcades.
The central foveal zone with horizontal diameter o f between 1.25° and 2.75° (Curcio, C. A. 
et al; 1990),(Curcio, C. A.; 2001) is described as being relatively rod free with a rod 
dominated parafovea. This distribution o f photoreceptors may therefore play a role in 
susceptibility o f the macula. The preferential vulnerability o f the rod system in ageing and 
ARM has been shown by various studies including work described in the latter part o f this 
thesis involving fine matrix mapping carried out predominantly by Hendrik Scholl and 
colleagues (Scholl, H. P. et al; 2004a).
In histological studies o f the maculae o f older adults with no visible dmsen or pigmentary 
change, the number o f cones in the macula has been shown to remain stable until the ninth 
decade (Curcio, C. A. et al; 1993) with the number o f rods reducing by 30% especially at 
the parafovea. Another study o f early and late ARM eyes, demonstrated preferential loss of 
rods in 3 out o f 4 eyes (Curcio, C. A. et al; 2000).
This selective vulnerability o f rods may be explained simply by the relatively large number 
o f rods in the peripheral macula. In the young adult, rods outnumber cones in the macula by 
9:1 (Curcio, C. A. et al; 2000). Another explanation may result from the ability o f the cone
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system to utilise an alternate visual cycle to regenerate opsin photopigments involving 
Muller cells (Mata, N. L. et a l; 2002) rather than relying on recycled products of 
phagosomal degradation from the RPE. The increased cone density in the nasal retina (40- 
45% higher) compared to temporal retina may also play a role in the relative protection of 
this region (Curcio, C. A. et al\ 1990).
The subset o f patients with longitudinal data showed an increased susceptibility o f the 
temporal and infero-temporal areas o f the macula. An explanation for this increased 
susceptibility could be related to the increased photoreceptor to RPE cell ratio in this 
region compared to more nasal regions, the difference being more significant in those over 
the age o f 50 (Dorey, C. K. et al; 1989). This would result in a higher phagocytic and 
metabolic load to the RPE cell, causing preferential accumulation o f lipofuscin, a toxic by­
product o f outer segment renewal, which may ultimately lead to photoreceptor death 
(Dorey, C. K. et al; 1989), (Holz, F. G. et al; 1999b), (Schutt, F. et al; 2000), (Okubo, A. et 
al; 2000). Evidence to support this comes from spatial distribution studies o f lipofuscin 
using spectrophotometry and autofluorescence imaging. Delori has shown higher rates of 
accumulation o f lipofuscin temporally compared to at the fovea with maximum 
fluorescence occurring at 7° eccentricity (Delori, F. C. et al; 2001).
Light exposure has previously been put forward as a possible aetiological factor. It would 
be expected that the retina exposed to the most light would be in the inferonasal region. 
However studies by Kooijman and Pflibsen and colleagues, revealed no evidence of 
increased illumination at the posterior pole, but rather a homogeneous retinal light 
distribution regardless o f pupil size (Kooijman, A. C.; 1983; Pflibsen, K. P. et al; 1988).
A potential source o f bias in this study comes from patient ascertainment. It is more likely 
that patients with foveal atrophy rather than extrafoveal atrophy would be referred to 
hospital clinics. In spite o f this, the study population contained patients with a spectrum of 
atrophic changes with a significant proportion with no significant visual impairment and 
areas o f non-foveal atrophy.
Page 194
Detailed Clinical Phenotyping o f the Ageing Retinal M acula
Sam antha S. Dandekar
Refractive error could not be corrected in our patients due to lack o f data, but those with 
significant refractive error (> +/-6D) would have been excluded from the original study. 
Additionally, rotational misalignment between images o f those patients with longitudinal 
data in this study may have affected the results, but every effort was made to match up 
subsequent images as accurately as possible using markers on vessel bifurcations.
In summary, the results show that the area most susceptible to early GA lies at a temporal 
and infero-temporal location in relation to the fovea, progressing most commonly in a 
circumferential direction. The risk o f atrophy also reduces outwards towards the vascular 
arcades. The process appears to occur in a predominantly rod rich area and the increased 
susceptibility o f the temporal region may be related to the increased density and turnover o f 
rod outer segments suggested by an increase in photoreceptor to RPE ratio and lipofuscin 
accumulation rather than light exposure.
5.7 W hat does AF imaging tell us about the RPE in CNV  
development?
This part o f the study demonstrated and characterised the inherent retinal autofluorescence 
o f eyes with CNV or PED and showed that the RPE appeared to remain viable at least 
initially. It has been assumed that a continuous area o f autofluorescence represents 
surviving RPE and there is good evidence to support this assumption (Holz, F. G. et al; 
1999a).
O f interest is that those eyes in groups 1 & 2 often had preservation o f RPE 
autofluorescence, in comparison to those eyes in group 3 (those with earlier visual loss) 
where patches o f decreased AF were seen. These results may indicate preservation o f RPE 
viability in the initial lesion and in some cases for a long period, which would have 
implications for treatment interventions and long term visual prognosis.
Page 195
Detailed Clinical Phenotyping of the Ageing Retinal M acula
Sam antha S. Dandekar
The fact that the median visual acuity in group 1 was better than group 3 suggests that 
visual outcome may be determined by maintenance of RPE function and these conclusions 
are supported by the good visual acuity in those with intact autofluorescence at the fovea. 
Unfortunately the time frame to RPE dysfunction and cell death is not known, but is likely 
to occur in the first few weeks or months following onset o f leakage from new vessel 
complexes as shown by the results o f this study.
Evidence that the RPE may determine the behaviour o f the CNV comes from work by 
Uyama (Yamagishi, K. et a l,; 1988) where sodium iodate (NaI03) was used to damage RPE 
cells in primates while inducing CNV with photocoagulation. Viable RPE was required to 
induce new vessel growth and later in the course o f disease, it suppressed the neovascular 
process. It was thought that the RPE produced diffusible factors that then influenced the 
integrity and permeability o f the choroid (Blaauwgeers, H. G. et al; 1999). Experiments in 
rodents have demonstrated that over expression o f Vascular Endothelial Growth Factor 
(VEGF) in the RPE can induce intra-choroidal neovascularisation (Schwesinger, C . et al; 
2001) and high concentrations o f VEGF and VEGF receptors have been detected in 
choroidal neovascular membranes and in the RPE (Kliffen, M. et al; 1997; Kvanta, A. et al; 
1996; Wada, M. et al; 1999). The fact that RPE can be seen to be present in the early 
stages o f CNV development and overlies the area o f maximum leakage, supports this 
hypothesis. Subsequently there may be upregulation o f pigment epithelial derived growth 
factor (PEDF) expression (Ohno-Matsui, K. et al; 2003), which is believed to be 
antiangiogenic, and may cause the lesion to form an inactive scar.
The extent o f the main abnormal areas as measured on AF imaging in group 1 was larger 
than that on FFA in 18/20 cases. Although the difference was small it was statistically 
significant and has been interpreted as implying that the RPE abnormality is more extensive 
than the main area o f FFA hyperfluorescence. AF imaging may therefore more accurately 
delineate areas o f choroidal neovascularisation. In support o f this, a histological study 
(Bynoe, L. A. et al; 1994)of sub foveal neovascular membranes from six patients (4 with 
AMD), showed that the excised CNV complexes were significantly larger than expected 
from fluorescein angiogram. Moreover, they demonstrated that the distribution o f blood
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vessels was irregular and large areas o f the complex periphery were avascular and hence 
would not show up on fluorescein angiography. If  this interpretation is correct it has 
implications for recurrence o f CNV following laser treatment based on the fluorescein 
findings, and supports the need to include a surrounding area o f apparently normal retina in 
any treatment.
Classic & occult lesions
In 13/20 eyes from group 1 and 4/8 from group 2, areas o f increased AF were seen adjacent 
to areas o f FFA hyperfluorescence. These areas did appear to be more prevalent in those 
eyes with a classic component on fluorescein angiography. This observation may be 
explained by the fact that increased autofluorescence may be due to phagocytosis o f 
laterally diffused debris derived from the new vessel complex that would be greater in those 
with classic new vessels, and would not necessarily only define the area o f leakage.
The differences in the anatomical site o f neovascular complexes in eyes with classic and 
occult CNV was investigated in a clinicopathological study o f 28 eyes by Lafaut and 
colleagues (Lafaut, B. A. et al; 2000). They showed that 18/19 classic complexes had a 
predominantly sub-retinal fibrovascular component as opposed to occult lesions (n=T0) that 
all contained a sub RPE fibrovascular component. It is hypothesised that classic membranes 
start in the sub RPE space and then grow through the plane o f the RPE to proliferate in the 
subretinal space (Green, W. R. et al; 1993). If  this were the case we would expect to see 
more abnormalities on the AF images o f classic membranes than on those o f occult 
membranes.
Areas o f  decreased AF
In all three groups, areas o f decreased AF imaging corresponded to areas o f atrophy, 
subretinal blood or intra-retinal exudate. In 3 eyes an increase in AF was seen adjacent to
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areas o f RPE atrophy. This phenomenon is known to occur in primary GA in eyes with 
AMD (Holz, F. G. et al; 1999a) and represents areas o f RPE with abnormal function and 
vulnerability to subsequent atrophic change.
Pigment epithelial detachments
Also o f interest is the normal autofluorescence intensity from RPE overlying avascular 
pigment-epithelial detachments. This would be in accord with the view that these lesions 
occur due to changes in the structure o f  the underlying Bruch’s membrane and that the 
anatomy and function o f the overlying RPE would remain relatively undisturbed (Bird, A. 
C.; 1991; Pauleikhoff, D. et al; 1990c). In one o f these cases, a rim o f decreased 
autofluorescence on AF imaging surrounded the pigment epithelial lesion and corresponded 
to an area o f subretinal fluid noticed on biomicroscopic examination (see figure 18 e& f 
[page 160]).
Autofluorescent imaging, unlike other forms o f  retinal examination, exclusively examines 
the retinal pigment epithelial layer, and in this study provides further information on 
integrity o f this layer in excess o f that provided by fluorescein angiography alone. It also 
gives support to the theory that the RPE is important in modifying the behaviour o f CNV. 
Further longitudinal studies, using AF imaging, o f eyes presenting with CNV may allow us 
to document the extent o f RPE viability during the evolution of these lesions and also the 
changes consequent upon treatments such as photodynamic therapy. Additionally, the 
presence o f some residual AF in long standing lesions implies preserved integrity o f the 
RPE and photoreceptor cells and may suggest that vision could be rescued in such cases, 
and questions the disappointing results o f treatment to-date.
5.8 How does smoking influence the lesion occurring in late 
AMD?
This study demonstrates no bias in the distribution o f CNV and geographic atrophy 
amongst smokers and non-smokers even when pack years (which represents a measure o f
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lifetime exposure to smoking) were considered, despite high numbers o f patients with 
AMD. Additionally age and gender did not appear to show any association with the type o f 
lesion occurring in patients with AMD.
The lack o f association between smoking status and type o f AMD lesion confirms the 
absence o f a consensus o f opinion in the literature. (Klein, R. et al; 1993; Vinding, T. et al; 
1992; Vingerling, J. R. et al; 1995a) (Seddon, J. M. et al; 1996). Additionally, the power o f 
the study should have been sufficient to detect a clinically significant difference if  one 
existed.
The demographic data o f our cohort o f AMD patients showed that 72% males and 54% of 
females had smoked at some stage in their lives. Our figure is similar to the findings o f 
other studies for males but much higher for females (i.e. the Blue Mountain study where 
68% of the males and 39% o f the females had smoked (Smith, W. et al; 1996) and the 
POLA study where 74% males and 15% o f females had smoked at some point (Delcourt, C. 
et al; 1998). This difference may represent smoking trends in the UK compared to Europe 
and Australia.
Smoking has been proposed to promote the development and progression o f subretinal new 
vessels (Klein, R. et al; 1993) and promote atherosclerotic and hypoxic damage to the 
choroidal vasculature (Vingerling, J. R. et al; 1995a),(Paetkau, M. E. et al; 1978). This 
would suggest a greater association with CNV compared to GA but it could be argued that 
choroidal damage could affect the viability o f the RPE and Bruch’s membrane, causing 
atrophy to occur. This study however, showed no evidence to suggest that smoking 
predisposes to subretinal neovsacularisation over geographic atrophy or vice versa.
Other confounding factors such as history o f coronary artery disease, hypertension, lipid or 
cholesterol levels cannot be ignored as they could have affected the chances o f finding an 
effect, but these factors have not been found to be important in late AMD in other studies 
(Klein, R. et al; 1993) .
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In conclusion, smoking is known to be a significant risk factor for AMD but at present 
there is no evidence to suggest that there is a difference in the type o f AMD occurring in 
smokers compared to non smokers.
5.9 W hat do areas of increased AF tell us about 
photoreceptor function?
Areas o f increased AF in the ARM & AMD patients studied showed moderate to severe 
scotopic sensitivity loss with consistently less reduced photopic sensitivity; either being 
normal or showing a minor decrease. Thus, in all cases in whom scotopic and photopic 
FMM was available (n=6) rod sensitivity loss exceeded cone sensitivity loss. This suggests 
that areas o f increased AF can be correlated with photoreceptor function and there is 
preferential dysfunction o f the rod system. This substantiates the findings from the work 
on macular susceptibility discussed earlier.
Although evidence exists as to the origin o f  fundal AF (Delori, F. C. et al; 1995a), the 
functional significance o f focal lipofuscin accumulation within the RPE is still unresolved. 
Holz et al. have shown that areas o f increased AF precedes the development and 
enlargement o f GA (Holz, F. G. et al; 2001). Further observations by Dorey et al have 
demonstrated that the number o f  photoreceptor cells is reduced in the presence o f increased 
lipofuscin content in the RPE thus preceding cell loss (Dorey, C. K. et al; 1989).
The results o f this study are particularly interesting as it appears that scotopic sensitivity 
loss exceeds photopic sensitivity loss in all types o f ARM and AMD including CNV, GA, 
and drusen. It is however, not clear if  the primary event occurs in the RPE and then 
subsequently affects photoreceptor function or if  the initial event is in the photoreceptors 
with the RPE being affected later. Longitudinal studies o f both AF and rod and cone 
photoreceptor function are required to answer this question.
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In the seven patients studied, it was observed that the distribution of drusen and AF was 
poorly correlated and that photoreceptor dysfunction deficits followed the distribution of 
both increased and decreased AF rather than the distribution o f drusen. In previous 
psychophysical studies including both scotopic and photopic sensitivity testing, no 
correlation between drusen and photoreceptor dysfunction was found (Owsley, C. et al; 
2000; Sunness, J. S. et al, 1988).(Sunness, J. S. et al; 1985; Sunness, J. S. et al; 1988) The 
sensitivity loss therefore seems to reflect a more diffuse disease o f the retina and retinal 
pigment epithelium and is not a direct effect o f drusen. It can be concluded that drusen and 
AF have different functional implications. This supports the hypothesis that they represent 
two independent measures o f ageing in the retina (Lois, N. et al; 2002).
The one exception to this was the large soft foveal druse in patient #5 which appeared to 
correspond to areas o f increased AF as observed previously (Lois, N. et al; 2002). 
Moreover, the area covered by the large soft druse showed mildly reduced photopic and 
considerably reduced scotopic sensitivity. One explanation for this is that large foveal 
drusen often represent small RPE detachments and therefore it is not surprising that 
scotopic sensitivity is affected. Furthermore, these drusen may be somewhat different to 
soft drusen elsewhere (Lois, N. et al; 2002).
These data are in accord with recent functional studies that showed that the rod system is 
preferentially affected in ageing and ARM. In a recent psychophysical study it was found 
that in early ARM there can be prominent dark-adapted dysfunction (Owsley, C. et al;
2000). The mean scotopic sensitivity at the posterior pole was significantly lower in early 
ARM patients compared to age-matched controls. (Owsley, C. et al; 2000).
The preferential vulnerability o f the rod system in ageing has been discussed in the 
previous section (see section 4.7) and appears to be substantiated by these results.
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A hypothesis to explain the sensitivity loss in rods proposes that diffuse deposits of 
abnormal material derived from the RPE, deposited into the inner portion o f Bruch’s 
membrane might account for both choroidal perfusion abnormality and functional loss by 
acting as a diffusion barrier against exchange between the choriocapillaris and the RPE 
(Chen, J. C. et al; 1992). In those patients with ARM and manifest choroidal perfusion 
abnormality, scotopic FMM has shown discrete areas of scotopic sensitivity loss compared 
with age-matched controls (Chen, J. C. et al; 1992).
Vitamin A deprivation in the visual cycle is known to lead to outer segment degeneration 
and photoreceptor death in vivo (Katz, M. L. et al; 1991; Katz, M. L. et al; 1993).(Katz, M. 
L. et al; 1993) In ARM, a lack o f  vitamin A may occur due to changes in the diffusion 
characteristics o f B ruch’s membrane or an inability to recycle products o f phagosomal 
degradation in the RPE (Okubo, A. et al; 2000). It is also known that vitamin A deficiency 
affects primarily rods but eventually impacts on cones as well (Carter-Dawson, L. et al; 
1979; Kemp, C. M. et al; 1988; Kemp, C. M. et al; 1989). Relative retinoid deficiency at 
the level o f the RPE and Bruch’s membrane would therefore explain our observation that 
there is topographic correspondence o f ARM-related photoreceptor dysfunction and RPE 
dysfunction reflected by increased AF. Moreover, there is recent evidence from Mata and 
co-workers o f an alternate visual cycle that allows pigment regeneration in cones. This 
alternate cycle is independent from the RPE and may involve Muller cells (Mata, N. L. et 
al; 2002). This implies that visual-pigment regeneration in cones is not exclusively 
dependent on RPE function in contrast to the rod system. Therefore it is proposed that 
retinoid deficiency due to RPE dysfunction, as reflected by abnormal AF, would explain 
the higher susceptibility o f the rod system relative to the cone system observed in this 
study.
These findings may have implications for future intervention to maximize cone survival in 
ARM. Rod photoreceptors serve as an early indicator o f impending cone dysfunction and 
are known to contribute a diffusible substance essential to preserve cone survival (Fintz, A.
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C. et al; 2003; Hicks, D. et al; 1999). In this study, since cone photoreceptor function was 
either normal or only mildly reduced, fine matrix mapping may serve to indicate an 
appropriate disease stage for early intervention to preserve the cone system.
6 Conclusions
This thesis provides a descriptive study o f 879 patients with ARM and AMD and 44 
spouses with normal maculae, acting as a comparison group. Fundal features have been 
characterised from colour photographs, auto fluorescence imaging and fluorescein 
angiography (where indicated) to allow a more detailed phenotyping o f study subjects than 
has previously been described.
Furthermore, a revised grading system for use with digital colour fundus photography has 
been introduced and been shown to be reliable for use in future studies. A pilot grading 
system for autofluorescence images has also been introduced.
During the collection o f these phenotypic data, other important contributions have been 
made in terms o f understanding underlying disease mechanisms:
(A) The demonstration o f greater discordance between eyes in those with bilateral AMD 
than has been previously documented for eyes with drusen (ARM) suggests that late AMD 
may be less informative than early signs o f drusen for studies designed to discover 
susceptibility genes and environmental risk factors. Other locally acting factors may 
therefore be influencing the final phenotype in each eye.
(B) Drusen characteristics and AF changes in the fellow eye may predict the cause o f visual 
loss in the first eye, especially in GA. These may also indicate the nature o f the 
pathogenetic mechanisms involved.
(C) Particular areas o f the macula may be more susceptible to damage in GA and may be 
related to the distribution o f rod photoreceptors. The additional demonstration o f a loss of 
scotopic rather than photopic sensitivity in areas o f increased autofluorescence in ARM and 
AMD confirms a preferential vulnerability o f the rod system in ageing.
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(D) The preservation o f the integrity o f the RPE shown during the early stages o f CNV 
development, from autofluorescence images, may have important implications for 
treatment o f AMD.
(E) Lastly, although smoking is a known environmental risk factor for AMD, as yet we 
have no evidence to suggest that it is more likely to cause a CNV lesion compared to GA in 
the late stages o f disease.
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7 Future W ork
In view o f the lack o f a suitable animal model for AMD, different approaches are required 
to increase our understanding o f the disease process. To date, it is felt that genetics may 
play an important role in susceptibility to AMD, especially with the finding o f the CFH 
(complement factor H) polymorphism. So far, approaches to search for genes that confer 
risk for ARM and AMD have yielded limited results, most likely due to the complex nature 
o f the disease and the fact that it comprises a group o f very different phenotypes.
As part o f this study, in addition to the clinical data, DNA samples have been collected 
from all 879 patients resulting in a large panel o f DNA from subjects where the phenotype 
has been well characterised. This will allow the segregation o f patients according to 
phenotype to produce purer samples o f disease such that genetic investigation is likely to be 
more successful. This cohort will therefore serve as an invaluable resource for future 
association studies and phenotype- genotype correlations, pushing us towards identifying 
the important environmental and genetic aetiological factors for AMD. Defining the genetic 
influences would point to the relevant pathogenic mechanisms involved and help identify 
those at high risk o f visual loss. U ltimately to try to reduce the burden o f blindness 
produced by this progressive disease.
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11 Appendices
11.1 Appendix 1
Coding Manuals
• Colour fundus photograph grading
• Fluorescein angiography image grading
• Autofluorescence image grading (Eye with visual loss)
•  Autofluorescence image grading (Fellow eye)
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A P P E N D I X  1: C O D I N G  M A N U A L  F O R  A M D  STUDY: C O L O U R  P H O T O G R A P H S
1. Photo quality 2. Drusen size ANSW ER FOR
DRUSEN SIZE
ZO N E 1-3 ZONE 1 ONLY
G ra d e  separate ly  fo r each 
size D rusen
---------------------------- Size N um ber C rysta lline  Drusen S ero g ra n u la r D rusen
0. Absent 0. Absent 0. Absent 0. Absent
1. Perfect image 
(Perfect stereo)
1. Questionable 1. Questionable 1. Questionable 1. Questionable
2, Reasonable image 
Reasonable stereo
2. < 63pm  
(Hard drusen)
2. 1-9 2. 1-9 2. Present
3. Acceptable image 
(Acceptable stereo)
3. 63pm  - 125pm intermediate, 
soft drusen
3. 10-19 3 .> 1 0
4. Poor, but main 
features still gradable 
(Poor stereo)
125- 250 pm
41 large semisolid distinct
42 large semisolid 
subconfluent
43 large semisolid confluent________
250-500 pm
51 large semisolid distinct
52 large semisolid 
subconfluent
53 large semisolid confluent
4. 20-50
5. Very poor image, 
no grading possible
(No stereo)
6. Not centred, but 
grading o f at least 
one zone possible
5. -50
>500 pm
61 large semisolid distinct
62 large semisolid 
subconfluent
63 large semisolid confluent
7. Cannot grade- obscuring 
lesions
8. Cannot grade- photo quality
7. Cannot grade - obscuring 
lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade - obscuring 
lesions
8. Cannot grade - photo 
quality
8. Cannot grade - 
photo 
quality
8. Cannot grade - photo quality
0 Missing 9. Missing 9. Missing 9. Missing 9. Missing
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3. Hyper­
pigmentation
4.Hypopigmentation Zone 1-3 
TOTAL area 
covered by Drusen
5. Geographic 
Atrophy
6. Neovascular AMD
Presence Type Presence 5.1 presence: Zone 1, 2 
and 3
5.3 TOTAL area covered 6.1 presence
O.absent O.Absent 0. Absent 0. Absent O.Absent O.Absent O.Absent
1. Questionable 1 .Questionable 1 .questionable 1. Questionable 1. Questionable 1. < 250 pm 1. Questionable
Present 
2. <63 pm
2. linear 2. <63pm 2. <10% 2. Present 2.250pm- 500pm 2. Present
3. >63 pm 3.punctate 3. > 63pm 3. <25% 3.GA due to CNV 3. 500pm - 1000 pm
4. Mixed 4. <50% 4. 1000-3000pm
5. Peripapillary 5. >50% 5. 3000-6000pm
6. Artefact 6. > 6000pm
7. Cannot grade 
-  obscuring lesions
7. Cannot grade
obscuring
lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
Obscuring lesions
7. Cannot grade -  
obscuring 
Lesions
7.cannot grade -  
Obscuring lesions
8. Cannot grade -  photo 
quality
8. Cannot grade 
photo quality
8. Cannot grade -  
photo quality
8. Cannot grade -  
photo quality
8. Cannot grade -  photo 
quality
8. Cannot grade -  photo 
Quality
8. Cannot grade -  photo 
quality
9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing
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6.2 Features 6.3 Scar/fibrous 6.4 Retinal haemorrhage 6.5 TOTAL area of 
Neovascular lesion
7.0 Predominant Phenotype
O.absent O.absent 0. Absent O.absent 0. Normal
1. Questionable 1. Questionable 1. Questionable 1. < 250 pm 1. Hard drusen only
2. Hard exudates 2. Subretinal 2. Subretinal 2. 250-500 2. Soft drusen
3. Serous neuroretinal 
detachment
3. Preretinal 3. In plane of retina 3. 500- 1000pm 3.GA
4. Serous RPE detachment 4. Neovascular membrane 4. Sub-hyaloid 4. 1000pm - 3000pm 4. Pigment Epithelial Detachment
5. Haemorrhagic RPE 
detachment
5. Intravitreal 5. 3000pm - 6000pm 5.CNV
6. > 6000pm 6. Other
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
8. Cannot grade -  photo quality 8. Cannot grade -  photo quality 8. Cannot grade -  photo quality 8. Cannot grade -  photo quality 8. Cannot grade -  photo quality
9. Missing 9. Missing 9. Missing 9. Missing 9. Missing
Coding manual is based on Survey of Ophthalmology, 39(5): 367-374
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CODING MANUAL FOR AMD STUDY: FLUORESCEIN ANGIOGRAPHY
Grade EARLY and LATE phases
1. Photo quality 6. Neovascular 
AMD (Grade 
proof sheet/late 
photo)
Grade proof sheet/late 
photo
Grade proof sheet Grade late photo
Presence Features Classification of CNV Total area of neovascular lesion
1. Perfect image O.absent O.absent O.absent O.absent
2. Reasonable 
image
1. Questionable 1. Questionable 1. Questionable 1. <250 pm
3. Acceptable image 2. Present 2. Hard exudates 2. 100% classic 2. 250-500
4. Poor, but main 
features still 
gradable
3. Serous neuroretinal 
detachment
3. 50-99% classic 3.500- 1000pm
5. Very poor image, 
no
grading possible
4. Serous RPE detachment 4. 1-50% classic 4. 1000pm - 3000pm
6. not centred, but 
grading of at least 
one 
zone possible
5. Haemorrhagic RPE 
detachment
5. 100% occult 5. 3000pm - 6000pm
6. RPE tear 6. > 6000pm
7. Cannot 
grade -  obscuring 
lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  
obscuring lesions
7. Cannot grade -  obscuring 
lesions
9. Missing 8. Cannot grade -  
photo quality
8. Cannot grade -  photo 
quality
8. Cannot grade -  photo 
quality
8. Cannot grade -  photo quality
9. Missing 9. Missing 9. Missing 9. Missing
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CODING MANUAL FOR AMD STUDY: AUTOFLUORESCENCE (SLO) IMAGES (grade whole photo)
1. Photo quality 2. Predom inant 
Phenotype
3. Main area o f altered
Auto-fluorescence
(Decreased)
4. Main area of 
decreased Auto- 
Fluorescence 
(Total area)
5.Corresponding 
decreased 
Autofluorescence 
(colour)
6. Fovea 
involved in 
lesion
7. Increased Auto­
fluorescence
8. Corresponding 
increase Auto­
fluorescence 
(colour)
9. Background 
fluorescence
0. Normal 0. Absent 0. Absent 0. Absent 0. Absent 0. Absent 0. Absent: no corr 0. Homogeneous
1. Perfect image 1. Hard drusen only 1. Questionable 1. < 250 pm 1. Geographic Atrophy 1. Questionable 1. Questionable Corresponds with
11. Scattered Drusen
12. Parafoveal drusen
1. Questionable
2. Reasonable 
image
2. Soft drusen 2.
Unifocal 
Homogeneous 
Decreased AF
2. 250-500 pm 2. Neovascular lesion 2. Yes 21: reticular pattern 2. Corresponds with 
pigmentary RPE 
changes
2. Diffusely irregular
3. Acceptable 
image
3.G A 3.
Multifocal 
Homogeneous 
Decreased AF
3. 5 0 0 -  1000 pm 3. Soft drusen 22::focal 3. Edge of lesion 3. Focal increases
4. Poor, but main 
features still 
gradable
4. Pigment 
Epithelial 
Detachment
4. Normal decreased AF 
at fovea
41. homogeneous 
42 heterogeneous
4. 1000- 3000pm 4. blood 23: lacelike pattern 4. Scar / Fibrous
5. Very poor image, 
no grading possible
5.CNV 5.
Unifocal
Heterogeneous AF
5. 3000- 6000pm 5. exudates 32: partial band (<50%) 
33: band (>50%)
5. Detached retina (SRF)
6. Not centred, but 
grading of at least 
one zone possible
6. Other 6.
Multifocal 
Heterogeneous AF
6. >6000 pm 6.edge 34: mixed 6. Exudates
7. Cannot grade 
obscuring 
lesions
7. Obscuring lesion 7. Obscuring lesion 7. Obscuring lesion 7. Obscuring 
lesion
7. Obscuring lesion 7. Obscuring lesion 7. Obscuring lesion
8. Cannot grade -  
photo quality
8. Cannot grade- photo 
quality
8. Cannot grade- photo 
quality
8. Cannot grade- photo 
quality
8. Cannot 8. Cannot grade- 8. Cannot grade- photo 
quality
8. Cannot grade- photo 
quality
9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing
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CODING MANUAL FOR AMD STUDY: AUTOFLUORESCENCE FELLOW EYE (SLO) IMAGES (grade whole photo)
1. Photo quality 2. P redom inant 
Phenotype
3. Decreased Auto­
fluorescence
4. Decreased 
Auto-
Fluorescence 
(Total area)
5.Corresponding 
decreased 
Autofluorescence 
(colour)
6. Fovea 
involved in 
lesion
7. Increased Auto­
fluorescence
8. Corresponding 
increase Auto­
fluorescence 
(colour)
9. Background 
fluorescence
0. Normal 0. Absent 0. Absent 0. Absent 0. No 0. Absent 0. Absent: no corr 0. Homogeneous
1. Perfect image 1. Hard drusen only 1. Questionable 1. < 250 pm 1. Geographic Atrophy 1. Questionable 1. Questionable 1. Geographic Atrophy 1. Questionable
2. Reasonable 
image
2. Soft drusen 2.
Unifocal
Homogeneous
2. 250-500 pm 2. Neovascular lesion 2. Yes 2. focal increases only 2. Neovascular lesion 2. Diffusely irregular
3. Acceptable image 3. GA 3.
Multifocal
Homogeneous
3. 5 0 0 -  1000 pm 3. Soft drusen 3. reticular pattern 3. Soft Drusen
31. scattered drusen
32. parafoveal drusen
33. foveal drusen
3. Focal increases
4. Poor, but main 
features still 
gradable
4. Pigment Epithelial 
Detachment
4. Normal decreased AF 
at fovea
41. homogeneous 
42 heterogeneous
4. 1000- 3000pm 4. hard drusen 4. lacelike pattern 4. Hard Drusen
41. scattered drusen
42. parafoveal drusen
43. foveal drusen
5. Very poor image, 
no grading 
possible
5.CNV 5.
Unifocal
Heterogeneous
5. 3000- 6000pm 5. RPE pigment 
changes
51. reticular and focal
52. reticular and lacelike
53. lacelike and focal
54. speckled (mixed)
5. RPE pigment changes
6. Not centred, but 
grading of at least 
one zone possible
6. Other 6.
Multifocal
Heterogeneous
6. >6000 pm 6.blood 6. patchy increase (>200p- 
larger than focal increases
6. blood
7. Cannot grade 
obscuring 
lesions
7. Obscuring lesion 7. Obscuring lesion 7. other 7. Obscuring 
lesion
7. Obscuring lesion 7. other 7. Obscuring lesion
8. Cannot grade -  
photo quality
8. Cannot grade- photo 
quality
8. Cannot grade- photo 
quality
8. Cannot grade- 
photo quality
8. Cannot 8. Cannot grade- 8. Cannot grade- photo 
quality
8. Cannot grade- photo 
quality
9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing 9. Missing
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11.2 Appendix 2
Instructions for digital grading
1. Open selected colour image for grading in Adobe Photoshop (CD)
2. Adjust size o f image to 80% on right side o f screen and press return (Navigator). This is
to maximise the image on the screen.
3. Minimise or Close windows on right o f screen (colour, history and layers NOT 
Navigator)
4. Open file ‘transparent template’ for grading grid
5. Go to Select ‘all’
6. Then go to Edit ‘Copy’ (to copy the grid)
7. Go back to the colour image by clicking on it, maximise it and make sure it is sized 
correctly to fit the image size using the navigator
8. Centre image using scroll bars
9. Then Edit, ‘Paste’ grid onto photo
10. Go to Edit ‘free transform’
11. This allows you to move the grid over the underlying picture to centre it with the mouse
12. To increase the size o f the grid, go to the ‘link’ button on the top tool bar (looks like 
two interlocking chains) and select it
13. Then go to the width or height window next to it and either type in 160 or 170% or use 
the ‘up’ arrow to increase the size without distortion. It should be sized so that the 
distance between the centre o f the disc and the fovea is 3000pm (two disc diameters).
14. You can move the grid around to centre it again using the mouse
15. If  you want to remove the grid while grading, select the grid by double clicking it and 
go to Layer on the tool bar and ‘delete layer’. It will ask you if  you want to delete 
layer 1, say ‘yes’ to the prompt. Go to ‘undo’ to get the grid back or ctrl+Z.
16. Note: You cannot then resize the grid or move it without going to edit, ‘free 
transform’ again.
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17. You are now ready to start grading in each o f the three zones, the same way as 
conventional grading.
18. To open the next image go to file ‘close’, don’t apply transformation, don’t save 
changes to image and don’t close the grid and then open the next image
19. After re-sizing and maximising the colour image you should be able to just press 
‘paste’ to apply the grid and continue from no 12.
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11.3 Appendix 3
Letters o f Ethics Committee Approval
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Moorfields Eye Hospital
NHS Trust
Patron: Her Majesty The Queen
Chairman
Sir Thomas Boyd-Carpenter
Chief Executive
I .A.J Balmer
I I  July 2002
Professor Alan Bird MD FRCS FRCOphth 
Professor of Clinical Ophthalmology 
Moorfields Eye Hospital
Dear Professor Bird
City Road 
London 
EC1V2PD
Tel 020 7253 3411 
Minicom 020 7566 2279
D irect dial 020 7566 2455 
E m ail :frances.stobbs@ m oorfields.nhs.uk
BIRA1008
Genetic investigation of age-related macular disease
Professor A lan Bird, M r Andrew W ebster et al
The revised patient information sheet and consent form  under cover o f the letter from  Dr Dandekar and 
Ms Jenkins dated 10 June 2002 relating to establishing D N A  cell lines w as approved at the M oorfields 
Local Research Ethics Committee m eeting on 26 June 2002. You had declared your interest in the protocol 
and took no part in the approval process.
Yours sincerely
Frances Stobbs
Administrator, M oorfields Eye Hospital LREC
www.moorfieids.nhs.uk
MOORFIELDS EYE HOSPITAL
N.H.S. TRUST 
Patron: Her Majesty The Queen
CI T Y  R O A D  
LON D ON  
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Chairman
Leila Lessof
House Governor and Chief Executive
I. A. J. Balmer
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Email frances.stobbs@ m oorflelds.ntham es.nhs.uk
Professor Alan C Bird MD FRCS FRCOphth 
Professor o f  Clinical Ophthalmology 
Moorfields Eye Hospital
30 August 2000
Dear Professor Bird
Characterisation of the phenotype in age-related macular disease (AMD) in
patients with unilateral visual loss 
Project No 
I am writing to confirm that this project has approval by the Ethics Com m ittee at 
Moorfields.
Yours sincerely
Miss Linda Ficker 
Deputy Chairman 
Ethics Committee
Request for approval for change of protocol
Characterisation of phenotype in age-related AMD in patients with unilateral
visual loss
Characterisation o f phenotype in age related macular disease in patients
with unilateral visual loss 
 Genetic investigation of age-related macular disease
Project 498/BIRA 1003 was approved in May 1998. It covered 500 individuals and their 
relatives. It was to run from April 1998 for 3 years.
Project BIRA1008 was approved in October 2000. It is an extension o f Project 498. The 
time period has been extended for the study to run from October 2000 for 4 years. The 
number of subjects has extended to 3000 which necessitated an application to the MRC 
for funding. That funding has been awarded.
There is now a request for ethical approval for a protocol amendment to BIRA1008 to 
take blood not just from patients and their blood relatives but also from the patient's 
spouse. The numbers involved will be 2500 patients and 500 spouses. Professor Bird has 
drafted an explanation to the spouse and consent form.
This request for a protocol amendment is to be raised as Any Other Business at the 
Moorfields LREC meeting on Wednesday 25 April. The Committee will also consider 
the explanation to the spouse and consent form.
Frances Stobbs 
LREC Administrator 
24 April 2001
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